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A C TIO N S
Oxycodone is a semi-synthetic narcotic analgesic with actions qualitatively
similar to those of morphine, particularly involving the central nervous
system and organs composed of smooth muscle. The principal therapeutic
actions are analgesia and sedation. Oxycodone retains at least one half of
its analgesic activity when administered orally. In addition to caffeine.
Percocet and Percocet-Demi also contain the non-narcotic antipyretic anal
gesic acetaminophen, which exerts its effects in a manner similar to the
salicylates, but without the anti-inflammatory or uricosuric properties.
Acetaminophen is rapidly and almost completely absorbed in the gastro
intestinal tract: peak plasma levels are reached within ten minutes to
one hour.

IN D IC A TIO N S
Relief of moderate to moderately severe pain (Percocet), or relief of mild to
moderate pain (Percocet-Demi), with or without fever, especially in patients
who are allergic to acetylsalicylic acid or for whom acetylsalicylic acid is
contraindicated.
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C O N TR A IN D IC A TIO N S
Status asthmaticus, pre-existing respiratory depression or convulsive states,
hypersensitivity to oxycodone, acetaminophen, or caffeine.
Unlike acetylsalicylic acid, acetaminophen is not contraindicated in pa
tients with peptic ulcer or gout.

W A R N IN G S
Oxycodone can produce drug dependence of the morphine type and has the
potential for being abused. Psychic dependence, physical dependence and
tolerance may develop upon repeated administration, as with other oral nar
cotic medication. May impair the mental and/or physical abilities required
for the performance of potentially hazardous tasks, such as driving a car or
operating machinery. Patients should be cautioned accordingly. Additive
CNS depression may occur in patients receiving other narcotic analgesics,
general anesthetics, monoamine oxidase inhibitors, tricyclic antidepres
sants, phenothiazines or other tranquilizers, sedative-hypnotics or alcohol.
If combined therapy is contemplated, the dose of one or more of the agents
should be reduced. Safe use in pregnancy has not been established
relative to possible adverse effects on fetal development, therefore Per
cocet or Percocet-Demi should not be used in pregnant women unless, in
the judgment of the physician, the potential benefits outweigh the possible
hazards. The administration of Percocet or Percocet-Demi to obstetrical
patients in labor may be associated with respiratory depression of the new
born. Percocet should not be administered to infants or children, although
Percocet-Demi may be considered for children of six years or older.
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P R E C A U TIO N S
The respiratory depressant effects of narcotics and their capacity to elevate
cerebrospinal fluid pressure may be markedly exaggerated in the presence
of head injury, other intracranial lesions or a pre-existing elevated in
tracranial pressure. The diagnosis or clinical course in patients with head
injuries or with acute abdominal conditions may be obscured by narcotic
drugs. Give cautiously to elderly or debilitated patients due to the risk of
cardiac or respiratory depression, as well as to patients with hemorrhage,
severe impairment of hepatic, respiratory or renal function, hypothyroidism,
Addison's disease, prostatic hypertrophy or urethral stricture. Narcotic
analgesics should only be employed for the treatment of headaches when
no other treatment is effective, in order to minimize risk of psychological
and physical dependence.

AD VER SE REACTIO NS
Light-headedness, dizziness, sedation, nausea and vomiting may occur, as
well as euphoria, dysphoria, constipation and pruritus.

D R U G IN TER A C TIO N S
May be additive with other CNS depressants.

M A N A G EM EN T OF OVERDOSAGE

Peicocel

fits the pain and the patient
Only Percocet combines acetaminophen with the
effectiveness of oxycodone, to provide relief of moderate
to moderately severe pain.
A single dose of Percocet begins to act within 15—30
minutes, and may provide up to six hours of soothing relief.

£ndo Laboratories
7 0 0 0 Park Avenue,
Montreal, P.Q. H3N 1X1

PRECAUTION This product has
the potential for being abused.

Subsidiary of E.l. Dupont de Nemours Co. (Inc.)

<JUP0RT>

* Registered

Signs and symptoms: Respiratory depression, extreme somnolence progress
ing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and
sometimes bradycardia and hypotension. In severe cases, apnea, circulatory
collapse, cardiac arrest and death may occur. Acute acetaminophen intoxi
cation is characterized by anorexia, nausea, vomiting and sweating within
two or three hours of ingestion, and possibly cyanosis with methemo
globinemia; enlargement and tenderness of liver, accompanied by
abnormally high liver function tests, occur within 48 hours, followed by
jaundice, coagulation defects, myocardiopathy, encephalopathy, renal
failure and death due to hepatic necrosis. A dose of 10 g of acetaminophen
is intoxicating, possibly fatal in excess of 15 g. Hepatic toxicity occurs when
the plasma levels reach 300 p g /m l within four hours of ingestion.
Treatment: Re-establish adequate respiratory exchange. Naloxone, nalor
phine or levallorphan are specific antidotes against narcotic-induced
respiratory depression. An appropriate dose of antagonist should be ad
ministered preferably intravenously, and repeated as needed to maintain
adequate respiration; the patient should be kept under continued
surveillance. Instructions in the package insert provided by the manufac
turer should be carefully followed. Do not administer an antagonist in the
absence of clinically significant respiratory or cardiovascular depression.
Employ oxygen, intravenous fluids, vasopressors and other supportive
measures as indicated. Gastric emptying by emesis or lavage may be
helpful. Hemodialysis carried out within ten hours of ingestion may be of
some value. Plasma levels of acetaminophen should be determined.

DOSAGE A N D A D M IN IS TR A TIO N

Percocet Tablets: Usual adult dose is one tablet every six hours, as needed
for pain.
Percocet-Demi Tablets: Usual adult dose is one or two tablets every six
hours. Children twelve years and older: half a tablet every six hours.
Children six to twelve years: a quarter of a tablet every six hours. Not in
dicated for children under six years of age.
Dosage should be adjusted according to the severity of the pain and the
patient’s response.

DOSAGE FORM S
Percocet Tablets: Bottles of 40,100 and 500 white, scored tablets, each
containing oxycodone hydrochloride 4.5 mg, oxycodone terephthalate 0.38
mg, acetaminophen 325 mg, caffeine 32 mg
Percocet-Demi Tablets: Bottles of 40,100 and 500 blue quadrisected
tablets, each containing oxycodone hydrochloride 2.25 mg, oxycodone
terephthalate 0.19 mg, acetaminophen 325 mg, caffeine 32 mg.
Complete prescribing information available on request.
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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Management of Postirradiation Thyroid
Nodules—Too Much or Too Little?
There is little doubt that people sub
jected to irradiation of the neck in
childhood, either by external beam
radiotherapy for conditions of the
tonsils, adenoids, thymus, lymph nodes
or skin1 or from radioactive fallout,2
are prone to diseases of the thyroid
gland many years later. Palpable ab
normalities of the thyroid are found in
25% to 30% of such asymptomatic
individuals who are recalled for rou
tine examination.3'6 Thyroid cancer is
reportedly found in 30% to 45% of
those explored surgically.3'7 These high
figures are not based on the presence
of clinically evident cancers but on
reports of specimens in which all or
almost all of the thyroid was removed
and sectioned closely. The cancers
found are usually papillary in type
and when they are adequately excised
the patient’s prognosis is excellent.8
Many of the cancers are not found in
the nodule for which the operation
was performed but elsewhere in the
gland. In up to 80% of reported cases,
the cancer is “occult”, a lesion rarely.
if
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from patients with nonirradiated
glands who have been followed up for
periods of over 25 years.910
The identification of such a highrisk group of patients in whom the
thyroid cancer if often multicentric,
and the frequent finding of occult
lesions in locations other than the
palpably suspect area have led to
considerable controversy and differ
ing opinions on the optimal sur
gical management. Total thyroidec
tomy with its increased risk of recur
rent laryngeal nerve damage and post
operative hypoparathyroidism11 has
been practised by many surgeons3'7'12
while a conservative approach consist
ing of partial thyroidectomy plus sup
pression by feeding thyroid is ad
vocated by some.8 The roles of scan
ning3'7’13 and needle aspiration biopsy14
VOLUME 23, NO. 6, NOVEMBER 1981

in the early detection and diagnosis of
radiation-related thyroid abnormalities,
and of thyroxine suppression and use
of radioactive iodine in the postoper
ative treatment remain equally con
troversial.1517
Getaz and colleagues, in this issue
(page 558) report on 85 patients who
had previously received irradiation to
the head and neck. They were given
thyroid hormones orally for the treat
ment of palpable nodules detected in
a screening program, a finding gener
ally considered an indication for im
mediate surgical exploration.1 The
authors suggest that there is a group
of patients whose nodules will disap
pear completely or partially with sup
pression therapy, the implication being
that these patients will not require
surgical intervention. This conclusion,
although attractive, is not necessarily
supported by their data.
Although operation was recom
mended for all 61 patients who did
not show a complete response, only
21 consented. The authors do not in
d i c a t e the c a t c g u i y o f i c s p u iis iv e n e s s
for each of these 21 patients. At least
one carcinoma was in a partial re
sponder. Therefore, at best, the con
servative approach must be confined
to those who are complete respond
ers— in this case only 28% of the
total. In one patient who achieved an
initial complete response the condi
tion later progressed and a carcinoma
was found.
The authors correctly reaffirm
the importance of close follow-up
in this group of patients. Unfor
tunately, nowhere in their manuscript
do they report the period of time
allowed or required to achieve a com
plete response with suppression ther
apy or the duration of follow-up of
patients in their study. They found
malignant thyroid lesions in approxi
mately 30% of patients operated
/

upon. This rate is consistent with
those reported by most thyroid clinics
in the United States. Presumably, 30%
of their 40 patients who refused
operation have carcinoma. Carcino
ma may also exist in 30% of those
who had a complete response of
the palpable nodularity, since histol
ogic examination of these glands
was not carried out and we are not
told whether the carcinomas that
were found were in the nodules
clinically palpated
and
suspect.
Many clinics use thyroid feeding in
all patients exposed to neck irradia
tion in the absence of dominant
nodularity on the assumption that such
therapy will prevent the subsequent
growth of nodules and possibly even
cause regression of occult carcinomas.
Results of animal studies have led to
the theory that suppression of thyroid
stimulating hormone (TSH) by ex
ogenous thyroid hormone can pre
vent the development of thyroid
neoplasms.18'20 This conclusion has
proved to be valid in irradiated
ia is
and
m ic e ,
but
has
not
been demonstrated conclusively in
man. Nevertheless, many believe that
the improved survival reported in pa
tients with thyroid carcinoma who
have been subjected to conservative
resection is related to the beneficial
effects of thyroid feeding on other
remaining foci and occult lesions.8'10
Again, close follow-up in this group
of patients is emphasized. In other
circumstances, suppression therapy
with exogenous thyroxine has allowed
previously indistinct nodules to be
come clinically more apparent by sup
pressing the surrounding normal tis
sue.
Getaz and coworkers attempt to
compare their result using triiodothy
ronine (T3) and dessicated thyroid in
irradiated glands with those of
Shimaoka and Sokal21 who compared
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the suppressive effect of thyroxine
(TO and T3 in nonirradiated glands.
Any such comparison is obviously
fallacious and no valid conclusions
can be drawn. Unfortunately, TSH
levels and corresponding thyroid doses
are not reported although presumably
they were estimated. Probably there
is no difference between the use of
T.s, T„ or dessicated thyroid as long as
the dose is large enough to obtain suf
ficient suppression of TSH and the
drug product is from a reliable source
with high quality control.
Although aspiration cytology was
apparently performed on all nodules,
the data are not reported. Getaz and
colleagues suggest that patients with
thyroiditis may respond to suppression
but fail to report on any correlation
between the cytologic findings and
the response to suppression. The very
high rate of Hashimoto's disease and
other forms of thyroiditis occurring in
the excised glands has been com
mented upon by other authors.
Swelstad and colleagues7 found that
70% of irradiated patients with carci
noma had associated benign condi
tions of the thyroid, especially thy
roiditis.
The role of needle biopsy, whether
core, cell block or smear, is worthy of
further comment. Twenty years ago,
the diagnosis of carcinoma of the
thyroid was a challenge to most
pathologists. They needed full per
manent sections of the capsule and tu
mour before they could make a deci
sion. Initially, needle biopsy was used
only rarely in cases of solitary
nodules.22-23 Few pathologists would
risk a decision on a minute specimen.
Moreover, the technique was rarely
used to confirm a suspicious diagnosis
of carcinoma for fear that cancer cells
might be seeded along the needle tract.
In recent years, increasing emphasis
has been placed on cytologic diag
nosis with the result that now pathol
ogists can decide on the basis of an
aspiration biopsy whether a tumour
is malignant. Since a thyroid nodule
is usually all benign or all malignant,
there is little possibility of being
misled by a nonrepresentative speci
men. The myth of seeding tumour
cells along the needle tract has been
dispelled and the accuracy and safety
of needle biopsy has now been con
firmed by several large studies.24'28 It
should, therefore, be just as effective
a diagnostic aid in patients with
previous irradiation as in patients
without such a history, assuming that
one wishes to know only the histology
of the palpable nodule.14 Its use must

be limited to institutions where special
expertise in the use of this technique
has been developed. The specimen
must be interpreted by a pathologist
who is thoroughly acquainted with the
pathology of the thyroid gland and
experienced in the evaluation of needle
biopsy material and cytologic tech
niques.
In summary, sufficient time has
elapsed and numbers of cases have
accumulated for us to reconsider our
management of patients with radia
tion-related thyroid disease. It seems
reasonable to consider a trial of thy
roid suppression therapy in these pa
tients, even those with palpable ab
normalities of the thyroid gland, in
the expectation that 25% to 30% will
show complete response and disap
pearance of the palpable abnormal
ities as reported by Getaz and col
leagues. Confidence in this approach
might be strengthened further by an
initial needle biopsy of the palpable
nodules that fail to show neoplasm, as
strongly advocated by Crile, Esselstyn
and Hawk.14 Clearly, continued close
follow-up is necessary and the parent
must be maintained on suppressive
doses of thyroxine indefinitely. Period
ic examinations should assess the
state of the gland by palpation and
the adequacy of thyroid therapy by
measuring TSH levels and by ensuring
that the dosage is not producing
chronic hyperthyroidism. One must
recognize that up to 30% of these
glands may harbour an occult car
cinoma; however, it is believed that
the patient’s welfare will not be en
dangered if consideration of surgery
is delayed until a nodule can
be palpated. In the event that oper
ation is needed, the procedures
selected should be dictated by
the pathological findings and clinical
assessment at the time as for any car
cinoma of the thyroid which is not
radiation-related.12 The frequent oc
currence of multifocal and occult le
sions and the common finding of car
cinomatous foci in areas other than
the palpable abnormality should not
necessarily lead to automatic total thy
roidectomy except by surgeons special
ized in thyroid surgery and with de
monstrated proficiency in this opera
tion. On the other hand, it must be
recognized that when surgery is con
servative the problem remains: the
thyroid or at least part of it is still in
the neck and the patient must be
closely followed up indefinitely. Also
if reoperation becomes necessary it is
often hazardous because of fibrosis
and scarring. Nevertheless, the re

VOLUME 23, NO. 6, NOVEMBER 1980 /

latively benign natural history of these
carcinomas encourages a conservative
surgical approach.
M arvin I. W e x l e r , m sc , m d , c m ,
fa c s , fr c s [c]

Department of surgery,
Royal Victoria Hospital,
McGill University,
Montreal, PQ
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Remuneration of Part-Time Faculty for
Undergraduate Surgical Teaching
Members of university faculties have
responsibilities for teaching, in re
search and administration, in clinical
departments of the faculty of medicine
and in the day-to-day care of patients.
The fourth function is intimately re
lated to the teaching of students, in
terns and residents in hospitals affi
liated with the university. The degree
of responsibility in each category
depends on department requirements
and personal commitment by the fa
culty member.
Only a few years ago all clinical
teaching was provided gratis by doc
tors in private practice. The physi
cians' donation of time and effort to
the undergraduate was looked upon
as an academic privilege. Now, in
creasing numbers of geographical full
time staff are being taken on by uni
versity-affiliated hospitals and are
being paid a salary for teaching and
other activities. Part-time clinicians,
however, continue to shoulder a sub
stantial portion of the teaching load.
For this they receive little or no finan
cial recognition.
Teaching programs in the under
graduate curriculum are expanding
because of the rapid growth of med
ical scientific knowledge and increas
ing complexity and diversity of med
ical technology. In the clinical years,
the trend is towards more individualiized student-teacher contact. Increas
ingly smaller groups of undergraduates
meet with individual members of the
faculty. As students advance, the
teaching pattern changes from class
lectures to seminars, tutorials and case
presentations. In addition to such as
signed teaching, faculty members

provide preceptorial teaching on the
wards, at the outpatient clinics and
in the operating rooms. All faculty
members, working full time or part
time, participate in undergraduate
case-study programs that bring stu
dents into contact with clinicians of
widely varying knowledge and ex
perience.
With the introduction of govern
ment-financed universal “free” hos
pital care in Canada about 10 years
before government-financed universal
“free” medical care, a great impetus
was given to hospital-based health
care. This increased the emphasis on
the hospital-based specialist. That trend
now appears to be decreasing and the
need to train more community-based
physicians is being recognized. Com
munity-based part-time faculty mem
bers have an essential role in clinical
teaching within the university and in
preparing trainees for medical and
surgical practice outside the univer
sity.
Teaching by the university faculty
cannot be provided without cost
to the department’s budget or to the
physicians' time. Whether it is
provided on a university campus or in
a teaching hospital by geographical
full-time or part-time staff, teaching
deserves an appropriate monetary re
ward. Members of the medical profes
sion who are on the attending and
academic staff at teaching hospitals
welcome active participation in teach
ing programs of the university. How
ever, commitment to teaching by parttime faculty should be coupled with
a reasonable financial commitment by
the university. To date, there has been
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little in the way of specific financial
remuneration for the teaching pro
vided by part-time faculty. At one
time, when no clinical teachers were
paid, teaching without financial re
muneration was at least equitable. At
present, some are paid and others are
not.
While the office practice overhead
of part-time clinical teachers increases
yearly there is only marginal im
provement in payment for professional
services. No such financial disadvan
tages apply to the geographical full
time faculty.
Academic surgeons in private prac
tice give up valuable time from their
practices to teach in the university.
Since the federal government has
assumed financial responsibility for
so many social services that were
formerly voluntary, such “subsidiza
tion” has ceased to be appropriate.
Government now pays for the serv
ices provided by doctors for the med
ical care that they give to patients.
It is therefore logical that, through the
university, the government should re
imburse clinical teachers for their
contribution to the university curri
culum.
All teaching that is recognized in a
university curriculum should be paid
for from the faculty budget. This bud
get should support all teaching equit
ably, whether it is provided by full
time or part-time faculty.
T. K enneth T horlakson,
FRCS[ c ] , FACS

md , frcs ,

Surgeon general,
Division of general surgery,
Winnipeg Clinic,
Winnipeg, Man.
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CORRESPONDENCE

Effects of Oral Contraceptives
on the Liver
To the coeditors.—I read with in
terest Dixit’s review article con
cerning the liver and oral contra
ceptives (Can J Surg 23: 222, 1980),
and I think attention should be drawn
to one or two possibly erroneous gen
eralizations and inaccuracies.
The author refers to both oral con
traceptives and menopausal replace
ment medications and lists a group of
general long-term effects which he de
scribes as being “common”. In fact,
their rate of occurrence is quite low.
Endometrial carcinoma has been re
ported to be associated with estrone
sulfate therapy but not with combined
estrogen-progesterone oral contra
ceptives; however, Silverberg and
Makowski1 reported several cases of
endometrial carcinoma associated with
the use of the sequential oral contra
ceptive Oracon, a product containing
dimethisterone. Sequential agents are
no longer used and indeed it is pos
sible that combination agents may have
a protective effect vis-a-vis endome
trial carcinoma.2 Further, it is con
fusing to state that estrogen may be
causally associated with carcinoma of
the cervix; this was not the intent of
the quoted article.3
All currently used oral contracep
tives contain 19-nortestosterones but
substituted progesterones have been
used in the past. The progestins that
have been used are numerous but
should include norithisterone and
d-norgestrel, the latter being one of
the most widely used synthetic pro
gestins. Estrogens are currently used
in doses as low as 0.02 mg, and 0.035mg doses are usual.
The plasma coagulation proteins
are indeed elevated (page 225) but in
addition to those mentioned, factors
V and VIII should have been in
cluded.
In the section on changes in preg
nancy (page 226), “increased serum
fibrinogen” is mentioned. Surely the
author means “plasma fibrinogen”, as
Contributions to the Correspondence sec
tion are welcomed. They should be type
written and double spaced.

serum is totally devoid of that partic
ular protein.
This very comprehensive review
emphasizes the effect of these potent
agents on hepatic function in general.
In view of the elevation of coagulation
protein levels produced by oral con
traceptives (and the consequent ten
dency to hypercoagulability), it might
be interesting to ask general surgeons
how frequently they discontinue oral
contraceptive medication before they
perform elective surgery.
A shley T. C oopland ,

m d , frc s [c ]

Associate clinical professor,
Yale University School of Medicine,
Director, Department of obstetrics
and gynecology,
Waterbury Hospital Health Center,
Waterbury, Conn.
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To the coeditors.—In response to Dr.
Coopland's letter I wish to clarify
some of the points he has raised.
The use of the term “common” in
relation to adverse effects, was in
tended to refer to those conditions
most readily recognized, rather than
to frequency of occurrence. The in
cidence of serious adverse effects is
without doubt “low” but nevertheless
is important. The use of oral contra
ceptives is associated with a four
fold increase in the occurrence of
thromboembolic disease. The pre
valence of deep venous thrombosis is
dose-related but even the smallest
effective dose is not free of risk.
About 40% of healthy women taking
oral contraceptives show retention of
bromsulfalein. If the infusion techni
que is used, almost all women using
oral contraceptives show increased
retention. In 53% of women taking
oral contraceptives, raised blood pres
sure will be recorded on one visit.
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and in about 30% on more than one
visit. The biochemical effects of the
oral contraceptives are reversible and,
in most cases, transient.
I still regard oral contraceptives as
a reasonably safe method of contra
ception.
Estrogen prescribed for menopausal
symptoms is of questionable benefit
and is associated with an increased
risk of endometrial carcinoma. Se
quential oral contraceptives have been
discontinued in Canada and the
United States for nearly 3 years.
Whereas endometrial carcinoma is
rarely seen in women under 40 years
of age, it has been reported in women
of this age group who have taken
sequential oral contraceptives. The
biological effects of estrogens, regard
less of the indications for use, gen
erally remain the same and were there
fore included in my review.
While it is correct that plasma coa
gulation proteins are elevated, factors
V and VIII were not mentioned in
the articles quoted, hence the omis
sion. Factor VIII is produced by the
reticuloendothelial system. Premarin,
which has been used in the past for
controlling postoperative bleeding is
no longer recommended for this in 
dication.
Dr. Coopland is correct in pointing
out that “serum fibrinogen” should
have been “plasma fibrinogen”.
I know of no general surgeon who
discontinues oral contraceptives in
women before they undergo elective
surgical procedures. Although it
sounds logical, to my knowledge there
has been no publication to date sup
porting this view. Perhaps the posto
perative venous thrombosis and oral
contraceptive hypercoagulability do
not have an additive effect. The
history of oral contraceptive use is
not always recorded before general
surgical procedures. Should a study
of this aspect of contraceptive use be
undertaken, the results might prove
most interesting.
S.P. D ixit ,

f r c s , f r c s [c ], facs

Department of surgery,
Woodstock General Hospital,
Woodstock, Ont.
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REVIEW ARTICLE

Gallstones: Current Concepts of Pathogenesis and
Medical Dissolution
E ldon A. Shaffer , md, frcp [c], facp
Disease is very old, and nothing about
it has changed. It is we who change,
as we learn to recognize what was for
merly imperceptible.

is not invasive) of a living population
at risk most accurately determines
prevalence.10 Such studies are more
accurate than others because the pre
J ean M artin C harcot sence of gallstones is detected in both
symptomatic and asymptomatic pa
Gallstones have afflicted mankind tients, especially if an entire popula
since antiquity,' but their treatment tion is examined. The true prevalence
has received little attention. Ingel- has been examined in this manner
finger2 first emphasized the impor only on a Pima Indian reservation in
tance and economic burden of this Arizona"1 and in Micmac Indian
seemingly mundane digestive condi women in Nova Scotia.12These women
tion in 1968. Since then, calculous have an extraordinarily high rate of
disease of the biliary tract has become gallbladder disease which starts in
recognized in Canada as a major the third decade of life. The reported
cause of hospitalization, accounting frequency of gallstones in different
for about 130 000 admissions, result countries derived from autopsy studies
ing in 80 000 cholecystectomies, an varies widely, from being very rare in
nually.'1Cholecystectomy is one of the the Masai tribe of East Africa and
La lithiase biliaire represente un
most
frequently performed abdominal Canadian Eskimos to being very
probleme majeur de sante dans le
operations,
particularly in Canada," common (more than 30%) in northern
monde occidental en depit du succes
although
in
Sweden the frequency Europeans. The rate for North Amer
du traitement chirurgical, la choleof
cholecystectomy
is decreasing." ican white people ranges from 10%
cystectomie. Au cours de la derniere
This
may
reflect
either
a greater ten to 30%.10
decennie, on a ete temoin de
dency
of
the
Canadian
population to
The natural history of gallstones is
progres considerables dans les
suffer
from
biliary
tract
disease, im also poorly defined. Most patients are
connaissances des changements de la
proved diagnostic expertise or better asymptomatic; only one third to one
chimie physiologique de la bile qui
health-care delivery. It could also half have been reported to experience
preside a la formation de calculs de
imply
that therapeutic usefulness has symptoms during a 10- to 20-year
cholesterol. Cette connaissance a
been
exceeded
and eventually might period.” Further, a radiologic survey
permis d'etablir les fondements
lead
to
excessive
mortality.6'7 Care in a Welsh industrial town demon
logiques de I'identification des
must
be
taken
not
to
misinterpret the strated that the dyspeptic symptoms
substances capables de dissoudre les
number
of
deaths
attributed
to chole commonly associated with gallstones
calculs biliaires, et de la definition
cystectomy.8
The
annual
mortality
did not discriminate between those
des desordres qui predisposent a la
from
gallbladder
disease
in
Canada
is
with and those without gallbladder
formation des calculs biliaires,
less
than
0.5%
(about
580
deaths).3
disease.13 The frequency of these clin
desordres qui peuvent etre elimines
The
morbidity,
annual
cost
(estimated
ically
“silent gallstones” is therefore
ou traites preventivement. Cette
at
$280
000
000
in
Canada)
and
the
difficult
to determine since a dilemma
revue examine les notions sur la
drain
on
surgical
facilities9
make
cal
exists
in
formulating a clinical defini
formation des calculs biliaires et
culous
biliary
tract
disease
a
major
tion
of
asymptomatic
cases that are
indique I’etat actuel du traitem ent
health
problem.
found
fortuitously.1"16
Why was the
medical.
Epidemiologic studies documenting radiologic examination done in the
the occurrence of cholelithiasis have first place? What about gallstones
Department of internal medicine,
been based mainly on clinical and discovered incidentally during an ab
faculty of medicine, University of
Calgary, Calgary, Alta.
autopsy information which contain dominal operation? The tendency to
Supported by Medical Research Council both selection and detection bias. Such cause symptoms appears unrelated to
of Canada grant MA -5080
a data base underestimates the true size, number or type of gallstone
Accepted for publication Sept. 19, 1979 frequency and obscures any valid present.17 The silent gallstone therefore
Reprint requests to: Dr. Eldon A.
associations by failing to identify is probably not part of a specific
Shaffer, Rm. 1885, Gastrointestinal
asymptomatic disease. A random sur lesion but represents the asymptomatic
research unit, Division of medicine,
vey by cholecystography or, even stage of cholelithiasis. Because our
University of Calgary, Calgary, Alta.
T2N 1N4
better, by ultrasonography (because it knowledge of the natural course of
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Gallstone disease constitutes a major
health problem in the western world,
despite a successful form of surgical
therapy, cholecystectomy. The past
decade has witnessed considerable
advances in our understanding of
the physiochemical changes in bile
that lead to cholesterol gallstone
formation. This knowledge has resulted
in a rational basis for identifying
agents that could dissolve gallstones
and for defining conditions that
predispose to gallstone formation
which might be eliminated or treated
prophylactically. This review examines
the concepts of gallstone formation
and indicates the current status of
medical therapy.

this disease is deficient, the indications
for cholecystectomy in such cases are
not absolutely clear. The older patient
with relatively asymptomatic calculous
disease can present a particular dilem
ma for the surgeon. The danger of
a nonoperative approach is the pos
sible development of acute cholecys
titis with its high mortality and mor
bidity. The warning features in such
elderly patients are premonitory symp
toms18 or the development of a radiologically nonfunctioning gallbladder.19
The diabetic patient with cholelithiasis
also presents a problem for the sur
geon.20,21 Although the risk-benefit
ratio of cholecystectomy is not fully
known in patients without symptoms
these guides, such as age, radiologic
function of the gallbladder and dia
betes, can serve as an indication for
operation.22
Human gallstones fall generally into
two chemical categories, pigment
stones and cholesterol stones.23
Pigment Gallstones

Pigment stones are composed of
bile pigment, calcium and a matrix of
organic material. They contain only
trace amounts (less than 20%) of
cholesterol. These small, irregular,
dark (black, brown or green) stones
are amorphous. They result from
abnormal metabolism of bile pigment.
Those present in the gallbladder look
like tarry concretions, whereas stones
forming in the common duct resemble
reddish brown mud. Most (67%)
radiopaque stones are of the pigment
variety; their calcium content is high.24
From a different perspective, 50%
of pigment stones are opaque roentgenographically.
Pigment stones have been known
for years to be common in Asiatic
people. They also constitute 10% to
20% of gallstones in Occidentals.23,25,20
Certain disease states, particularly al
coholic cirrhosis27,28 and chronic hemo
lysis,29 are associated with pigment
lithiasis. If these small gallstones pro
duce biliary obstruction, the ensuing
clinical picture can create a complex
management problem. Even the red
dish brown biliary “sludge”, which
frequently complicates stasis and
common-duct strictures, consists of
pigment material. Intraductal pigment
lithiasis is common in the Orient, and
often there are no stones in the gall
bladder.30
Pigment stones may be classified
into two types: bile pigment-calcium
stones and pure pigment stones.31'33
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Bile Pigment-Calcium (or Calcium
Bilirubinate) Stones
These are commonly associated
with bacterial infection and can be
found anywhere in the biliary system
including the intrahepatic tree. The
black pigment in concretions from the
gallbladder and the reddish brown
material found in the common duct
are only sparingly soluble in most
organic solvents, making chemical an
alysis difficult and inexact. The one
definite characteristic is a relatively
high bilirubin and low cholesterol
content.
The possible mechanisms by which
these gallstones form include: secre
tion of an abnormal pigment that
readily precipitates in bile, excessive
hepatic secretion of normal pigment
which surpasses its solubility in bile,
or extrahepatic conversion of a nor
mal constituent into an insoluble pre
cipitate. Maki31 developed the last
thesis to explain the genesis of calcium
bilirubinate stones in Asiatics who
commonly have parasitic infections
(e.g., Ascaris lumbricoides, Clonorchis
sinensis) that cause stasis and bac
terial infection within the biliary tract
(Fig. 1). Bilirubin is a tetrapyrrole that
is normally esterified in the liver and
secreted into bile as a water-soluble
glucuronide (bilirubin diglucuronide),
perhaps in conjunction with biliary
lipids. The enzyme ^-glucuronidase
can hydrolyze conjugated bilirubin
into free (unconjugated) bilirubin and
glucuronic acid. The normal biliary
tree is free of this lysosomal enzyme
and even contains an inhibitor of
^-glucuronidase, D-glucaric acid (glucaro-1,4-lactone).34 Coliform infec

g lu c a ro -l, 4 - l a c t o n e in h ib its

eeucuRONic

,
I

tions of the biliary tree, however,
can elaborate /J-glucuronidase. The
ensuing hydrolytic sequence trans
forms the diconjugated bilirubin into
a monoconjugated form and finally
into unconjugated bilirubin.32 The
free bilirubin then combines with the
available calcium in bile to produce
insoluble calcium bilirubinate. These
tetrapyrrole units aggregate to form
a biopolymer resulting in the forma
tion of a pigment gallstone.33'35 That is,
calcium bilirubinate stones result from
chemical alteration of conjugated bili
rubin within the biliary tree producing
an insoluble product that then poly
merizes. Such a sequence theoretically
could be aborted by dietary mani
pulation to increase glucaric acid in
bile and so reduce ^-glucuronidase
activity.34 The deconjugating enzyme
may also come from the gallbladder
epithelium itself.36 In fact, spontaneous
nonenzymatic hydrolysis could be in
itiated by stasis in the biliary tract and
then compounded by bacterial infec
tion. This hypothesis is much more
attractive because in the Occident in
fection has never been established as
the primary event in gallstone dis
ease.37,38
Pure Pigment Stones
Stones of this type contain heavy
metals and pigment other than bili
rubin. The gallbladder is the usual
site of stone formation.39 Pure pig
ment stones can occur in hemolytic
states, but are relatively uncommon,
even in Japan.26,31,33 Their formation
(Fig. 1) involves precipitation of cal
cium carbonate or phosphate in con
junction with some calcium biliru-
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FIG. 1—Mechanism of pigment stone formation.
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binate. Stasis with altered pH may be
conducive to the precipitation of such
calcium salts. Copper and iron also
can be involved as a complex with
bilirubin derivatives.39
The true importance of pigment
stones in the West may be much
greater than their relatively low
prevalence indicates. Almost every
cholesterol gallstone has a pigment
centre, indicating that pigment also
plays a role in cholesterol stone forma
tion and growth.40 The central deposits
consist of calcium bilirubinate as a
protein-pigment complex often con
taining copper, mixed with calcium
phosphate and carbonate,41 and may
thus serve as a nidus for subsequent
precipitation of cholesterol from bile
supersaturated with cholesterol.
C holesterol G allstones

The composition of these stones is
predominantly (more than 70%)
cholesterol. Their formation involves
abnormal cholesterol and bile-salt me
tabolism. In fact, cholesterol means

bile solid. Even the so-called “pure
cholesterol” gallstone frequently has
some pigment at its centre, while the
“mixed cholesterol” stone also con
tains bile pigment, bile acids, calcium
salts and a protein matrix. The pure
cholesterol stone tends to be a large,
pale solitaire. Mixed stones are usually
smaller (diameter less than 2 cm) and
have a round or faceted surface de
pending upon the pressure of adjacent
stones. Their surface may be dark
brown, but in the cut section yellow
ish crystalline cholesterol is seen. If
enough calcium is present, these stones
can be radiopaque (33%), but 80%
to 86% of lucent stones consist of
cholesterol.24,42
Cholesterol is the major component
of most gallstones found in the people
of the Americas, Europe, India and
Africa.43 In lapan the percentage of
cholesterol gallstones is increasing
especially in urban areas, perhaps re
flecting dietary and environmental
changes.25,34 To understand the me
chanism of cholesterol gallstone for
mation and the basis for medical dis
solution, one must first appreciate
biliary physiology and how cholesterol
is rendered soluble in bile.
Physiology and Physical
Chemistry of Bile

FIG. 2— Enterohepatic circulation of
bile salts.

FIG. 3— Synthesis of primary bile
acids, cholic acid and chenodeoxycholic
acid, in liver. Solid arrow indicates site
of first reaction, hydroxylation of
cholesterol at 7 position; this step is
rate-limiting for overall conversion of
cholesterol into bile salts.

Bile formation begins in the bile
canaliculus, mainly in response to
the secretion of bile salts.44,45 Bile salts,
the most abundant organic solute, are
the driving force behind bile flow and
the principal determinant of bile com
position. They are synthesized ex
clusively in the liver from cholesterol.
Degradation occurs solely in the in
testine, the only excretory route being
fecal. Bile salts undergo an entero
hepatic
circulation
(Fig.
2).46,47
Secreted by the liver, they are stored
mainly in the gallbladder during the
interdigestive period. In the jejunum,
bile salts act as detergents to promote
fat absorption; their active absorption
occurs later in the terminal ileum.
After they have been absorbed into the
portal vein, bile salts return to the
liver, where they are effectively
cleared and secreted again into bile.
The major source for hepatic secre
tion during the day is bile salts recir
culated from the intestine, with only
a small portion derived from de novo
synthesis. Gallbladder storage and in
testinal transit are the slow points in
this circuit, whereas hepatic clearance
and intestinal absorption are rapid
and efficient. The total mass of bile
salts within the enterohepatic circula
tion represents the bile-salt pool. The

size of this pool multiplied by the rate
at which it cycles gives the bile-salt
secretion rate. This efficient recycling
system allows a small pool of bile salts
(about 50 mg/ kg body weight) to re
circulate 5 to 15 times a day, while
losing only a small portion (3 to 10
m g/kg body weight).46 With each cir
cuit, only 3% to 5% of bile salts are
lost. These small losses are accurately
replaced by hepatic synthesis from
cholesterol, maintaining a stable bilesalt pool.
Bile-salt synthesis is regulated by
the rate at which bile salts return to
the liver in a negative feedback man
ner: a low rate stimulates synthesis, a
high rate inhibits it. Loss of the bilesalt pool, such as through a T tube
postoperatively, decreases the rate of
bile-salt return to the liver. The liver
responds by augmenting synthesis.
Complete interruption of the entero
hepatic circulation, a maximal stim
ulus, can increase synthesis 10-fold
(about 5 g/d) in man.48 The rate-limit
ing enzyme in the overall biotrans
formation of cholesterol to bile salts
is cholesterol 7a-hydroxylase (Fig.
3).49 The activity of this enzyme is
controlled quantitatively by the total
mass of bile salts returning through
the portal vein. Qualitatively no dif
ferences exist between the individual
species of bile salts.50,51 After the ad
dition of the hydroxyl group at the 7
position (nuclear hydroxylation), the
subsequent steps involve two basic
pathways. If a second hydroxylation
occurs at the 12 position producing a
compound with three OH groups (3a,
7a, 12a-triol), shortening of the side
chain (side-chain degradation) results
in the formation of cholic acid. If
hydroxylation at the 12 position does
not occur, the two OH compound
(3 a , 7a-diol) ends up as chenodeoxy
cholic acid. Bile salts are then con
jugated with either glycine or taurine
before being secreted into bile. Normal
human bile has a molar ratio of gly
cine to taurine of about 3:1.
Conjugated bile salts undergo fur
ther metabolic processing in the in
testine, especially the ileum and colon.
Here the high bacterial content can
greatly alter the bile-salt molecule
(Fig. 4). Deconjugation first breaks
the peptide linkage, yielding free bile
acids.*52 Dehydroxylation then re
moves the hydroxyl group from the
*“Bile acid” should be applied to un
conjugated or free bile acids. “Bile
salt” the generic term, refers to those
bile acids conjugated with glycine or
taurine or the bile alcohols esterified
with a sulfate group.52
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7 position of the primary bile acid.
Cholic acid (with OH groups at the
3, 7 and 12 positions) is converted
into deoxycholic acid (with two OH
groups at the 3 and 12 positions).
Chenodeoxycholic acid (with OH
groups at the 3 and 7 positions) is
transformed into lithocholic acid (with
one OH group at the 3 position). Con
siderable dehydroxylation must occur
in healthy individuals because human
bile normally contains more than 25%
of the total bile salts in the secondary
form, chiefly as deoxycholic acid.
Deoxycholic acid and any free primary
bile acids are passively reabsorbed
from the colon and reconjugated in
the liver before being resecreted into
bile. Lithocholic acid with only one
polar OH group is insoluble in water
and so remains unabsorbed in the in
testinal lumen (as a stone or concre
tion, hence the prefix “litho”), bound
to bacteria or unabsorbed plant fibre.
Intestinal transformation of cheno
deoxycholic acid (3«, 7a-dihydroxycholanic acid) can also produce urso
deoxycholic acid (3a, 7a-dihydroxycholanic acid), which represents 1%
to 5% of all bile acids in bile.* Those
bile salts synthesized in the liver are
termed “primary”, whereas their bac
terial metabolites are “secondary”.
Cholesterol and bile-salt meta
bolisms are closely intertwined.5'1 Bile
salts are formed in the liver from
cholesterol and are its water-soluble
excretory products. Unlike most ani
mals, man tends to excrete cholesterol
as such, with comparatively limited
conversion to bile salts. Man absorbs
dietary cholesterol rather poorly and
any increase in the absorption of
cholesterol is not necessarily associated
with increased conversion into bile
salts. The liver is the principal site
for cholesterol production, with the
small intestine assuming a lesser role
under normal conditions.54"56 Choles
terol synthesis begins from the carbon
acetate fragments in an activated
form, acetyl-CoA (Fig. 5). Successive
condensation of three molecules of
acetyl-CoA forms /"j-hydroxy-^-methylglutaryl-CoA (HMG-CoA). HMGCoA is then reduced to mevalonate,
the first unique step in cholesterol
synthesis. The microsomal enzyme
controlling this key reaction, HMGCoA reductase, is rate-limiting for
the total sequence in cholesterogenesis.
The final product, cholesterol, consists
*Chenodeoxycholic acid was first iso
lated from goose bile (Greek chen,
goose), while ursodeoxycholic acid was
originally found in bear bile (Latin ursus,
bear).
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of 27 carbon atoms. As noted previ
ously, its catabolism to bile acids with
24 carbon atoms is rate-limited by the
enzyme, cholesterol 7a-hydroxylase.
The control of cholesterol and bilesalt synthesis is therefore governed by
two key enzymes: HMG-CoA reduc
tase and cholesterol 7a-hydroxylase.
The activity of HMG-CoA reductase
is turned off by increased cholesterol
return to the liver and may also be
suppressed by a high return of bile
salts.57 As bile salts are necessary for
cholesterol absorption and can influ
ence cholesterol catabolism to bile
salts, it is difficult to know whether
their effect on cholesterol metabolism
is direct or indirect.58 Certainly long
term administration of bile acids ap
pears to suppress cholesterol and bile
synthesis by decreasing the two ratelimiting enzymes. Chenodeoxycholic
acid has a greater inhibitory effect on
HMG-CoA reductase than on choles
terol 7a-hydroxylase,
suppressing
cholesterol synthesis to a greater extent
than bile-salt synthesis. The opposite
is true of cholic acid.59 The suppres
sive effect of chenodeoxycholic acid
on cholesterol synthesis may be me
diated through enhanced intestinal
absorption
of cholesterol.58 The
amount of cholesterol being converted
to bile salts also may play an indirect
role. Under conditions in which the
administration of bile acid had sup
pressed bile-salt synthesis, the in
creased cholesterol returning to the
liver would not be readily diverted
into bile salts but rather would in
hibit cholesterol synthesis. The regula
tion of hepatic cholesterol synthesis is
therefore complex, being influenced
by many variables such as total
caloric intake, stress and even diurnal
light cycling.60 The two mechanisms
responsible for adjusting the rate of
hepatic cholesterol synthesis are: (a)

the amount of cholesterol entering the
body through the gastrointestinal tract
and (b) the amount of sterol lost from
the body as bile acids. Elsewhere, the
nonhepatic cells in the body possess
a cell surface receptor that specifically
binds low-density lipoprotein (LDL)
which is the major cholesterol-carry
ing protein in human plasma. Once
bound to the receptor, at least in
human fibroblasts, LDL enters the
cell and is transferred to lysosomes
where both its protein and cholesterol
ester components are removed by acid
hydrolases. The resultant free choles
terol is then able to reduce endogenous
cholesterol synthesis by suppressing
the activity of HMG-CoA reductase.
The liberated cholesterol inside the
cell also neatly prevents any excessive
uptake of LDL-cholesterol by sup
pressing the synthesis of the cell sur
face LDL receptor.61 Hepatic choles
terol synthesis, however, is predomin
antly controlled by dietary cholesterol
which reaches the liver in the form
of chylomicron remnants rather than
by endogenous cholesterol contained
in LDL. In fact, free cholesterol
from plasma high-density lipoprotein
(HDL) and newly synthesized choles
terol within the liver appear to be the
principle substrate for transformation
of cholesterol into bile salts and may
be the source of cholesterol secreted
into bile.62"64
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FIG. 4— Deconjugation and dehydroxylation of primary bile salts in in'
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FIG. 5— Cholesterol metabolism in
liver. Key steps in cholesterol synthesis
and major degradation product, bile
salts, are depicted. Broken lines indicate
possible sites of feedback inhibition.
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The phospholipids in bile and plas
ma are synthesized only in the liver.
Despite a similar origin, the phospho
lipid secreted into bile is a lecithin
whose fatty acids (palmitic and linoleic
acids) differ from other hepatic leci
thins and from that in the plasma.
The synthesis of lecithin and its secre
tion into bile occur consecutively, both
events being dependent on bile-salt
secretion.65 Once in the intestinal
lumen, lecithin undergoes partial hy
drolysis to lysolecithin and fatty acids,
which are absorbed. Its products are
not substantially reused as a source
of bile lecithin, so that there is little
enterohepatic circulation of lecithin.66
The choline moiety may be preserved
for de novo hepatic synthesis.67
The flux of bile salts through the
hepatocyte and into the bile canali
culus profoundly influences the secre
tion of lecithin and cholesterol.65,68,69
The secretion rate of bile salts, as
noted previously, is governed by the
size of the bile-salt pool and the rate
at which it circulates enterohepatically.
Cholesterol output into bile is gen
erally coupled to the rate of bile-salt
secretion, while a close association
exists between lecithin and bile-salt
secretion. The relation between these
three is not fixed but is curvilinear.
At low rates of bile-salt secretion,
there is little secretion of lecithin.

Cholesterol secretion is also low but
less so than the other two, so that the
amount of cholesterol in bile com
pared with the other two rises. Con
versely, at high rates of bile-salt secre
tion, the lecithin and cholesterol out
puts plateau and the relative propor
tion of cholesterol diminishes. The rate
of bile-salt secretion is thus the prin
cipal determinant of biliary lipid com
position, but several modifying fac
tors exist.45 For example, patients with
significant liver disease have a low
rate of bile-salt secretion but also a
low rate of cholesterol secretion.
Hence, their bile does not contain a
relative excess of cholesterol despite
the low bile-salt output (Shaffer EA:
Unpublished observations). Moreover,
lecithin and cholesterol output can
be reduced by certain organic anions
and chemicals without any effect on
bile-salt secretion.70 The control of
biliary cholesterol secretion is further
complicated by the important role of
the liver in cholesterol metabolism.
Cholesterol secretion is increased in
obese people, presumably because of
the increased cholesterol synthesis
associated with obesity.69 Cholesterol
secretion into bile has been reported
to correlate directly with hepatic
cholesterol synthesis (as measured by
the activity of HMG-CoA reductase)71
but inversely with bile-salt synthesis.72

FIG. 6—Chemical formula and physical state of cholesterol, lecithin and bile
salts at oil—water interface. Upper part of figure shows chemical formulae of cho
lesterol, lecithin and sodium taurocholate. In lecithin, R and R' represent long-chain
fatty acids attached to glycerol skeleton by ester linkage. Lower part is schematic re
presentation of molecules. Shaded parts represent hydrophobic steroid nuclei of cho
lesterol and bile salt. Closed circles or ovals represent hydroxyl or ester groups,
respectively. + and — represent positively and negatively charged groups. Wavy
lines- are lipid-soluble hydrocarbon alkyl chains of lecithin.
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The control of biliary cholesterol sec
retion in terms of cholesterol and bilesalt synthesis is complicated by the
heterogeneous sources of free choles
terol destined for export into bile and
for the synthesis of bile salts; from
HDL-cholesterol in plasma and from
newly synthesized cholesterol in the
liver.62'64 The rate of hepatic uptake
of chylomicron cholesterol, the size of
the intrahepatic pool and the rate of
hepatic cholesterol synthesis probably
do not regulate biliary cholesterol out
put73 and HMG-CoA reductase ac
tivity may not truly reflect the overall
rate of cholesterol synthesis.74 Hence,
the determinants of cholesterol syn
thesis and secretion are not clear and
a variety of external factors such as
drugs and diet can influence its out
put into bile.75
Bile from healthy persons is a
homogeneous liquid, whereas that
from patients with cholesterol chole
lithiasis contains additional cholesterol
in a crystalline form that has pre
cipitated from solution.40,76 The pre
sence of cholesterol in solution and
as solid crystals, indicates that the
solubility of cholesterol in bile is
limited. Cholesterol is virtually in
soluble in water, yet human bile nor
mally contains about 10 mmol/1 cho
lesterol in solution. Bile is mainly
water, with solids accounting for only
5 to 10 g/dl (w/v). More than 90%
of the total solids in bile consist of
three organic components: bile salts,
lecithin and free cholesterol. The con
ventional chemical formulae depicted
in the upper portion of Fig. 6 are less
informative than the schematic draw
ings in the lower panel which repre
sent the physical state of the mole
cules at an oil-water interface.77 Each
substance is “amphiphilic” (loving both
sides), part of the molecule being
attracted to water and part to fat.
At the oil-water interface, the watersoluble parts are oriented into the
aqueous phase (downwards in Fig. 6)
while the oil-soluble parts are in the
oil phase (upwards in Fig. 6).
Cholesterol has a single hydroxyl
group which is water soluble.
The remainder of the molecule is the
water-insoluble (oil-soluble) 27-carbon
steroid ring. This single OH group
cannot possibly pull the bulky hydro
carbon moiety down into the water.
Therefore, cholesterol has only sur
face solubility on water and negligible
solubility within water. Lecithin (or
phosphatidyl choline) contains a phosphoryl choline group— 0 P ( 0 3) —CH2CH»N +(CHs)j— that, being hydrophi
lic, seeks water. The other portion
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of lecithin, the two long-chain fatty
acids esterified through glycerol (R
and R'), is hydrophobic and seeks oil.
The phosphoryl choline and ester
groups therefore lie below the water
surface, whereas the long hydrocarbon
chains point upwards into the oil phase
like a tuning fork (Fig. 6). Lecithin is
insoluble in water and forms crystals
of bimolecular leaflets, the hydrophilic
ends sticking into the water and hydrophobic ends being adjacent to one an
other. Water penetrates between the
hydrophilic phosphoryl choline groups
causing the crystals to swell, forming
“liquid crystals”. Cholesterol possesses
the ability to interdigitate between the
lecithin molecules with its hydroxyl
group sticking into the water layer and
the rest of the molecule buried deep
in the fatty acid, hydrocarbon interior
of the lecithin bilayer.77 In contrast,
bile salts are quite soluble with their
polar hydroxy] groups and taurine (or
glycine) conjugates attracted into
water. In aqueous solution above a
limiting concentration (the “critical
micellar concentration”), bile salts ag
gregate by association of their hydrophobic sides, forming “simple mi
celles”.78 Lecithin can be dissolved by
these bile-salt aggregates, creating
“mixed micelles”. This results in bi
layer discs appearing like stout drums
with a water-soluble coating and a
water-insoluble core. Cholesterol can
then be dissolved within the hydrophobic core between the fatty acid
chains of lecithin. Water is associated
with the polar groups of lecithin, act
ing to swell the micelles making it
possible to incorporate more choles
terol than could be contained by sim
ple bile-salt micelles alone. Thus, bile
salts are biologically active detergents
which, in cooperation with lecithin,
keep cholesterol in solution. The phy
sical coupling of these biliary lipids
and their secretion into bile may occur
at or near the canalicular membrane,
either within the membrane during
translocation or adjacent to the mem
brane in the newly formed bile.77
The solubility of cholesterol in
mixed micellar solutions is limited.
Physicochemical studies have shown
that the capacity of these micelles to
dissolve cholesterol is primarily re
lated to the relative amounts of bile
salts and lecithin.76'711Because there are
three components, triangular coor
dinates best represent the bile-salt—
lecithin-cholesterol mixture in bile
(Fig. 7). Any combination of these
three ingredients can be represented
on the triangle in terms of the relative
molar percentage of each component.
Thus point X in Fig. 7 represents a
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solution with 60% bile salts, 15%
cholesterol and 25% lecithin. Similar
ly, a point in the centre of the triangle
would represent bile with 33.3% of
each component. Admirand and
Small76 defined the limits of choles
terol solubility in bile-salt-lecithin
micellar solutions of different relative
proportions and represented the phy
sical properties of the resultant mix
tures on a triangular phase diagram.
The system chosen contained 90%
water and 10% bile salts plus lecithin
and cholesterol, similar to the solid
content of human gallbladder bile.
Out of all possible combinations of
bile salts, lecithin and cholesterol they
found only a small zone in which the
bile composition was micellar. The
solid line in Fig. 7 defines the bound
aries of the micellar zone and repre
sents the maximal solubility of choles
terol in varying mixtures of bile salts
and lecithin. Any bile having a com
position above this solid line (say at
point X) would contain excess choles
terol in either a supersaturated or
precipitated form. Supersaturated bile
contains the cholesterol in a single,
liquid phase, or as a two-phase system
of liquid bile plus solid crystalline
cholesterol. If very rich in lecithin, a
three-phase system could be present
as liquid bile, cholesterol crystals and
mixed liquid crystals. Excess choles
terol readily precipitates out of such
a supersaturated solution over a
relatively short period. Hence, in this
thermodynamically
unstable
bile,
termed “labile”, crystallization occurs
spontaneously. Many biological solu
tions that are supersaturated do not
necessarily continue to precipitate
their excess solute until an absolute
equilibrium is established, at least dur
ing the finite period of observation.
Precipitation may be extremely slow,
often requiring a nucleating agent to
initiate and hasten the process. Such a
solution represented by the shaded
area in Fig. 7 contains a slight excess
of cholesterol and exhibits a certain
stability, not readily precipitating
cholesterol crystals unless seeded, and
termed a “metastable” solution.80 The
absolutely true equilibrium (the
broken line below the metastable zone
continuous with the solid line on the
right of Fig. 7) defines the “stable”
micellar zone.79'82 The commonly ac
cepted “effective” line of cholesterol
solubility is best defined by the whole
solid line in Fig. 7 which includes the
area of metastable supersaturation.
The “true” limits exclude the meta
stable area. The physical chemistry
of cholesterol solubility in bile is even
more complex in vitro, depending on

a subtle variety of conditions, but for
physiologic bile at 37°C the major
determinants are the bile-salt to leci
thin ratio and the total lipid concentra
tion. A group of cholesterol solubility
curves determined for each total lipid
concentration has shown that, con
trary to popular notion, concentrated
bile holds more cholesterol than dilute
bile.79 Precise tables are now available
defining the limits of maximal choles
terol solubility in human bile.83
When the relative molar compo
sition of human bile is plotted on the
triangular phase diagram, patients
with cholesterol gallstones have a
biliary lipid composition different
from that of patients without choles
terol gallstones10,48,76'84'85 (Fig. 8). There
is even a close relation in various
populations between the prevalence
of gallstones and the frequency of
supersaturated bile in subjects without
overt gallstones.86 A discrepancy still
exists: there is no consistent decrease
in the cholesterol-holding capacity of
bile from patients with gallstones when
compared with bile from subjects
without gallstones. Much overlap
exists.87 The problem was further com
pounded when Hegardt and Dam81 and
Holzbach and colleagues82 found that
the micellar phase at true equilibrium
was smaller than that reported by
Admirand and Small.76 Most of these
discrepancies have been resolved by
Carey and Small.79 They meticulously
redefined the true solubility charac
teristics of cholesterol in micellar
solutions and applied their findings
to humans. Their results demonstrated
that all patients with cholesterol gall
stones have supersaturated bile, even
though metastable supersaturation was
frequent in both normal and abnormal
biles. The common denominator for
cholesterol precipitation was the ab
solute degree of cholesterol super
saturation.79 The prerequisite for

FIG. 7— Triangular phase diagram
for plotting relative molar concentrations
of three major components of bile (bile
salts, lecithin and cholesterol).
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Older Chilean women also show in
creasingly abnormal bile with age,97
but this is not related to a decrease in
the size of the bile-salt pool. Rather,
obesity appears to be a factor here,
so that increased cholesterol secretion
may be responsible.
The physical stage.—This second
stage occurs with a change in gall
bladder bile from a liquid, super
saturated with cholesterol, to a twophase system consisting of liquid bile
plus cholesterol crystals. There are
two possible situations. If the abnormal
bile is labile with a great excess of
cholesterol in a clear solution (that is,
above the metastable-labile line, say at
point X in Fig. 7), cholesterol crystals
spontaneously and readily precipitate.
This is “homogeneous nucleation” be
cause cholesterol molecules randomly
coalesce to form cholesterol micro
crystals without the influence of other
solids. If the supersaturated bile is me
tastable with just a slight excess of
cholesterol (in the shaded area in Fig.
7), the excess cholesterol can preci
pitate over a long period but usually
requires seeding by a crystal of the
same substance or by a crystal of a
different substance with a similar phy
sical configuration. This is “heterogen
eous nucleation”, because precipitation
occurs around a particle other than a
pure cholesterol crystal.98 A variety
of nucleating agents may initiate or
hasten crystal formation, including
desquamated epithelial cells, calcium
salts, precipitated bile acids and for
eign bodies. But once precipitation
starts, the solid crystals themselves
provide the seed for further nuclea
tion of cholesterol. The presence or
role of inhibitors in bile has not been
explored. The end result is that the
precipitated cholesterol is deposited
in an oriented, tightly-packed manner
as microcrystals, a process known as
epitaxy.99
The growth stage.—The third stage
consists of retention of these micro-

eases69 (Table I88-90). Nonobese patients
with cholesterol gallstones have a
decreased bile-salt pool,91 which cycles
Stages of Cholesterol Gallstone
to produce a reduced bile-salt and leci
Formation
thin secretion rate.69 The basic prob
Cholelithiasis is the end stage of lem appears to be inadequate hepatic
a long process that begins with a me synthesis; the liver does not sense the
tabolic defect causing the formation small circulating bile-salt pool. A dif
of chemically abnormal or “litho- ferent abnormality of bile-salt meta
genic” bile (the chemical stage),77 bolism occurs with ileal dysfunction.
proceeds to a physical change of state Loss of the site for active transport
in which microscopic crystals precipi results in significant bile-salt malab
tate from solution (the physical stage) sorption, and fecal losses exceed any
and ultimately results in growth to a compensatory increase in hepatic syn
macroscopic stone (the growth stage). thesis. The bile-salt pool then
Gallstones produce symptoms by decreases, secretion is low and bile
blocking the cystic or common duct, becomes supersaturated. This mechan
or by irritating the gallbladder.
ism probably accounts for the in
The chemical stage.—The liver has creased prevalence of gallstones in
clearly been identified as the source patients who have ileal disease or who
of lithogenic bile and gallstone dis have undergone ileal resection.92 The
ease has become known as a subtle principal problem in morbidly obese
disorder of liver metabolism84 (Fig. persons is excessive secretion of
8). The liver might produce such bile cholesterol rather than a deficiency
either by decreased secretion of the of bile salts.90 Most overweight pa
solubilizing agents, bile salts or leci tients with cholesterol gallstones prob
thin, or by an increased secretion of ably fall between these two extremes.
cholesterol, or both. In fact, the he They likely have a combined defect: a
patic defect involves several mechan- reduced bile-salt pool and secretion
ims, perhaps representing several dis- rate, and increased cholesterol secre
tion. This correlates with reports of in
creased HMG-CoA reductase activity
(implying enhanced hepatic cholesterogenesis) and decreased cholesterol 7ahydroxylase levels (suggesting im
paired bile-salt synthesis) in patients
with gallstones,93,94 but these results
must be interpreted cautiously because
of methodologic limitations.73,74
The age at which this critical
process begins is uncertain, but in
young North American Indian women
who are at high risk of stone forma
tion, lithogenic bile develops during
early puberty.95,96 The mechanism re
sponsible is a combination of increas
ing obesity in these teenage girls (with
presumed increased cholesterol secre
tion) without any corresponding aug
mentation of their bile-salt pool, which
their male counterparts demonstrate.
cholesterol gallstone formation then is
supersaturated bile.

FIG. 8— Lipid composition of bile
obtained at operation. Triangle represents
tbree-coinponent system for describing
biliary lipid composition in bile. Mean
compositions for (a) hepatic and (b) gall
bladder biles are represented by closed
circle for patients with cholesterol gall
stones, open circle for patients with pig
ment gallstones and closed triangle for
those without hepatobjjiary disease.
Areas bounded represent x ± 1 SEM for
each component; that for cholesterol
gallstone patients is shaded. Cholesterol
saturation of hepatic and gallbladder
bile from cholesterol gallstone patients
clearly differed from corresponding biles
in other two groups. In each case, hepa
tic bile was more saturated with choles
terol than gallbladder bile, indicating
that liver was source of abnormal gall
bladder bile.
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crystals in the gallbladder, their aggre
gation and subsequent growth produ
cing a macroscopic stone. Events in
the gallbladder are central to this
stage of gallstone formation.85 Reten
tion of the crystalline material, for
example, is critical and undoubtedly
occurs because the gallbladder never
completely empties.100 Mucopolysac
charides secreted by the gallbladder
mucosa may be another factor.101 They
can form a gel, trapping crystals or
small stones and preventing them from
leaving the gallbladder. Crystals grow
in layers by aggregation and by epi
taxy. The layer sequence may be biphasic with alternate depositions of
cholesterol and calcium bilirubinateprotein complexes.41 These complexes
may act as a cementing material hold
ing the layers of cholesterol crystals
together where epitaxy has not oc
curred. Gallstones then develop either
homogeneously as a simple stone, or
by adherence of simple stones forming
complex mulberry stones.102
The resultant stone by damaging
the gallbladder epithelium may alter
mucosal permeability to the biliary
constituents with a relatively rapid
loss of bile salts,103 rendering the bile
more unstable. Irritation of the gall
bladder or obstruction of the duct
system, or both, ultimately leads to
cholecystitis with clinical symptoms.
Loss of the gallbladder surgically48,69
or functionally in terms of roentgenographic filling104 causes a definite im
provement in biliary lipid composition.
The reduction in cholesterol satura
tion, however, may not be sufficient
to effect a return to completely normal
bile, especially in obese patients. The
beneficial effect of cholecystectomy
comes from an increased rate of bilesalt (and secondarily, lecithin) secre
tion. The small bile-salt pool cycles
more rapidly around the enterohepatic
circulation to increase bile-salt flux
through the liver and ameliorate bile
composition (Fig. 9). This finding has
further emphasized the role of the
gallbladder in cholesterol gallstone
formation.85 The primary defect may
be the hepatic production of abnormal
bile, but the presence of the gall
bladder and its effect on the entero
hepatic circulation is necessary to
elicit the liver defect.
Contributing Factors
Once the solubility characteristics of
cholesterol in bile were established, a
more critical approach to those con
ditions clinically and epidemiologically
associated with cholelithiasis was
feasible. Most of these states can be
linked directly to the occurrence of
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supersaturated bile. The risk factors
identified so far include obesity, diet,
female sex hormones, genetic and
ethnic factors, gastrointestinal disease
and hyperlipoproteinemia.
Obesity.—This common problem
has been epidemiologically linked with
gallstone disease. The mechanism re
sponsible for the production of satu
rated bile is excessive biliary secretion
of cholesterol, most likely related to
the increased cholesterol synthesis that
occurs in obese persons.69,105,106 During
active weight reduction, bile saturation
may increase in some patients but once
weight is stabilized at a reduced level,
bile composition improves.
Diet.—This has long been im
plicated, but the most obvious risk
factor so far has been a high-caloric
diet leading to obesity. Other dietary
features that have been suggested are:
high-caloric value,107 polyunsaturated
fats,108 high cholesterol,109 high carbo
hydrate110 and low vegetable fibre.111
Female sex hormones.— Estrogens
in particular adversely affect biliary
lipid composition and predispose the
patient to cholesterol gallstone dis
ease.112 When administered exogenous
ly estrogens reduce bile-salt synthesis
and secretion in animals113,114 and
reduce the size of the chenodeoxycholic acid pool in man.115 Their lithogenic effect is more likely related to
increased secretion of cholesterol,105,106 perhaps related in some
ethnic groups to obesity.96,97 The effect
of progesterone on gallbladder con
traction and the role of the sluggish
gallbladder is unknown.85
Genetic and ethnic factors.—A
genetic predisposition to cholelithiasis
is based on detecting familial aggrega
tion, both in terms of clinical disease
and formation of lithogenic bile.116 The
prevalence of cholelithiasis also cor
responds to the biliary lipid compo
sition of the racial group or geographic
region; gallstones and abnormal bile
are particularly common (up to 70%)
in native Indians of North America
and people from South America and
northern Europe. In contrast, the
Masai tribe of East Africa have low
serum cholesterol levels despite a highfat diet and high cholesterol absorp
tion, and are quite free of both gall
stones and atherosclerosis.117 These
tall, thin people seem to possess an
effective and unusual negative feed
back control of their endogenous
cholesterol synthesis which compen
sates for the influx of dietary choles
terol.
Gastrointestinal disease.-—Any gas
trointestinal condition that causes
malabsorption of bile acid (because of

ileal disease or as a result of ileal re
section) can lead to fecal losses that
may outstrip compensatory increases
in hepatic synthesis. The result is
depletion of the bile-salt pool, reduced
bile-salt secretion and eventually, in
creased cholesterol saturation.92 Cystic
fibrosis with pancreatic insufficiency
also results in malabsorption of bile
salts, production of lithogenic bile and
gallstones.118
Hyperlipoproteinemia-—Hyperlipo
proteinemia may be associated with
deranged bile-salt metabolism, but the
importance of this has not been
established.119 Hypercholesterolemia,
itself, does not heighten the propensity
to cholesterol gallstone formation, de
spite the increased serum cholesterol
largely as low-density lipoprotein, the
increased total body cholesterol and
the abnormality in conversion of
cholesterol to bile salts. Biliary lipid
secretion is normal in patients with
familial hypercholesterolemia (type
Ila hyperlipoproteinemia) and therapy
directed at correcting the disorder in
bile-salt metabolism and also creating
a net cholesterol loss has failed.120
In hypertriglyceridemia (type IV hy
perlipoproteinemia), the bile-acid pool
is large, yet many hypertriglyceridemic
patients have cholelithiasis.121 Their
problem is further compounded by
the fact that many are also obese. Un
fortunately, therapy in the form of
diet or drugs generally increases the
risk of gallstone formation.122,123 A diet
high in polyunsaturated fat, for exam
ple, increases the frequency of gall
stones108 in some patients with hyper
triglyceridemia by increasing biliary
cholesterol secretion and bile satura-

FIG. 9— Schematic representation of
effect of cholecystectomy on entero
hepatic circulation o f bile salts. After
cholecystectomy enterohepatic cycling
increases because bile-salt pool is never
trapped in gallbladder. Bile-salt pool may
be reduced but this is offset by rapid cy
cling which causes increased bile-salt and
also phospholipid secretion. Increased cy
cling with increased exposure of bile salts
to intestinal degradation results in high
proportion of secondary bile acids. In
testinal reabsorption of these secondary
bile acids can occur proximally, possibly
creating jejunohepatic shunt to speed up
enterohepatic circulation further.
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tion.124 Clofibrate, a drug used to treat
several types of hyperlipidemia, ap
pears to mobilize cholesterol stores
out of the tissues and to increase its
secretion into bile.125 It also impairs
bile-salt synthesis.112 The net result
is lithogenic bile.126 The same may
hold true for nicotinic acid.127 Chole
styramine resin, which binds bile acids,
is sometimes administered orally to
block intestinal absorption, partially
interrupt the enterohepatic circulation,
reduce bile-salt return to the liver and
so enhance the conversion of choles
terol into bile salts.128 Used in hypercholesterolemic patients to drain body
cholesterol, cholestyramine probably
has no effect on cholesterol saturation
in bile, except to alter bile acid com
position by trapping deoxycholic and
chenodeoxycholic acid in the intestine
with a compensatory rise in cholic
acid.105,106 When given to patients with
ileal dysfunction for therapy of their
bile acid-induced diarrhea, cholesty
ramine could magnify the bile-salt ab
sorption, deplete the bile-salt pool, de
spite enhanced hepatic synthesis and
worsen biliary lipid composition. Such
an effect has not been documented in
man, although this resin can produce
abnormal bile and gallstones in
baboons.129 At lower dosages, cholesty
ramine may have the opposite effect
in humans with hyperlipidemias127 or
gallstones.1™ If this is so, the most
likely mechanism is that originally
postulated by Strasberg, Petrunka and
Ilson;72 cholestyramine removes some
bile salt from the enterohepatic cir
culation, stimulating synthesis from
cholesterol and so reducing hepatic
cholesterol secretion.

finitive treatment of gallstones is cur on the degree of cholesterol unsatura
rently surgical and will likely remain tion, dissolution would be accelerated
so. A new era began, however, when by bedtime administration of cheno
gallstone formation came under scien deoxycholic acid combined with a low
tific scrutiny. The application of fun cholesterol diet.148
Not all stones dissolve on therapy.
damental knowledge has led to real
potential for medical prophylaxis and The 20% failure rate may represent
dissolution. Several extensive reviews the fact that not all radiolucent gall
on medical therapy have been pub stones consist predominantly of choles
lished,131"134 but I shall present a brief terol.24’42 Radiopaque stones are vir
tually unresponsive as most are pig
summary.
It was first demonstrated over 40 ment gallstones. Improved criteria for
years ago that exogenous administra detecting patients with cholesterol gall
tion of bile salts caused gallstones to stones should result from analysis of
disappear radiologically.135 This study cholesterol saturation in duodenal
was by no means definitive and curi bile149 and might therefore identify
ously part of the rationale for its use probable responders. The number and
was its properties as a cathartic! Not especially the size of the gallstones are
only was dyspepsia improved, but the definite factors in determining the
roentgenographic “shadows” tended duration of therapy necessary for dis
to vanish. When the physicochemical solution.133 Complete dissolution of
basis for gallstone formation was un small stones (diameter less than 5 mm)
covered76 and a metabolic basis— usually occurs within 6 to 12 months.
insufficient bile salts91— known, the Large stones may be resistant; a small
next logical step was to administer surface relative to a large mass
bile salts orally. The breakthrough provides less exposure to the decame when Thistle and Schoenfield126 saturated bile. Most stones larger than
were able to improve bile composition 1 cm in diameter require more than 2
with chenodeoxycholic acid in patients years to dissolve, while very large
with overt gallstones and also in sub stones (diameter more than 2 cm)
jects at high risk for the develop mav never respond. Stones that ap
ment of gallstones.95 Subsequent clin pear to float on oral cholecystography
ical trials proved that chenodeoxy may be more amenable to dissolution.
cholic acid promoted gallstone dis Obesity is a relative problem overcome
solution.136,137 Even more pertinently, by administering larger than normal
it soon became clear that this bile salt doses (18 to 20 m g/kg daily).150 Thus
was specific—the other two major bile certain determinants of efficacy are
salts in man, cholic acid and deoxy now clear (Table II), the most impor
tant being gallstone type.141
cholic acid, did not work.50,126,138,139
Potential adverse effects, especially
The efficacy of chenodeoxycholic
acid in dissolving radiolucent gall that of hepatotoxicity, were recognized
stones has now been fairly well early.151 Chenodeoxycholic acid is nor
established.140'142 In a dosage of 12 to mally transformed by intestinal bac
15 mg/ kg daily it will dissolve teria into lithocholic acid, a known
Medical Dissolution
approximately 80% of radiolucent hepatotoxin.152 Subhuman primate
Before the advent of modern sur gallstones. Low-dose therapy and studies have found that chenodeoxy
gery, when the physician possessed intermittent therapy, however do cholic acid therapy produces severe
only simple remedies, it was hardly not adequately revert bile to an hepatic lesions.153,154 Man, however,
surprising that numerous diets, potions unsaturated state.143,144 Bedtime admi appears to be protected from hepatic
and herbs were used in attempts to nistration of chenodeoxycholic acid145 toxicity; only transient elevations of
dissolve gallstones.1 As surgical tech and a diet low in cholesterol146 en serum transaminase levels have been
niques improved and the number of hance the desaturating effect, but not reported.131 Humans are quite capable
operative deaths decreased, the in plant sterols which block cholesterol of adding a sulfate moiety to litho
centive to find a medical cure for absorption.147 Since the rate of gall cholic acid rendering it less toxic
cholelithiasis evaporated. The de stone dissolution presumably depends and little is reabsorbed into the en
terohepatic circulation.155’156 Fears that
chronic therapy could also disturb
Table II - Factors in Successful Gallstone Dissolution
cholesterol metabolism, leading to
w ith Chenodeoxycholic Acid
cholesterol accumulation within the
Factor
body,151 were proven unfounded.157 In
Good
Bad
fact, chenodeoxycholic acid lowers
Patient weight
Normal
Obese
serum triglyceride levels but not those
On oral cholecystography
Stone size
< 1 cm
> 2 cm
of cholesterol.158 This indicates that
Gallstone type
Radiolucent (80% are cholesterol)
chenodeoxycholic acid could be useful
Floating (?)
Radiopaque,* calcified rim
when combined with clofibrate in
Gallbladder
Well visualized
Nonvisualized*
lowering serum triglyceride levels
’ Medical dissolution contraindicated.
while offsetting the adverse effect of
clofibrate on cholesterol saturation of
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bile.159 Despite their property of break
ing the gastric mucosal barrier, bile
salts administered orally have not been
associated with the development of
gastritis. Biliary colic, however, has
occurred, presumably from passage of
partially dissolved stones into the
common duct,1'17160 but most investi
gators have generally noted a lessen
ing of symptoms. Hence, chenodeoxycholic acid therapy is not suitable for
patients with biliary colic, acute chole
cystitis or cholangitis. It is most effect
ive in patients with mild symptoms, a
functioning gallbladder and an un
obstructed biliary tract. Its chief side
effect is diarrhea, which is dose-re
lated. The most distressing problem
is the likelihood of recurrence when
therapy is stopped.193 Because the un
derlying metabolic disorder has not
been permanently corrected in most
cases (unless an obvious risk factor is
eliminated, such as obesity or estrogen
therapy), gallstones can form again.
Because the risk of recurrence is life
long, a safe form of long-term pro
phylactic therapy is needed. Despite
these problems, chenodeoxycholic
acid has been used in some 10 000
patients and has been on the British
market since early 1978. It is safe and
effective.
The most intriguing aspect of this
gallstone story is why and how only
chenodeoxycholic acid works. Cholic
acid and deoxycholic acid do not.
Although the major bile salts of man
have similar properties and structure,
the liver must be capable of interpret
ing the subtle differences that do exist.
Even now we do not fully understand
the mechanism of action. Repletion of
the bile-salt pool was initially thought
to be the sole factor136 but oral ther
apy with cholic acid, the other primary
bile salt in man, did not benefit biliary
lipid composition or secretion.50 Deo
xycholic acid similarly had no real
effect on cholesterol saturation or
secretion.51,139 The key difference ap
pears to be a greater suppression of
cholesterol synthesis (reduced HMGCoA) by chenodeoxycholic acid, re
sulting in reduced cholesterol secretion
into bile.50,161,162 Patients with choles
terol gallstones tend to have increased
HMG-CoA reductase levels93 which
return towards normal with cheno
deoxycholic acid therapy.94 Whether
or not chenodeoxycholic acid acts by
reducing hepatic cholesterol synthesis
and secretion into bile, the net effect
is bile with less cholesterol relative to
bile salts and lecithin. The principal
benefit of chenodeoxycholic acid
could even be attributed to a meta
bolite, such as ursodeoxycholic acid.163
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Increased levels of this 7/3 epimer are
found in patients treated with cheno
deoxycholic acid. Acting upon this, a
Japanese group has recently demon
strated that oral ursodeoxycholic acid,
alone, is capable of dissolving stones.164
Its effective daily dose may even be
lower at 8 to 11 mg/ kg.165 This major
constituent of biliary bile acids in the
bear has been widely used for cen
turies in Japan and China as a general
remedy for liver ailments. Hence, its
safety may already have been proven.
As an added benefit, ursodeoxycholic
acid does not cause diarrhea, but
being manufactured from cheno
deoxycholic acid it costs more. Its
mechanism of action is probably sim
ilar to that of chenodeoxycholic acid.
Curiously the solvent characteristics of
ursodeoxycholic acid in vitro differ:
a little ursodeoxycholic acid is good
but more can lessen the cholesterol
holding capacity of bile. Further stu
dies are required on its efficacy, phar
macokinetics and mechanism of ac
tion.134
Alternative therapeutic agents are
also being actively investigated. Phenobarbital, for example, is a known in
ducer of microsomal enzymes in the
liver and causes marked changes in
hepatic structure and function. Obser
vations in the monkey have shown that
phenobarbital increases bile flow, bile
salt synthesis, pool size and secre
tion.166 The resultant improvement in
biliary lipid composition makes it a
logical choice for drug therapy in
patients with cholelithiasis. Unfor
tunately it also stimulates cholesterogenesis. Phenobarbital administration
in some clinical studies has decreased
cholesterol saturation, but so far
has not effectively dissolved gall
stones.160,167 Moreover, it does not en
hance the desaturation effect of cheno
deoxycholic acid.168 A surge of interest
has been created, resulting in a ple
thora of studies of various drugs. Of
these, lecithin and a-glycerophosphate
need further investigation whereas
older drugs, such as Zanchol169 and
Rowachol170 merit re-evaluation.
The role of dietary manipulation,
particularly in the form of a highfibre diet, could yield a very exciting
therapeutic modality. Burkitt, Walker
and Painter,171 have postulated that
the low frequency of gallstones and
atherosclerosis in parts of Africa and
Asia is the result of the high-fibre
content in the diet of these popula
tions. Dietary fibres are structural
components of plant cell walls which
cannot be digested within the in
testinal tract of man.172 Studies on the
effect of a high-fibre diet have so far

been uncontrolled and inconclu
sive.173,174 Bran may be effective in
desaturating bile of patients with
supersaturated bile175 or with overt
gallstones176,177 but it is not sufficiently
effective to dissolve the stones. The
beneficial effect of these dietary fibres
may be mediated by their binding of
bile acids in the intestinal lumen, re
ducing their absorption and return to
the liver, increasing bile-salt synthesis
and so decreasing biliary cholesterol
secretion.172 Once better designed stu
dies using chemically purer forms of
fibre have identified the most potent
component and defined an optimal
dose, then a natural plant material
could easily become the basis for long
term gallstone prophylaxis: to prevent
recurrences in patients whose gall
stones have been dissolved medically
and for those with abnormal bile at
high risk of stone formation.
The knowledge that biophysical
and metabolic investigations have im
parted over the past decade to the pa
thogenesis of gallstones has created
the field of medical management.
Medical dissolution of cholesterol gall
stones has become a reality and is
likely to become an increasingly im
portant mode of therapy in the future.
Cholecystectomy is currently excellent
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treatm ent for most patients with cal
culous biliary tract disease. The re
lative merits of medical dissolution
versus surgery, especially in patients
with minimal symptoms, should there
fore provide an interesting debate in
the next decade. Only careful obser
vations and cost-effectiveness studies
will demonstrate the practical feasibil
ity of medical therapy. Meanwhile,
research efforts should be directed
towards other goals: the detection of
people at risk, which presently re
quires aspiration of bile through a
duodenal tube for analysis; a more
complete understanding of cholesterol
gallstone formation and dissolution,
which should yield future therapeutic
agents; better comprehension of the
calcified pigment stone, which so far
has eluded accurate description or
dissolution; and safe, acceptable ther
apy to prevent recurrence in patients
who have undergone gallstone dis
solution.
I thank Mrs. Linda Ward for her
secretarial assistance. Figs. 3, 4 and 5
are reproduced by permission from
Shaffer EA, S mall DM: Gallstone
disease: problems and management, in
R avitch MM, et al (eds): Current
Problems in Surgery, copyright © 1976
by Year Book Medical Publishers, Inc.,
Chicago, and Figs. 8 and 9 from
Shaffer EA: The role of the gallblad
der in gallstone formation, in Gall
stones, F isher MM, G oresky CA,
Shaffer EA, et al (eds), Plenum Pr,
New York, 1979, p 223
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Dosage and administration: Adults: the intramuscular dose is 750
mg three times daily and the intravenous dose is 750 mg or 1.5 g
three times daily.
For most infections the usual recommended dosage is 750 mg every
8 hours (2.25 g/day) and may be administered either l/M or I/V.
For severe or life-threatening infections, the higher dose is sug
gested. For infections of the lower respiratory tract, caused by gram
negative organisms, the higher dose may also be required. A nti
biotic therapy for infections caused by B-hemolytic streptococci
should be continued for at least 10 days.
There is insufficient evidence for recommending the use of ZINACEF
in children or in nursing mothers.
Dosage in adults with impaired renal function: ZINACEF may be
used for patients with impaired renal function but a reduced dosage
must be employed and serum levels of cefuroxime may need to be
monitored. The following Table shows the dosage recommendations.
Serum creatinine
(mg/mL)
2.0 - 3.5
3 5 - 6.0
> 6 .0

Glomerular filtration rate
(mL/min)*

Dose of ZINACEF
(mg)

2 0 -5 0
1 0 -2 0
10

500 t.i.d.
500 b id
500 q.d.

<

4
4

4

T o r more precise calculations, whenever possible, the glomerular
filtration rate should be used.
Patients on dialysis should receive an additional dose of 500 mg at
the end of dialysis.
Preparation of solutions: For intram uscular use: Add 3.2 m l of
Water for Injection to a vial containing 750 mg of ZINACEF and
shake gently to produce an opaque suspension. The total volume
obtained is approximately 3.7 mL.
For intravenous use: When a single bolus injection is prepared. 750
mg of ZINACEF is dissolved in 7 mL of Water for Injection, which pro
vides a volume of approximately 7.5 mL. Reconstitution of 1.5 g of
ZINACEF is done by adding 19 mL of Water for Injection, thereby ob
taining an approximate volume of 20 mL.
For short intravenous infusion, 1,5 g of ZINACEF is dissolved in
49 mL of Water for Injection, resulting in an approximate volume of
50 mL.
Administration: Intramuscular: ZINACEF should be injected into a
large muscle mass to m inim ize pain. As the preparation is in
suspension form, a 21 gauge needle should be used
Intravenous: ZINACEF may be administered intravenously either by
a bolus injection or by a short intravenous infusion over a period of
approximately 30 minutes.
For continuous intravenous infusions, a solution of ZINACEF (1.5 g
dissolved in 19 mL of Water for Injection) may be added to a suitable
bottle containing an appropriate intravenous infusion fluid in the
amount calculated to give the desired antibiotic dose.
Compatibility: Reconstituted primary solutions of ZINACEF may be
further diluted with Sodium Chloride Injection B.P. 0.9% w/v. 5%
w /v Dextrose Injection B.P. or Compound Sodium Lactate Injection
B.P. (Hartmanns Solution).
NOTE: The pH of 2.74% w/v Sodium Bicarbonate Injection B.P con
siderably affects the colour of the solution, therefore, this solution is
not recommended for the dilution of ZINACEF However, if required,
for patients receiving Sodium Bicarbonate Injection by infusion, the
ZINACEF may be introduced into the tube of the set.
NOTE ZINACEF should not be mixed with aminoglycoside antibiotics
(e g. gentamicin sulfate, tobramycin sulfate, amikacin sulfate) be
cause of potential interaction.
Stability: The dry powder in vials should be stored below 25°C and
protected from light.
Suspensions of ZINACEF for intramuscular injection and aqueous
solutions for intravenous injection retain their potency for 6 hours if
kept below 25°C. and for 48 hours if refrigerated. More dilute solu
tions, i.e. 1.5 g in 50 mL Water for Injection, retain their potency for
at least 12 hours if kept below 25°C. and for 36 hours when re
frigerated. Some increase in the intensity of colour may occur on
storage.
Dosage forms: ZINACEF is available for intramuscular or direct in
travenous injection in 18 mL vials containing cefuroxime sodium
powder equivalent to 750 mg of cefuroxime, in packs of five.
For intravenous injection, 30 mL vials contain cefuroxime sodium
powder equivalent to 1.5 g of cefuroxime, in individual packs.
For intravenous infusion. ZINACEF is available in 75 mL vials con
taining cefuroxime sodium powder equivalent to 1.5 g of cefuroxime.
in individual packs.
Product Monograph available on request.
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Concomitant Revascularization of Intestines
during Aortoiliac Reconstruction:
Deterrent to Catastrophic Bowel Infarction
Jack H.M. K waan ,

md , facs ,

John E. C onnolly ,

This report points out the necessity
for revascularization of the intestines
in patients with asymptomatic
mesenteric occlusive disease at the
time of aortoiliac reconstruction.
Emphasis is placed upon the well
being of 15 patients followed up for 2
to 5 years, who underwent concomitant
bypass grafting of asymptomatic
stenosis or occlusion of the mesen
teric arteries, in contrast to the fatal
or near fatal outcome of 3 patients
who did not receive such corrective
measures. Aortomesenteric bypass
grafting in conjunction with aortobifemoral bypass grafting or endarterec
tomy does not involve additional
operative exposure or add greatly to
the operating time, but may prevent
catastrophic bowel infarction resulting
from progressive occlusion of the
mesenteric arteries.
Ce rapport fait etat de la necessity
de revasculariser I'intestin chez les
malades ayant une occlusion mesenterique asymptomatique au moment
de la reconstruction de I'aorte iliaque.
On souligne le bien-etre de 15 malades
suivis pendant 2 a 5 ans apres avoir
subi la greffe d’une derivation pour
une stenose ou une occlusion des
arteres mesenteriques, en comparaison
a I'issue fatale ou quasi fatale chez
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3 patients qui n'ont pas eu de telles
mesures correctives. Une derivation
de I'aorte mesenterique effectuee
de concert avec une derivation de
I'aorte femorale ou une endarteriectomie n'ajoute pas a I'exposition
operatoire et ne prolonge pas beaucoup
ie temps d’intervention, mais peut
prevenir un infarctus catastrophique
de I’intestin resultant de 1'evolution
d’une occlusion des arteres mesen
teriques.

md , frcs [c ]

concomitant correction of the occlu
sive mesenteric disease in contrast to
the fatal or near fatal outcome in
the other 3 patients who did not re
ceive these corrective measures at
the time of the aortofemoral pro
cedure.
Patients

We reviewed the records of 150
patients who underwent aortoiliofemoral reconstruction. Of these, 20
had significant occlusive disease in
volving the celiac and mesenteric
Following
the
introduction
of circulation, identified preoperatively
homologous grafting for abdominal by aortography. All 20 patients were
atherosclerotic occlusion by Oudot1 men, aged 56 to 68 years (mean 62
and for aneurysm by Dubost, Allary years). Two of the patients had had
and Oeconomos2 only 29 years ago, a previous myocardial infarction that
reconstruction of the aorta has be required hospitalization. Four others
come one of the most common vas had undergone carotid endarterec
cular operations. Successful correc tomy. None were diabetics, but all
tion of thrombotic, occlusive or were heavy cigarette smokers.
aneurysmal lesions of the aorta has
Intermittent claudication was the
resulted in the preservation of life main complaint leading to operation.
and limb. With refinements in sur The claudication was brought on by
gical technique, the operation has walking distances from 3 to 9 m.
become safe and complication rates No patient had a history of abdomi
continue to decline. One of the more nal symptoms or weight loss.
critical and yet preventable complica
The systolic blood pressure in
tions following aortic operation is these 20 patients ranged from 110
gangrene resulting from intestinal to 180 mm Hg (mean 130 mm Hg).
ischemia. While immediate postoper The diastolic range was 80 to 100
ative bowel infarction may be readily mm Hg (mean 90 mm Hg). Femoral
recognized, delayed bowel necrosis pulses were diminished in 12 and
from progressive constriction of a absent in 8 patients. Ankle and
known mesenteric arteriosclerotic oc popliteal pulses were absent in all.
clusive lesion has rarely been docu A bruit was clearly audible over the
mented.
mid-abdomen in 13 patients.
Aortography revealed aortoiliac
Twenty patients who underwent
aortobifemoral bypass grafting for stenosis in all patients, stenosis of
arterial insufficiency and in whom the deep femoral artery in 6 and
asymptomatic mesenteric artery oc occlusion of the superficial femoral
clusion was noted on the preopera artery in 16 patients. Of particular
tive arteriogram form the basis of importance was the lateral aortothis report. We emphasize the well gram: stenosis of the superior mesen
being of 15 of 17 patients, followed teric artery was noted in 6 and oc
up for 2 to 5 years, who underwent clusive disease of the superior and
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inferior mesenteric arteries was seen
in the remaining 14 patients. The
occlusive and stenotic mesenteric
lesions were the classic type of proxi
mal segmental arteriosclerosis.
Treatment and Results

Because of the differences in the
operative procedure and the clinical
outcome, the patients were arbitrarily
divided into two groups.
In group 1 were three patients
who underwent aortic reconstruc
tion only. Because of the lack
of intestinal symptoms, no attempt
was made to revascularize the intes
tinal circulation even though stenosis
of the superior mesenteric artery and
occlusion of the inferior mesenteric
artery were evident on the lateral
aortogram Two of these three pa
tients were readmitted 1 and V/z
years later because of abdominal
pain. In both instances, the aorto
gram showed progression of the su
perior mesenteric artery lesion (Figs.
1 and 2). At operation, impending
gangrene of the small bowel was
noted. Fortunately, emergency re
vascularization with an aortomesenteric bypass graft was successful. The
third patient, readmitted 2 years after
the aortofemoral procedure, had ir
reversible bowel changes that pre
cluded mesenteric revascularization
and died of massive intestinal infarc
tion.
In the second group (group 2) of
17 patients, concomitant revasculari-

FIG. 1—Preoperative lateral aorto
gram showing stenosis of celiac and su
perior mesenteric arteries (arrows).

zation was undertaken. Aortomesen- plished more than 20 years ago,4
teric bypass grafting with saphe operative revascularization of the in
nous vein or reinforced polytetra- testines is still carried out relatively
fluoroethylene was combined with infrequently. Eklof, Hoevels and
the insertion of a button of the in Ihse5 noted that, until 1977, only
ferior mesenteric artery. The addi about 200 cases of vascular recon
tional procedure did not require in struction for chronic intestinal is
creased operative exposure and chemia had been reported. Often
added no more than 1 hour to the the surgeon is confronted with an
operating time. Except for two pa acute abdominal condition for which
tients who died of myocardial infarc a frustrating and futile laparotomy
tion at 1 and 2 years after operation, for massive bowel gangrene is done.
respectively, the remaining 15 pa
Much of the emphasis in the cur
tients are well at follow-up periods rent literature is upon early recogni
of 2 to 5 years. None have experi tion of the signs and symptoms such
enced symptoms of malabsorption, as postprandial abdominal pain and
abdominal pain or weight loss refer weight loss, which are frequently
able to intestinal ischemia following vague and elusive, or upon labora
the concomitant revascularization tory tests such as dye dilution or
procedures. Subsequent follow-up intestinal absorption studies which
aortography has confirmed patency are often nonspecific and seldom
of the aortomesenteric graft in five pathognomonic in the early phases
of these patients.
of this lethal condition. Aortography,
especially in the lateral projection,
will identify arteriosclerotic stenosis
Discussion
or occlusion of the splanchnic ves
Advances in vascular surgery have sels. However, in the absence of
made it possible to correct occlusive clinical confirmation of mesenteric
disease of almost all major vessels ischemia, mesenteric revasculariza
and great strides have been made in tion is seldom attempted, even
saving limbs from the ravages of though the operative procedure can
atherosclerosis. In certain critical be performed with ease and without
vessels, such as the carotid arteries, complications.
revascularization is accepted even as
Our attention was first drawn to
a prophylactic measure.3 Equally the condition when angiographic evi
important is the operative correction dence of superior mesenteric artery
of the occluded celiac and mesenteric stenosis was noted incidentally in a
circulations. Although the surgical patient subjected to aneurysmec
treatment of symptomatic mesenteric tomy.1’' Failure to heed this critical
occlusive disease was first accom- information almost resulted in dis
aster, when the patient returned 1
year later with impending bowel gan
grene and a totally occluded superior
mesenteric artery. The revasculariza
tion should have been carried out
at the time of aneurysmectomy.
The experience in our group 1 pa
tients was similar except for the one
patient whose irreversible bowel
changes precluded subsequent mesen
teric revascularization. The clinical
course of these patients demonstrates
well the consequence of mesenteric
arterial occlusive disease. In fact, the
natural course of arteriosclerotic oc
clusion of the mesenteric vessels does
not differ appreciably from that of
other peripheral arteries such as the
femoral, deep femoral or popliteal
arteries.
The concept of prevention in ar
terial surgery is not new. As early
as 1961, Rob7 stated that “the ad
vances in arterial surgery have been
FIG. 2—Lateral aortogram, lV i years
such that in many patients with an
after aortobifemoral bypass showing
progression of disease with complete oc arterial stenosis, a prophylactic pro
cedure to prevent the development
clusion of superior mesenteric artery
(arrow).
of an arterial thrombosis is now jus-
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tified, not only for occlusion of the
extracranial cerebral arteries, but in
other sites including other visceral
arteries and the vessels to the limb”.
Although their concern centred upon
bowel ischemia immediately after op
eration, Johnson and Nabseth8 out
lined various conditions in which re
construction of the splanchnic circu
lation should be performed prophylactically at the time of aortic opera
tion. Eidemiller, Nelson and Porter9
reporting on the surgical treatment
of chronic visceral ischemia in eight
patients, mentioned that prophylactic
revascularization was carried out
during aortoiliac endarterectomy in
two of their patients in the hope of
avoiding bowel gangrene and death
in these asymptomatic patients dur
ing hypotensive episodes following
operation.
On the basis of our experience,
reconstitution of the mesenteric vas
culature at the time of aortoiliofemoral reconstruction is essential if

important arteriosclerotic mesenteric
disease is noted. An abdominal bruit
may be an important clue. The ad
vantages of obtaining a lateral aortogram are emphasized for identifying
occlusive lesions of the mesenteric
artery. The meandering mesenteric
artery, when present, is also helpful
in that it indicates the need to ob
tain a lateral view of the abdominal
aorta. Clearly, the addition of a
simple concomitant aortomesenteric
bypass graft does not complicate the
standard aortic reconstructive proce
dure, but may forestall future inte
stinal ischemia or infarction associated
with a poor prognosis and high m or
tality.
References
1. O udot J : La greffe vasculaire dans
les thromboses du carrefour aortique. Press Med 59: 234, 1951
2. D ubost CM, A llary M, O economos N : Resection of an aneurysm
of the abdominal aorta: reestablish

3.

4.

5.

6.

7.

8.
9.

ment of continuity by preserved hu
man arterial graft, with result after
5 months. Arch Surg 64: 405, 1952
T hompson JE, P atman RD, P ersson
AV: Management of asymptomatic
carotid bruits. Am Surg 42: 77, 1976
M ikkelsen WP, Z aro JA j r : In
testinal angina: report of a case
with preoperative diagnosis and sur
gical relief. N Engl J Med 260: 912,
1959
E klof B, H oevels J, I hse I: The
surgical treatment of chronic intes
tinal ischemia. Ann Surg 187: 318,
1978
K waan JH, C onnolly JE, M olen
RV. et al: The value of arteriographj
before aneurysmectomy. Am J Surg
134: 108, 1977
Rob CH: The indications for opera
tion in occlusive disease of the
visceral arteries. J Cardiovasc Surg
( Torino) 3: 223, 1962
J ohnson WC, N abseth DC: Visceral
infarction following aortic surgery.
Ann Surg 180: 312, 1974
E idemiller LR, N elson JC, P orter
JM: Surgical treatment of chronic
visceral ischemia. Am J Surg 138:
264, 1979

Carotid Endarterectomy:
Early and Late Results in 161 Patients
C harles R. L y e , m d , fr c s [c ]* and A llan R. D o w n s , m d , fr c s [ c ], FAesf

Over a 15-year period, 161 patients
underwent 186 carotid endarterec
tomies. O f these patients, 97% had
symptoms preoperatively. The incidence
of new neurologic deficits appearing
immediately postoperatively was 7%
(13 of 186), and 1.6% (3 of 186)
were major permanent strokes. Nine
teen patients were lost to follow-up.
The cumulative patient survival was
83% at 5 years and 59% at 10 years.
The cause of death in the late
postoperative period was ascertained
in 22. of 24 patients; it was related
to ischemic cardiac disease in 16.
There w ere no late deaths from
neurologic complications. New or
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recurrent neurologic symptoms
developed in the late postoperative
period in 22 patients. There were
no disabling strokes in this group.
The cumulative rate of freedom from
new neurologic symptoms was 82%
at 5 years and 71% at 10 years.
Repeat angiography was carried out in
12 patients who had new or recurrent
neurologic symptoms in the late
postoperative period. The repaired
artery was found to be widely
patent in nine, stenosed in one
and occluded in two. Reoperation
of the same carotid was
not performed in this series. Routine
intraoperative angiography aided the
detection and correction of potential
technical problems.
Au cours d'une periode de 5 ans,
161 patients ont subi 186 endarteriectomies carotidiennes. De ces malades,
87% presentaient des symptomes
avant I’operation. L'incidence des
nouveaux deficits neurologiques
apparaissant immediatement apres
I’intervention fut de 7% (13 sur 186),
e t 1.6% (3 sur 186) etaient des
accidents cerebro-vasculaires majeurs
permanents. Dix-neuf malades ne se
presentment pas aux examens de

controle. Le taux cumulatif de survie
a 5 ans fut de 83%, et de 59% apres
10 ans. La cause du deces dans la
periode post-operatoire tardive a pu
etre precisee pour 22 patients sur 24;
celle-ci etait rattachee a la maladie
coronarienne dans 16 cas. II n'y eut
aucune mort tardive resultant de
complications neurologiques. Durant
la periode post-operative tardive il y
a eu apparition ou recidive des
symptomes neurologiques chez
22 patients. On n’a enregistre aucun
accident cerebro-vasculaire invalidant
dans ce groupe. Le taux cumulatif
des cas exempts de symtomes
neurologiques fut de 82% apres 5 ans
et de 71% apres 10 ans. Des angio
graphies de rappel ont ete pratiquee
chez 12 malades presentant une
recidive des symptomes neurologiques
durant la periode post-operatoire
tardive. La reparation s'est averee
amplement fonctionnelle dans neuf cas,
stenosee dans un et obliteree dans
deux cas. Aucune re-operation de la
meme carotide n'a ete effectuee dans
cette serie. L'angiographie pratiquee
systematiquement durant I’operation
a aide a detecter, puis a corriger les
problemes techniques possibles.
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Carotid endarterectomy is now estab
lished treatment for transient ischemic
attacks and for preventing stroke in
patients with extracranial carotid oc
clusive disease. While the reported
operative morbidity and mortality
vary widely, it is generally believed
that mortality should be less than
1% and permanent neurologic se
quelae less than 4% .' This paper will
review early and late results in a
series of patients who underwent
carotid endarterectomy at the Health
Sciences Centre in Winnipeg.
Patients and Methods

Between Jan. 1, 1965 and Dec.
31, 1979, 161 patients (108 men, 53
women) underwent 186 endarterec
tomies. Their ages ranged from 42
to 81 years (median 64 years). Of the
25 patients with bilateral operations,
the second side was operated on with
in 3 months in 22 and in 1 to 4 years
because of recurrent symptoms
in the other 3. Five patients (3%)
were asymptomatic. In 87 (54%)
the symptoms were limited to tran
sient ischemic attacks. A further 63
(39% ) had sustained strokes but had
recovered relatively well; the strokes
had occurred at least 3 weeks before
operation. Six patients (4%) had sus
tained an acute stroke and underwent
operation within a few hours to a
few days.
Of our patients 146 (91%) pre
sented with complaints referable to
one carotid system; 98 (61%) had
paresis, 52 (32%) had paresthesia,
52 had amaurosis fugax and 39
(24%) had dysphasia. Carotid bruits
were present unilaterally in 42%,

bilaterally in 36% and were absent
in 22%. Eleven patients (7%) had
vertebrobasilar symptoms and 13
(8%) had global symptoms preoperatively.
Preoperative angiograms were re
viewed and each carotid stenosis was
classified by maximal reduction of
diameter (Table I). Eighty-five per
cent of the lesions repaired were
hemodynamicaily important; 28 pa
tients (16%) had contralateral occlu
sion.
All endarterectomies were per
formed under general anesthesia.
Blood pressure was maintained at or
near ward levels with pharmacologic
agents when necessary. Arterial pres
sure of carbon dioxide was main
tained at normal or slightly hypocarbic levels. A Javid shunt was
used in 97 patients (36%). Endar
terectomy was completed with simple
running closure in all but four pa
tients in whom saphenous vein
patches were used to widen the out
flow. Angiography was done at the
end of the operation in 113 patients
(70%) and in two instances prompted
immediate revision of a seemingly
adequate repair.
Results

Early Results
One death occurred within 24
hours of operation. The patient sus
tained a stroke intraoperatively and
this was complicated by myocardial
infarction. Stroke occurred perioperatively in 10 patients, 6 of whom
made rapid and relatively complete
recoveries. Four patients, including

the patient who died, had relatively
severe neurologic deficits. Three pa
tients suffered a transient ischemic
attack during the operation. The re
lation of preoperative clinical status
to immediate postoperative status
is shown in Table II.
Late Results
Nineteen patients have been lost
to follow-up. Twenty-four patients
have died, 16 of cardiac disease.
New or recurrent neurologic symp
toms developed in 22 patients—
strokes in 6 and transient ischemic at
tacks in 16. Symptoms were ipsilateral
to the original repair in 12, contra
lateral in 6 and nonspecific in 4.
There have been no late deaths due
to stroke. Cumulative patient survival
calculated by the life-table method
was 83% at 5 years and 59% at 10
years (Fig. 1). The cumulative rates
for freedom from new neurologic
events were 82% and 71% at 5 and
10 years, respectively (Fig. 2). In
five of the six patients who had a
new stroke, the deficit was mild. The
only patient to have a severe late
stroke did so during an operation to
clip a giant intracranial aneurysm 1
year following his endarterectomy.
Cumulative rates for freedom from
stroke, including operative stroke,
were 93% at 1 month, 90% at 5
years and 82% at 10 years.
Twelve patients underwent repeat

¥
*

Table I— Degree of Stenosis of Internal Carotid Artery Expressed as Reduction of Vessel
Diameter
Reduction of diameter, % of patients

100%

f

Status
Repaired carotid
Opposite carotid

(occluded)

>60%

<60%

0.5
16

84
18

15
66

FIG. 1— Cumulative survival of 161
patients following carotid endarterec
tomy.

Table II— Relation of Preoperative Clinical Status to Immediate Postoperative Morbidity
New postoperative deficit, %

►

Preoperative status
(no. of patients)

Transient
ischemic
attack
None

Cerebrovascular
accident

Major
cerebrovascular
accident

Asymptomatic (5)
Transient ischemic attack (87)
Stable cerebrovascular accident (63)
Acute cerebrovascular accident (6)

89
90
97
84

0
3
0
0

11
7
3
16

11
1
3
16

Mean

92

2

6

3

FIG. 2— Cumulative rates of freedom
from new neurologic symptoms follow
ing carotid endarterectomy in 161 pa
tients.
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angiography following the onset of
new neurologic symptoms. The origi
nal repair was widely patent in nine,
stenosed in one and occluded in two.
Endarterectomy of the contralateral
carotid artery alleviated symptoms
in three cases. There were no reoper
ations for recurrent stenosis or occlu
sion in this series.

tervention in the patient with fluctu
ating mild stroke and stroke in the
immediate postoperative or postangiographic periods.6 We currently
limit our indications for operation
to the patient with a mild, acute,
fixed deficit, in whom superimposed
severe or crescendo transient ischemic
attacks develop. We have not in-

D iscussion

Carotid endarterectomy has been
shown to reduce the incidence of
subsequent stroke in patients with
transient ischemic attacks and to re
duce the incidence and severity of
recurrent stroke.1 To influence fav
ourably the natural history of carotid
occlusive disease, operative morbidity
and mortality must be held to a mini
mum. This in turn demands adequate
preoperative assessment and selec
tion of patients as well as meticulous
technique.
Ninety-three percent of our pa
tients underwent endarterectomy fol
lowing either a transient ischemic at
tack or a stroke followed by good
recovery. This is the group for whom
the benefits of endarterectomy have
been best established. In contradis
tinction to earlier reports,2-3 the over
all incidence of cerebral deficits in
the present study was greater in the
group with transient ischemic attacks.
However, we found no substantial
difference in permanent major neu
rologic morbidity between the groups
with a transient ischemic attack and
with stable stroke.
The management of the patient
who presents with an asymptomatic
carotid bruit remains controversial.4,5
Although some surgeons take a more
aggressive approach we limit investi
gation and treatment to those pa
tients about to undergo major intra
abdominal or intrathoracic vascular
procedures. One such patient in our
series sustained a permanent hemi
plegia which was probably related to
intraoperative hypotension occurring
during the endarterectomy procedure
in the absence of a temporary shunt.
Six patients in this series under
went endarterectomy within 72 hours
of the onset of an acute stroke.
Although there were no deaths, no
patient was immediately improved
and one was appreciably worse
postoperatively. Most surgeons no
longer consider the acute pro
found stroke a surgical lesion because
of the associated high operative mor
tality and relatively small benefit de
rived. There is, however, consider
ably more support for operative in
538

Fig. 3b
FIG. 3— Bilateral percutaneous caro
tid punctures in patient with recent
stroke: (a) right carotid occlusion (ar
row). (b) Critical stenosis of left carotid
artery (arrow).
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vestigated or reoperated upon pa
tients with acute strokes postopera
tively.
Complete preoperative arch and
selective biplane carotid angiography
of high quality are absolutely essen
tial both for the adequate assessment
of occlusive lesions and for the ex
clusion of intracranial lesions. Such
angiography should be performed
using a remote catheter technique
since direct percutaneous carotid
puncture is hazardous in patients
with suspected extracranial occlusive
disease (Fig. 3). The carotid bifur
cation must be clearly visualized as
small lesions can be hidden by adja
cent overlying vessels (Fig. 4).
Angiography at the end of the
operation has been nearly routine for
the last 7 years of the study, al
though some authors have suggested

Fig. 4b
FIG. 4— (a) Selective innominate and
(b) right carotid angiograms in patient
with recently formed embolus in right
middle cerebral artery. Crossing vertebral
artery completely obscures localized
stenosis of carotid artery (arrow).
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a low benefit to risk ratio with this
technique.7 Seventy percent of our
patients had “completion angiogra
phy" and the overall incidence of
neurologic deficits postoperatively
was 4%. The rate of severe perma
nent strokes in this group was 2%.
In contrast, patients who did not
undergo completion angiography had
overall and severe neurologic com
plication rates of 15% and 4% re
spectively. In two patients notable
technical defects were identified
(Figs. 5 and 6). One was repaired
with a distal vein patch, the other by
proximal extension of the endarterec

tomy. Both patients did well. It is
entirely possible that similar unde
tected lesions were responsible for
part of the increased morbidity in
the second group. There was no
evidence of increased risk associated
with the angiography itself and we
continue to advocate its use.
Stable anesthesia, with blood pres
sure maintained at ward levels, and
meticulous operative technique are
probably the most important factors
in reducing operative morbidity.
Ideally all patients should have ar
terial lines in place before anesthesia
is induced since it is at this time

that hypotension is most likely to
occur. Marked fluctuations in blood
pressure are not infrequent perioperatively and must be controlled
promptly.8,9 Particularly hazardous
are hypotension before and during
endarterectomy and extreme hyper
tension in the immediate postopera
tive period. These two complications
were associated with at least two of
the severe permanent strokes in our
study. Hypotension is managed by the
use of pressor agents such as NeoSynephrine or aramine and hyperten
sion with nitroprusside. Induction
doses of intravenous barbiturates have

Fig. 5b
Fig. 5a
Fig. 5c
FIG. 5—(a) Preoperative and (b) intraoperative angiograms of patient with severe stenosis of right carotid artery
(arrow). Although repair appeared adequate externally, completion angiogram (b) demonstrated distal end-point stenosis (ar
row). This was corrected by application of vein patch (c).

Fig. 6a
Fig. 6b
Fig. 6c
FIG. 6—(a) Preoperative and (b and c) intraoperative angiograms of patient with severe stenosis of left carotid artery.
Repair was performed with temporary shunt and residual proximal atheromatous plaque was not recognized until completion
angiogram was obtained. Endarterectomy was subsequently extended.
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been used occasionally when the
cerebral collateral circulation ap
peared marginal and the use of a
shunt was undesirable. This tech
nique may, however, result in pro
longed and profound hypotension.
The use of temporary shunts re
mains controversial.*0 A shunt was
used in 36% of the patients in this
series and the decision to shunt was
based on a number of factors includ
ing recent stroke, severe contralateral
disease,
absence of hemispheric
cross-fill, poor back-bleeding at the
time of operation and a carotid
stump pressure of less than 50 mm
Hg. The last two indices can be
unreliable since back-bleeding is of
ten hard to quantify and accurate
stump pressures are dependent upon
reliable equipment and a knowl
edgeable anesthetist. Moreover, the
systemic blood pressure must not be
allowed to drop below that measured
at the time the stump pressure is
assessed. At least one operative
stroke in our series was probably re
lated to placing inappropriate trust
in an erroneously high stump pres
sure. In contrast to earlier re
ports,11'12 we were not able, in this
study, to define any consistent gen
eral relationship between operative
morbidity and either shunt use or
stump pressure. There was, however,
increased morbidity in the presence
of severe contralateral disease; 4 of
28 patients with contralateral occlu
sions sustained strokes intraoperatively. This has been observed by
others.13 Conversely, results were
best when the repaired carotid was
critically stenosed. Among 59 pa
tients with stenosis of more than
9 0 % who underwent endarterectomy
without a shunt there was only one
operative stroke. We continue to use
shunts on a selective basis following
our earlier guidelines, but particu
larly in patients with less severe
stenosis.
The absence of late death due to
stroke in our series supports the
prophylactic value of endarterec
tomy. Late recurrence of cerebral
symptoms was uniform throughout
the initial 10 postoperative years with
an average attrition rate of 3% to 5%
annually. Symptoms were seldom
severe and usually were not related
to recurrent stenosis of the repair.
No secondary repairs were per
formed in this series but we advocate
angiography for patients with new
or recurrent complaints.
Summary and Conclusions
In this series 161 patients under
went 186 endarterectomies with an
540

operative mortality of 0.5% and
permanent major neurologic m or
bidity of 2 % . The 5- and 10-year
cumulative mortality rates were 83%
and 5 9 % , respectively, and 5- and 10year rates of cumulative freedom
from all neurologic symptoms were
82% and 71% respectively. Late
neurologic symptoms were not se
vere. Intraoperative angiography was
found to be valuable and safe. We
shall continue to use intraoperative
shunting in selected patients.
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Silver sulfadiazine is a light-stable white powder, very slightly soluble in
water and most organic solvents, but readily dissolved in nitric acid and
concentrated ammonia solutions.
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The action of silver 2-(4-ammobenzenesulfonamide)-pyrimidine is
bactericidal. Little of the active ingredient is absorbed; the silver
sulfadiazine acts as a drug depot which reacts slowly with cellular debris
and microorganisms on the burn wound to release that amount of
sulfadiazine which is absorbed. The silver remains largely at the wound
surface.
There is little delay in the bactericidal activity of silver sulfadiazine, and
the experimental evidence suggests that its site of action is the bacterial
cell membrane. Silver sulfadiazine inhibits DNA, RNA, and protein
synthesis which may explain its bactericidal activity.
Silver sulfadiazine has been shown to be effective in vitro against various
strains of the following pathogens isolated from infected burn wounds:
Pseudomonas aeruginosa, Aerobacter aerogenes, E. coli, Proteus mirabilis,
Candida albicans, Proteus vulgaris. Staphylococcus aureus, Klebsiella
spp.. Aspergillus mger.
Indications and Clinical Uses

Flamazine is indicated for the adjunctive treatment and prevention of
infection in severe burns and leg ulcers. Flamazine is particularly effective
against Gram negative organisms, such as Pseudomonas aeruginosa.
Flamazine has not caused electrolyte disturbance, acidosis or subsequent
hyperventilation. It causes very little skin sensitization and there is no
pain on application. Flamazine does not cause argyria and does not cause
staining of the skin or bedclothes. The development of bacterial resistance
to Flamazine would seem to be slight.
A disadvantage that has been noted, in burn therapy, is a delay in the
separation of slough from the burn wound, due to the absence of bacteria
which contribute to slough separation by producing proteolytic enzymes
and by stimulating leucocytosis.
Contraindications

Flamazine is contraindicated in women of child-bearing age, unless the
burnt area is more than 20% of the total body surface, or in the
investigator's judgment benefit outweighs risk. Further, because
sulfonamide therapy is known to increase the possibility of kermcterus,
Flamazine should not be used in pregnant females at term, in premature
infants, or in newborn infants in the first month of life.
Warnings

Flamazine should not be used in patients with a known, or suspected,
sensitivity to sulfonamides.
Precautions

Flamazine should be used with caution if hepatic or renal function is im
paired. The cream should be applied with a sterile gloved hand or spatula.
Each jar and tube of Flamazine cream should be reserved for the exclusive
use of a single patient, and any remaining cream should be discarded on
completion of treatment. Flamazine should be stored in a cool place.
Adverse Reactions

Sensitivity has been observed, but the incidence is lower than with other
sulfonamides. A fall in white blood count has been demonstrated occa
sionally, but this is not thought to be associated with the treatment per se
and more likely reflects the condition of the burned patient.
Symptoms and Treatment of Overdosage

As a topical preparation. Flamazine does not lend itself to overdosage by a
systemic route; topically applied it has shown little evidence of toxicity in
experimental animals, and the clinical situations in which it has been
studied are such that evidence of systemic toxicity, if any, is unlikely to be
revealed.
The absorption studies which indicate that only a small percentage of
sulfadiazine and virtually no silver are absorbed suggest that overdosage
following topical administration, even on burned skin, is unlikely to be a
problem.
Dosage and Administration

Flamazine should be applied topically in a layer approximately 3-5 mm
thick with a sterile gloved hand or spatula, daily, or more often as
required. The wound may be dressed or left open.
Duration of administration can be from a few days to several months,
depending upon the nature and severity of the wound. Treatment should
be continued until satisfactory healing has occurred or until the burn site
is ready for grafting. The drug should not be withdrawn from the
therapeutic regimen while there remains the possibility of infection
except if a significant adverse reaction occurs.
Dosage Forms

Flamazine is presented as a cream containing 1% w /w silver sulfadiazine
in containers of 500 g and tubes of 50 g.
Complete product monograph available on request.
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body defences

They should share the
same treatment.

mazine

The antibacterial of choice
for burns is also the logical
choice for leg ulcers.
Flamazine
has met one of the toughest challenges of
topical antibacterial therapy. Major burns
And the reasons that have made it the
number one antibacterial in burn
therapy make it the logical anti
bacterial for the treatment of
leg ulcers.
Unsurpassed effectiveness.
Flamazine is bactericidal and
fungicidal. Its exceptionally
broad spectrum covers most
major pathogens, including
Staph, aureus, Pseudomonas
aeruginosa and Candida
albicans.

And the dual bactericidal action of silver and sulfadiazine prevents the
emergence of resistant strains.
Unsurpassed safety. Flamazine has been used extensively on full
thickness burns, yet the incidence of systemic effects and sensitization
was reported to be less than 'U of 1%!' Sensitization to topical anti
biotics or antiseptics often disrupts the
treatment of leg ulcers. This problem
is unlikely to occur with Flamazine.
Soothing pain relief.
Flamazine actually relieves
the pain and itching of leg
ulcers. And its water-miscible
base allows it to be removed
easily and painlessly.
1. Data on File. Smith & Nephew Inc.

S.N

Smith & Nephew Inc.
2100, 52 Avenue
Lach ine, Que., C anada
H8T 2Y5

Hemodynamic Assessment of the Aortoiliac Segment:
a Prospective Study
G.G . B arber ,

m d , f r c s [c ],

H. F o ng ,

A test for assessing stenosis in the
aortoiliac segment is described in
which femoral pressure is measured
directly by continuous monitoring
and an intra-arterial injection of
papaverine is used to augment blood
flow. This test has been described
previously but is not widely used.
A prospective study of this test
was carried out on 64 patients and
the results were compared with those
obtained by aortography. The test
helped to determine whether an
operation on the aortoiliac segment
was indicated. Clinical results were
assessed. Thirty-two of the 64 patients
were found to have significant inflow
disease (more than 50% stenosis).
They underwent aortic reconstruction
with total relief or improvement of
symptoms in all cases. Aortography
demonstrated an essentially normal
aortoiliac segment in 3 of the 32
patients and 16 had only irregular
segments with no definite stenosis.
The authors conclude that any
patient presenting with sufficient
indication to warrant reconstructive
surgery who has a normal or equivocal
angiogram should undergo the
papaverine pressure test.
On decrit une epreuve permettant
d'evaluer une stenose de I'aorte iliaque,
alors que la pression femorale est
mesuree directement sous controle
continue e t oil de la papaverine est
injectee par voie intra-arterielle
afin d’augmenter le debit sanguin.
Cette epreuve a ete decrite precedemment mais elle est peu utilisee.
Une etude prospective de cette
epreuve a ete realisee chez 64
malades e t les resultats ont ete
compares a ceux qui ont ete obtenus
par aortographie. Ce test a contribue
a determ iner si une operation de
I’aorte iliaque etait indiquee. Les
resultats cliniques ont ete evalues.
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Trente-deux patients sur 64 ont
presente une atteinte de I'apport
sanguin (avec une stenose superieure
a 50%). Ms ont subi une reconstruction
de I'aorte donnant un soulagement
complet ou une amelioration des
symptomes dans tous les cas.
L'aortographie a demontre une aorte
iliaque essentiellement normale chez
3 patients sur 32 et 16 ne montraient
que des segments irreguliers sans
stenose evidente.
Les auteurs concluent que tout
patients presentant les conditions
suffisantes pour indiquer une
restauration chirurgicale mais qui
montre un angiogramme normal ou
equivoque devrait passer le test
de tension a la papaverine.

A decision must often be made on the
basis of knowledge, sufficient for action
but insufficient to satisfy the intellect.
I mmanuel K ant

We wish to reintroduce a method of
hemodynamic assessment of the aor
toiliac segment in order to add intel
ligence to our actions in performing
reconstructive surgery. The success
of reconstructive arterial surgery in
relieving the symptoms of ischemia
depends on an accurate assessment of
the level at which arterial diseases
cause functional impairment and then
on bypass of the diseased segment.
It is well recognized that clinical
assessment and single-plane angio
graphy may not detect significant
(more than 50% stenosis) aortoiliac
occlusive disease.1,2 This may con
tribute to early failure of a femoropopliteal bypass graft if reconstruc
tion is performed when occult inflow
disease (aortoiliac segment) is pres
ent.'1 Gosling, King and Woodcock,4
Johnston5 and Harris and associates6
assessed aortoiliac flow before opera
tion using the Doppler principle. Al
though they confirmed the value of
this method it is expensive in terms
of equipment used.
To obtain a more accurate estimate
of the extent of aortoiliac im
pairment, blood flow and pressure
characteristics must be measured
during exercise or at least during in
creased flow. Moore and Hall7 meas
ured directly arterial pressure and
responses to increased flow during
exercise. Quin, Evans and Bell8 car
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ried out a similar test but used papa
verine to simulate the increased flow
of exercise. The relative drop in
pressure that confirmed the presence
of significant aortoiliac disease was
18%. In our prospective study, which
was carried out to confirm the ac
curacy of this method, 20 mg of
papaverine was used to increase
blood flow.
Patients and Method

Sixty-four patients were studied at
the Ottawa Civic Hospital between
July 1, 1977 and Mar. 31, 1980; 63
had intermittent claudication and 1
had gangrene. All patients were
suspected clinically to have arterial
occlusive disease of sufficient severity
to warrant arterial reconstruction
and were considered to be acceptable
operative risks, if an appropriate
anatomic lesion was detected. Aorto
graphy was carried out on all pa
tients by the translumbar or the Seldinger transfemoral approach. Aorto
iliac segments were then graded as
follows: grade 1—normal (17 pa
tients), grade 2— irregular but with no
notable stenosis (31 patients), grade
3—stenosis greater than 50% (13
patients) and grade 4—occluded (3
patients). On the basis of clinical
assessment and aortography, the
papaverine pressure test was applied
to two groups of patients. In one
group clinical examination and aorto
graphy demonstrated that the patients
had significant (more than 50% ste
nosis) aortoiliac disease; the pressure
test was done to assess its ac
curacy. In the second group were
patients with essentially normal aortograms who were thought, on clin
ical grounds, to have occult aortoiliac
disease. In them the papaverine pres
sure test was done as a diagnostic
procedure.
The common femoral artery was
cannulated with an 18-gauge plastic
needle (Becton, Dickinson and Com
pany, Rutherford, NJ) and with a
pressure transducer (Statham Instru
ments, Oxnard, Calif.) the pressure
tracings for each artery were re
corded on photographic paper with a
VR6 Simultrace Recorder (Electronics
for Medicine, White Plains, NY).
Papaverine (20 mg) was introduced
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into a manometer line through a three- bypass grafting) and all had either
way tap, care being taken to avoid complete relief of symptoms or appre
introducing air bubbles. The pres ciable improvement of symptoms by
sure changes induced by the papaver clinical assessment at follow-up from
ine were recorded on the multichannel 2 to 34 months later. Eleven of the
recorder (Electronics for Medicine) 22 patients had serious femoropopliwith the opposite leg being used as a teal occlusive disease; of these 11, 4
control. Relative percentage falls in might have undergone only femorothe systolic pressure were noted. After popliteal grafting (with possible graft
allowing 10 minutes for dissipation of failure) if the pressure test had
the drug we studied the pressure re not been carried out. Of the three pa
sponse to papaverine in the other tients who did not undergo an inflow
leg. Most of the tests were performed operative procedure, two were consi
under local anesthesia without seda dered unacceptable candidates for an
tion; all patients experienced a burn aortic graft and one underwent a dis
ing sensation.
tal procedure alone for limb salvage.
Several patients with unilateral iliac
Thirty patients had a pressure drop
artery thrombosis were studied at between 8% and 18%. Of these, 11
operation after exposure of the com had grade 1 disease as shown by aor
mon femoral artery. The other side tography, 13 had grade 2 disease and
was thought to have normal inflow. 6 had grade 3 disease. Our decision to
The test was done to measure the flow operate on these patients was influ
increase with papaverine, using the enced by clinical and radiologic cri
electromagnetic Gould-Strattan flow teria as well as by the results of the
meter (model SP2204; Statham Instru papaverine pressure test. Of the pa
ments), and to compare the response tients in this group 10 had an aortic
on the two sides.
graft and all had clinical improve
Patients were divided into three ment, 5 underwent femoropopliteal
groups according to the results of the bypass grafting, 1 had a sympathec
pressure test: (a) patients with a re tomy and 14 had no treatment.
lative pressure drop more than 18%,
Nine patients had a pressure drop
(b) those with a pressure drop be of less than 8% ; two patients had
tween 8% and 18% and (c) those grade 1 disease and seven had grade 2
with a pressure drop of less than 8%. disease as shown by aortography. One
Arteriograms were compared with the patient underwent a femoropopliteal
results of hemodynamic assessment bypass graft, one had a sympathec
and the treatment and results of treat tomy and seven were not operated
ment were studied. No complications upon. The two operative cases in this
were attributed to the procedure.
group had a good short-term result.
In two of the three patients who
had complete occlusion on one side,
Results and Discussion
the opposite side showed no evidence
Twenty-five patients had a pres of disease on angiography and the
sure drop greater than 18% (Table I). femoral pulses were normal. On pres
On the aortogram 4 of these patients sure testing, the pressure dropped
had no apparent aortoiliac disease, 11 33% and 28% on the occluded side
patients had grade 2 disease, 7 patients and 16% and 15% on the other side.
had grade 3 disease and 3 patients
Of the 32 patients who received an
had grade 4 disease. In other words, aortic graft, 18 had a standard exer
15 of these 25 patients had insufficient cise response test in which the ankle
angiographic evidence of disease of pressures were measured using the
the aortoiliac segment to indicate the Doppler principle. Of the 18 patients
need for an aortic graft. Twenty-two tested preoperatively and postoperof these 25 patients underwent an in atively, 16 showed a notable improve
flow operative procedure (aortoiliac ment after the aortic graft was placed.
The papaverine pressure test is ac
curate if an 18% drop in pressure is
used as the level of significance.
T a b le 1 - C o r re la tio n o f A o r to g r a p h ic G rade

Twenty-two patients with this pressure
drop underwent aortic grafting as did
10 patients with a pressure drop be
tween 8% and 18%. Our follow-up is
short, but each patient selected for
operation with the aid of the pressure
test was either improved or completely
relieved of symptoms. Three patients
had normal aortoiliac segments and
16 patients had only irregular seg
ments. Therefore, 19 patients would
not have been considered candidates
for an inflow operative procedure
without the benefit of the pressure
test, yet they were all improved
by aortic grafting (Table II). Two
patients had previously undergone
femoropopliteal grafting with no im
provement and were helped only after
the aortic graft was inserted. One of
these patients had functioning grafts
and the other occluded grafts at the
time of aortic operation.
Our conclusions are very similar to
those of Brener and associates9 who
used reactive hyperemia to increase
blood flow and Moore and Hall7 who
used exercise to increase flow. Any
patient presenting with indications for
arterial surgery whose aortogram de
monstrates a normal or an equivocal
aortoiliac segment should undergo the
papaverine pressure test. The test is
diagnostic of aortoiliac disease if there
is a pressure drop greater than 18%
(100% good results even if the aor
togram is not impressive). If the pres
sure drop is between 8% and 18%
the test may be used in conjunction
with clinical and angiographic assess
ment to determine the level at which
vascular reconstruction should be
done. The papaverine pressure test has
helped us to avoid performing femoro
popliteal reconstructions alone on pa
tients with occult aortoiliac disease.
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Enhancement of Thrombus Formation by
Vascular Prostheses
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The stagnation point flow experiment
has been used to identify the micro
scopic events that occur in thrombus
formation on foreign surfaces. In this
investigation it was used to study
the role of vascular grafts in pre
activating blood, as well as the role
of pretreatment of these grafts to
remove the gas nuclei. The experiment
was carried out under two conditions:
(a) in which whole blood was
led from the carotid artery of a dog
to the undersurface of a microscope
coverslip (control experiment) and
(b) in which blood flowed from
the left carotid artery of the dog
through a 10-cm vascular graft to the
right carotid artery and finally to
the flow chamber for visualization.
The thrombus morphology, time to
thrombus formation and thrombus
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adhesiveness to the foreign surfaces
were compared using knitted Dacron,
woven Dacron, expanded polytetrafluoroethylene (PTFE) and saphenous
vein grafts. Blood led through the
vascular grafts showed a marked
predisposition to thrombus formation,
with no change in clotting times. Knitted
Dacron most highly preactivated the
blood, while PTFE showed a lesser
degree of preactivation.
Treating expanded PTFE so that it
may be completely wetted eliminated
any activation of blood and caused
blood to behave as if it had not
contacted a foreign surface. It was
the only graft material, including
autogenous vein to demonstrate this
property. Therefore, of the materials
tested, hydrophobic Teflon with no
entrapped gas appears blood
compatible.
[.'experience du debit au point de
stagnation a ete employee afin
d'identifier les evenements qui
surviennent a I'echelle microscopique
pendant la formation du thrombus sur
des surfaces etrangeres. Dans ce
travail de recherche, il a ete utilise
dans le but d'etudier le role des
greffons vasculaires sur la pre
activation du sang, de meme que le
role d'un pre-traitement de ces
greffons visant a eliminer les noyaux
gazeux. L'essai a ete realisee sous
deux conditions experimentales: a) une
ou le sang entier a ete transports
de la carotide d'un chien sous la
lamelle d'un microscope (controle) et
b) I'autre oil le sang a circule de la
carotide gauche du chien a travers un
greffon vasculaire de 10 cm vers
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la carotide droite et, finalement,
jusqu’a une chambre a circulation
pour etre visualise.
La morphologie du thrombus, le
temps de formation du thrombus et
I'adhesivite du thrombus sur des
surfaces etrangeres ont ete compares
pour les mailles de Dacron, le tissage
de Dacron, le polytetrafluoroethylene
(PTFE) dilate et les greffons de
veines saphenes. Le sang qui avait
circule a travers les greffons vascu
laires a manifesto une nette predis
position a la formation de thrombi
sans alteration du temps de coagula
tion. Les mailles de Dacron ont
preactive le sang le plus fortement
alors que le PTFE a demontre le plus
faible degre de pre-activation.
Lorsque le PTFE dilate a ete traite
de facon a ce qu'il puisse se mouiller
completement, I'activation du sang
a ete eliminee et celui-ci s'est
comporte comme s'il n'etait pas venu
en contact avec une surface etrangere.
C'est le seul material! utilise pour les
greffes, y compris les veines autogenes,
qui a demontre cette propriety, En
consequence, de tous les materiaux
testes, le Teflon hydrophobe purge
des gaz qui y adherent semble le
plus compatible avec le sang.
T h e interaction o f b loo d w ith foreign
surfaces m ay lead to thrombosis,
hem olysis or p rotein denaturation.1
N ew er
vascular
prostheses
have
achieved
su fficien t biocom p atib ility
that these problem s are less evident
on an im m ediate o r short-term basis.
N evertheless when b lo o d is in contact
w ith large areas o f fo r e ig n surface as
in hem odialysis and cardiop u lm on ary

T H E C A N A D IA N J O U R N A L O F S U R G E R Y

bypass, the more subtle effects of
foreign surfaces on blood become in
creasingly important.
Means for gauging these bloodsurface interactions are not well de
fined. The standard Lee-White clotting
time has two disadvantages: it is a
static test that measures clotting time
rather than thrombogenesis and the
blood is in contact with several foreign
surfaces (air, the needle and syringe
used to draw the blood) other than
the surface of interest.
The stagnation point flow experiment2,3 offers an opportunity to ob
serve blood in its native state as it
contacts a foreign surface (Fig. 1). It
also allows the experimenter to have

FIG . 1— Stagnation point flow experi
ment. Carotid artery is rigidly mounted.
Blood emerges from artery at 2 m l/m in
and central stream enters region of ob
servation. Blood diverges from stagnation
point in radially symmetric manner to
collecting gulley around coverslip.

F IG . 3— Blood flow within stagnation
point flow chamber. Blood accelerates
away from stagnation point at rate pro
portional to its distance from stagnation
point.

the blood contact any amount of for
eign surface before observation.4 In
this study, the rate at which thrombi
form upon initial contact with a glass
surface is compared under two sets of
conditions: (a) control conditions in
which blood has contacted no foreign
surface before the surface of observa
tion (b) test conditions in which blood
is led through a vascular prosthesis
before entering the region of observa
tion.
M e th o d s

Control Experiment
The stagnation point flow experi
ment was used in its original form to
serve as a control. The left carotid ar-

FTG. 2— Left: stagnation point flow
experim ent in usual configuration. C a
rotid artery is divided low in neck so th a t
blood passes through circle of W illis
before entering flow chamber. This
diminishes tendency for pulsatile flow
within observation cham ber. R ight: sys
tem fo r evaluating vascular grafts. G ra ft
is placed from right to left carotid artery
so that blood flowing into cham ber has
previously passed through graft.

tery of a dog weighing 20 kg was
divided low in the neck to allow the
mobilized distal segment to enter the
flow chamber freely (Fig. 2). Within
the chamber blood flowed to the
undersurface of a glass coverslip (Fig.
3). The blood diverged at the stagna
tion point in an axisymmetric fashion
and collected in a circumferential gut
ter around the field of observation
Blood was withdrawn from the cham
ber (and the animal) at a rate of 2
ml/min. Before each run the chamber
was primed with saline. A typical run,
measured from the time of blood with
drawal until the field of observation
was 80% to 100% covered with
thrombus, lasted approximately 15
minutes. Eight runs were performed
in each experiment, leading to a
gradual blood loss in the dog of 250
to 300 ml. No blood was returned to
the animal.
Observation of the glass coverslip
was by dark field reflected light micro
scopy. Events were recorded perma
nently by means of Polaroid photo
micrography at x 4 0 magnification.
The estimated surface coverage by
thrombus (expressed in percent) was
obtained from these photographs (Fig.
4). In any run, surface coverage was
estimated at four separate times and
the best-fit linear approximation to
these points was drawn. This line was
used to obtain an estimate of the time
to 50% surface coverage which was
the point used for comparison of all
runs.

F'lG. 4__Photograph of throm bus covering approxim ately 50% o f surface
taken at 8 minutes into run. N um ber of w edge-shaped throm bi point to w ards stag
nation point (S). D iscrete white dots are individual leukocytes and areas of a m o r
phous cloudy m aterial (arrows) are fibrin and platelet aggregate (reduced by 28%
from X 40).
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Test Experim ent

To test the activation of the blood
by vascular prostheses, an 8 X 8-cm
segment of prosthesis was inserted
joining the right and left carotid arte
ries and held in place with two T
tubes (Fig. 2). Since the pressure is
higher in the right carotid artery than
in the distal segment of the left, the
blood flowed through the graft, down
the left carotid artery, into the cham
ber and the field of observation.
Knitted Dacron, woven Dacron,
microporous polytetrafluoroethylene
(PTFE) and autogenous vein were
used. The time for 50% thrombus for
mation to take place was measured.
Heparin was not administered. Hema
tocrit and leukocyte counts were meas
ured in all experiments and a run
was discounted if these were abnor
mal. Leukocyte counts typically
reached levels of 15 to 20 X 109/1
during the course of the experiment.
The results with PTFE that was
treated so as to assure complete wet
ting of the hydrophobic material are
presented. (Details of this form of
pretreatment and the rationale for its
application are presented elsewhere.4)

natural vascular endothelium prior to
its observation.
The stagnation point flow experi
ment is readily modified to interpose
vascular graft material before the point
of observation. By timing the rate at
which thrombi form within the cham
ber, the blood-activating properties of
different vascular prostheses may be
compared. It is instructive to note
that the morphology of thrombi form
ing from blood that contacts a
vascular prothesis differs from blood
that does not. In the control case,3
thrombi grow downstream from dis
crete initiation points on the foreign
surface, thus developing a wedgeshaped mass pointing towards the
stagnation point. However, when a vas
cular graft is interposed, the blood is
activated, leading to thrombus growth
in concentric rings around the stagna
tion point. Thrombus typically starts
near the periphery of a field and
grows towards the stagnation point.
This is consistent with the fact that

Results

Typical results for any one run are
presented in Fig. 5, which also shows
how the time to 50% coverage was
estimated.
Control data were obtained from 13
runs.
Fig. 6 shows the average time to
50% coverage in all cases. All the
vascular grafts used with the exception
of the thoroughly wetted PTFE led to
marked enhancement of thrombus for
mation, the time to surface coverage
being approximately one fifth of the
control time.
When expanded PTFE is treated to
remove all entrapped air within this
hydrophobic material, the blood-gas
interface is removed so that blood will
contact no surface other than the
PTFE. This inert material shows no
activation of blood by our criteria and
was the only material to give this re
sult.

FIG. 5—Time taken for 50% surface
coverage by thrombus. In each run,
four points are taken presenting ap
proximate rate of thrombus growth on
surface. Straight line is best fitted to these
points and time to 50% coverage is inter
polated from this line.
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Discussion

The stagnation point flow experi
ment was originally conceived to study
thrombus formation on foreign sur
faces.2 As such it revealed the micro
scopic events that occur around the
time of thrombus inception and
growth. A variety of surfaces have
been studied3 in which blood touching
the foreign surface under study has
contacted no surface other than
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the peripheral blood is more highly
activated, since it would have been the
blood in contact with the vascular
graft.
In other work4 we have shown that
the surface contacted by blood flow
ing through expanded PTFE, inserted
in the standard surgical manner, is
approximately 80% gas and 20%
PTFE. The detrimental effects of a
blood-gas interface have been known
since the days when the bubble oxy
genator was in use, but the potential
detrimental effects of submicroscopic
amounts of gas have never been de
monstrated. Trudell, Boudreau and
Van de Water,5 using ethanol as a
priming solution, were able to obtain
better contact of blood with PTFE
than would occur with standard sur
gical techniques and they showed
improved tissue ingrowth into the
pores of the PTFE. It is known clinic
ally that PTFE grafts frequently are
encapsulated rather than incorporated
into the surrounding tissue. Trudell,
Boudreau and Van de Water stated
that the ethanol seemed to improve the
porosity of the PTFE, a result con
sistent with simple wetting of this hy
drophobic material.
Dacron is known to be a highly
active material in contact with blood
and indeed relies upon blood clotting
for integrity of the knitted graft. The
thrombus-initiating effect of Dacron
is well illustrated in these experiments.
Similarly, autogenous vein in the dog
served to activate blood. This is not
surprising, since dissection of the vein
is traumatic. Whether this finding is
applicable to the model of human
saphenous vein is uncertain. No vein
in a dog is subjected to the pressures
of the saphenous vein in the human.
Nevertheless, damage to human sa
phenous vein also occurs during its
removal, so that it would be expected
to activate blood as well, at least
until the vein is well healed.

4. M adras PN, W ard CA, J ohnson W R:
age using vascular grafts. Data from all
runs. Control data were obtained from
13 runs while figures for any vascular
prosthesis were obtained from 7 runs
each. Bars represent one standard devia
tion.

VOLUME 23, NO. 6, NOVEM BER 1980 /

Enhanced thromboresistance of sur
faces by denucleation. Trans A m Soc
A rtif Intern Organs (in press)
5. T rudell LA, Boudreau L, V an de
W ater JM, et al: Alcohol-treated
PTFE vascular grafts. Trans A m Soc
A rtif Intern Organs 24: 320, 1978

THE CANADIAN JOURNAL OF SURGERY

Transluminal Dilatation in the Treatment of Peripheral
Arterial Occlusive Disease
K.W. J ohnston, md, frcs[c], facs,* R.F. C olapinto, md, FR C P[c],f E.P. H arries-Jones, md , ch b, FRCP[c],t
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B.S. Goldman, md, frcs[c], facs,* J.A. K ey, mb , ch b , frcs, frcs[c]* and R.D. W eisel , md , frcs[c], facs*
The authors review their experience
over a 2-year period with transluminal
arterial dilatation using the Griintzig
catheter. In 96 patients 136 aortoiliac
or femoropopiiteal arterial segments
were dilated. The success rates at
1 year were 76% and 70%, respectively,
for aortoiliac and femoropopiiteal
dilatations. The early and late
results indicate that this procedure
is useful in managing peripheral
arterial occlusive disease in certain
patients and that there are few
complications when the procedure is
carried out by a skilled angiographer.
Les auteurs passent en revue une
experience de 2 ans de la dilatation
de la lumiere arterielle a I'aide du
catheter de Griintzig. Une dilatation
a ete pratiquee sur 136 segments
arteriels aorto-iliaques ou femoropoplites, chez 96 malades. Les taux
de reussite apres un an ont ete
de 76% et 70% respectivement pour
les dilatations aortoiliaques et
femoro-poplitees. Les resultats a court
et a long terme indiquent que cette
intervention est utile au traitement
des maladies obliterantes des arteres
peripheriques chez certains patients,
et que les complications sont rares
quand I’intervention est pratiquee
par un specialiste en angiographie
experiments.

Transluminal dilatation of stenosed or
occluded arteries is popular in Europe
but until recently there has been
relatively little interest in the technique
in North America. Dotter and
Judkins1 first described percutaneous
recanalization of arteries in 1964, but
their method was similar to bouginage
and was associated with a high rate
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of thrombotic and embolic complica
tions. Thus it never became popular.
An important advance was made in
1974 by Griintzig and Hopff2 who
developed a dilating catheter similar
in design to a Fogarty embolectomy
catheter hut having a cylindrical rather
than a spherical balloon. It consists
of an inner base catheter, through
which dye can be injected for angio
graphy and pressures measured, and
an outer catheter with a balloon
dilating segment.
The purpose of this paper is to de
scribe our experience with translu
minal dilatation using the Griintzig
catheter and to discuss the role of this
technique in managing patients with
peripheral arterial occlusive disease.
Patients and Method

The details of the technique have
been described previously.3’4 We do
not perform percutaneous transluminal
dilatation at the time of diagnostic ar
teriography but rather as a planned
second procedure. This approach
provides time for the radiologist and
vascular surgeon to determine the best
method for managing the vascular dis
ease and to discuss the therapeutic
alternatives with the patient. Anti
platelet drugs are administered for 2
or 3 days before the procedure and
for 2 to 3 weeks after. Heparin (5000
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units) is administered during the dila
tation procedure but anticoagulants
are not used on a long-term basis.
Under local anesthesia the femoral
artery is punctured. The angiographic
catheter is introduced percutaneously
and passed through the stenosis or oc
clusion. Once beyond the obstruction
the catheter is withdrawn over a
guidewire and replaced by a Griintzig
dilating catheter with a balloon of
appropriate length and diameter. The
balloon is inflated and after the dila
tation, arteriography is repeated. The
success of the procedure is evaluated
hy measuring the pressure gradient
across the stenosis and comparing
it with the predilatation value.
In the last 2 years at the Toronto
General Hospital, 96 patients have
undergone transluminal dilatation of
136 aortoiliac or femoropopiiteal ar
terial segments. The procedure was
considered an early success if all of
the following improved: angiographic
appearance, systolic pressure gradient
and ankle systolic pressure. Subse
quently, dilatation was considered suc
cessful if the symptoms, the ankle
systolic pressure and Doppler ultra
sonographic recordings were im
proved.
Results

Of the 136 arterial segments dilated,
evaluation of the early or late results,
or both, was impossible in nine cases
because the results were equivocal,
because no pressure gradient was
present across the stenosis or because
the patient could not be re-evaluated
owing to associated medical problems.
The results of nine miscellaneous
dilatations are shown in Fig. 1. Of
38 dilatations for femoropopiiteal ste
nosis or occlusion, 1 (2.6%) was a
technical failure because the catheter
could not be advanced through the
stenosis. The success rate at 1 year
was 76% (Fig. 2). Of 79 aortoiliac
dilatations, 3 (3.8%) were technical
failures. At 1 year the cumulative suc
cess rate was 70% (Fig. 3).
The results of aortoiliac dilatation
differ depending on the site and ex
tent of the disease. The cumulative
success rate at 1 year was much
greater for dilatations of isolated com-

FIG. 1—Results of miscellaneous dila
tations. Success is denoted by open circle,
failure by closed circle. Cl = common
iliac, El = external iliac, CF = common
femoral, SF — superficial femoral,
DF = deep femoral.
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mon iliac lesions and of external iliac
lesions alone than for dilatation per
formed for combined common and
external iliac lesions (Fig. 4).
Complications in our series were
few. Small hematomas of the groin
were common. One patient had a
large groin and scrotal hematoma
which delayed his discharge from hos
pital but the hematoma resolved spon
taneously. Ischemia due to thrombosis
occurred in two patients, in one fol
lowing common iliac dilatation of a
diffusely diseased aortoiliac segment
and in the other following dilatation
of a segment of the deep femoral ar
tery. Both patients were given heparin
immediately and were improved with
in 2 to 3 hours. Ischemia due to em
bolic complications was not a serious
problem clinically, although small em
boli were frequently seen on the post
dilatation angiogram. Other complica
tions, such as rupture of the vessel or
of the balloon, did not occur.
Discussion

No patient should undergo trans
luminal dilatation without first being
assessed by a physician or surgeon
who is fully aware of the alternatives
for treating peripheral arterial occlu
sive disease. The patient is best man
aged on an individual basis, which
requires close cooperation between
the angiographer and the vascular
surgeon.
Transluminal dilatation should be
performed only by skilled, well trained
angiographers. Before attempting the
procedure, the physician should have
extensive general experience in angio
graphy and should take the op
portunity to observe the technique in
a centre where it is performed often.
The role of transluminal dilatation
is not yet clearly defined. It may be

a useful adjunct to operation, in treat
ing surgical complications or an al
ternative to operation in certain pa
tients. When a patient has multilevel
disease, but the principle lesion is in
the femoropopliteal segment, we have
found that transluminal dilatation is
a useful adjunct to distal vascular re
construction since it can be used to
correct a minor localized iliac lesion
which might jeopardize the patency of
the distal repair. Although our ex
perience is limited, the technique may
also be useful for correcting minor
lesions at the time of vascular recon
struction.
Transluminal dilatation may play
a role in treating certain complications
of saphenous vein bypass grafting,
such as valve bicuspid hyperplasia,
intimal hyperplasia or atherosclerosis.
Anastomotic defects are unlikely to be
corrected by dilatation.
Transluminal dilatation works in
some patients and is clearly an altern
ative to operation, but the selection of
patients is difficult. The majority of
those with notable ischemic symptoms
of the lower extremity have diffuse
disease involving the aortoiliac, femo
ropopliteal or tibial artery segments,

or all three. Thus, it is not surprising
that only a small percentage of patients
with vascular problems are candidates
for transluminal dilatation. The clinic
al and hemodynamic improvements
observed following this procedure are
less impressive than those following
operation, but this is offset by the
lower mortality and morbidity, short
ened hospital stay and reduced cost.
For patients with mild claudication
who do not accept their mild disabil
ity, transluminal dilatation is a good
alternative. For them, the procedure is
not really an alternative to operation
since we do not operate on patients
with mild claudication. For patients
with severe, disabling claudication,
transluminal dilatation appears to be
a good alternative to operation if the
aortoiliac or femoropopliteal lesion is
localized, less than 10 cm long and
not calcified, if the symptoms are of
recent onset and if the patient is a
poor surgical risk. Patients with severe
manifestations of peripheral vascular
disease including ischemic pain, ul
ceration or gangrene usually do not
have localized disease which is
amenable to dilatation and, in general,
require operation.
Summary

FIG. 3—Results
tations.

of aortoiliac

dila

We have presented our experience
at the Toronto General Hospital with
transluminal dilatation. In the last 2
years, 136 peripheral arterial segments
have been dilated. The early and late
results indicate that the procedure is
useful in managing certain patients
with peripheral arterial occlusive dis
ease and that there are few complica
tions when the procedure is carried
out by a skilled angiographer.
We thank Mrs. C. Mori for her sec
retarial assistance and Mrs. B. Hanson
and Mrs. S. Ungaro for performing the
vascular laboratory studies and assisting
in the patient follow-up.
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FIG. 2—Results of femoropopliteal
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ber of patients at each follow-up interval.
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mon iliac (square), external iliac (circle)
and combined common and external iliac
(triangle) segments.
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1980 GALLIE MEMORIAL LECTURE

Lung Cancer in Historical Perspective: Lessons
from the Past, Implications of Present Experience,
Challenges for the Future
N orman C. D elarue, md , m s ( to r ), facs, fccp , frcs[c ]*

Initial experience with a review of
the 5882 patients with lung cancer
admitted to the Toronto General
Hospital since 1933 was encouraging
as the salvage rate seemed to improve.
By 1966, the overall salvage rate had
increased from 3% to 13%. At that
time, a 16% salvage rate was predicted,
based on a resectability rate of 40%
and a 5-year survival for resected
cases of 40%. It seemed reasonable
to anticipate continuing improvement
as the value of treating early cases
became more apparent.
A recent review of 450 consecutive,
unselected patients seen in primary
referral showed that significant
changes have not occurred in the past
decade despite therapeutic innovations.
These innovations have included radical
combination therapy (preoperative
radiotherapy) for biologically favour
able, locally advanced disease (e.g.,
a 5-year survival of 31% in squamous
carcinoma), limited resection in the
compromised host (e.g., 5-year survival
rate of 18% following sleeve resection),
and combination chemotherapy with
irradiation for small cell anaplastic
carcinoma (e.g., approximately 20%
free of active symptomatic disease
for longer than 2 years). Unfortunately,
the relatively small number of patients
affected by these special maneuvers
does not appreciably alter the
overall survival rate.

In the 450 patients, the resectability
rate has been 43.5% with a 5-year
survival of 42.0% in resected cases,
producing a salvage rate of 18.3%.
There was a 5-year survival of 2.4%
in inoperable disease treated by other
means (primarily radiotherapy). Sal
vage has, therefore, been achieved,
in only one of five patients— scarcely
an acceptable figure.
The profession must encourage
greater use of screening programs
and offer the stimulus for increased
interest in withdrawal programs. The
potential dividends of these programs
are outlined. Short of these measures,
modifications of management are
unlikely to be reflected in
acceptable improvements in patient
salvage. The professional challenge
is clear-cut and exciting.

depit des innovations therapeutiques.
Ces innovations englobent le traitement
radical dissociation (la radiotherapie
preoperatoire) pour les tumeurs locales
avancees mais biologiquement
favorables (p. ex. une survie a 5 ans
de 31% dans I’epithelioma malpighien),
la resection partielle chez le malade
hypotheque (p. ex. une survie a 5 ans
de 18% a la suite d'une resection
en manchon), et I'association de
chimiotherapie et de radiotherapie
dans les cas de cancer anaplasique
a petites cellules (p. ex. environ
20% de patients exempts de maladie
symptomatique active pendant plus
de 2 ans). Malheureusement, le nombre
relativement petit de malades touches
par ces interventions speciales ne
modifie pas de fapon appreciable
le taux de survie d’ensemble.
Chez les 450 patients, le pourcentage
de cas operables a ete de 43.5%
et le taux de survie a 5 ans, de 42.0%
pour les cas operes, donnant un
pourcentage de malades possiblement
sauves de 18.3%. On a enregistre
un taux de survie a 5 ans de 2.4%
chez les malades inoperables traites
par d'autres moyens (par radiotherapie
surtout). La recuperation des malades
n'a pu etre obtenue que chez un patient
sur cinq, une statistique difficilement
acceptable.
La profession doit donner son appui
a une plus grande utilisation des
programmes de depistage et offrir
le stimulus necessaire pour accroitre
I'interet dans les programmes de
sevrage. Les benefices escomptes
de ces programmes sont soulignes.
Ces mesures mises-a-part, les
modifications de traitement sont peu
susceptibles de se traduire par une
amelioration acceptable du nombre
de malades aptes a etre sauves.
Le defit pour la profession est net et
stimulant.

Reprint requests to: Dr. Norman
C. Delarue, 25 Donlea Dr.,
Toronto, Ont. M4G 2M1

La premiere impression qui s'est
degagee de I’etude des 5882 malades
atteints d'un cancer du poumon,
accueillis au Toronto General Hospital
depuis 1933, a ete encourageante
puisque le taux des patients susceptibles d'etre sauves a semble s'etre
ameliore. En 1966, le pourcentage
global des sujets possiblement sauves
etait passe de 3 a 13%. A ce moment,
etant donne un pourcentage de cas
operables de 40% et une survie a
5 ans pour les cas operables de 40%,
on prevoyait un pourcentage de
sujets possiblement sauves de 16%.
II semblait raisonnable d’anticiper
une amelioration constante puisque
I’interet de traiter les cas des le debut
etait devenue plus evidente.
Une etude recente de 450 malades
non choisis, vus consecutivement en
premiere consultation, a revele qu’aucun
changement significatif n’est survenu
au cours de la derniere decennie en
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Mr. President, honoured guests, fel
lows of the College and assembled
“Gallie slaves”.
Today we gather to honour the
memory of Dr. Gallie. I have very
special personal memories of that
great man which must inevitably
colour my expression of respect for
the enormous contributions he made
in the professional arena even though
they seemed to emanate from him
in an unending stream of unique
images.
From the purely persona] standpoint
it would be no exaggeration to state
that any of us who were fortunate
enough to have been put through our
paces as “Gallie slaves”, and most
particularly as his chief residents,
would consider the opportunity to
deliver the Gallie memorial address
the climax of our own careers—such
was the affection, loyalty and admira
tion with which we viewed Dr. Gallie
and his deep concern for our educa
tion and welfare. Seldom does anyone
in a position of authority earn such
love and respect from those for whom
he has assumed responsibility. Dr.
Gallie assumed that responsibility with
such enormous zeal and enthusiasm
that he became personally involved
in all our careers. A warm and com
fortable feeling of camaraderie de
veloped amongst us as a bond which,
once forged, could never be broken.
Consequently we owe him a debt of
gratitude that can never be fully
repaid.
At no time was this more apparent
than during World War II when he
kept in touch with all of us no matter
where we were. How important it was
for us to be reassured in those sad
times by his protective and proprietary
influence.
It is always Dr. Gallie's personal
warmth and concern which those who
were close to him recall so fondly.
The stories that are told and retold
relate not to his pioneer use of fascia
lata as a forerunner of the transplan
tation of living tissue nor to his far
sighted training scheme for young
surgeons, but rather to his joy of life
and the enthusiastic manner in which
he participated in every activity
whether it be fishing, enjoying the
beauty of nature in which he felt so
comfortable or the social interplay
amongst his associates that he
cherished so highly, particularly when
his willing “slaves” were involved.
His spontaneity was perhaps best
illustrated by his legendary reputa
tion as a raconteur nonpareil. Never
did he fail to hold his audience en
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thralled. To say that he always left
them buzzing with excitement or roar
ing with laughter after some under
stated anecdote— usually offered at
his own expense—would be a master
piece of understatement. Dr. Banting
perhaps expressed our admiration
most succintly in a letter to Mrs.
Gallie following the 1938 meeting of
the Royal College of Physicians and
Surgeons of Canada. This note, pen
ned on the stationary of this same
grand old hotel [Chateau Laurier in
Ottawa] is as follows:
October 30. 1938
Dear Mrs. Gallie:
Your husband filled us with pride last
night when he replied to His Excellency’s
speech. I congratulated him. His reply
was “Please tell my wife”.
Hence this note.
Sincerely,
Fred Banting
It was in 1940 that Dr. Gallie gave
the first annual lecture in surgery to
this College. In the same year, he was
elected president of the American Col
lege of Surgeons, a position he was
to hold for an unprecedented 6-year
term.
It is small wonder that his circle of
friends, as distinct from mere acquain
tances, did in truth encircle the globe.
Challenges from the Past

I would like, therefore, to begin
today with some observations by two
close friends and contemporaries of
Dr. Gallie, both of whom rank as
North American pioneers in the man
agement of lung cancer. I was for
tunate enough to have had the
privilege of working closely with both
of them.
Dr. Norman Shenstone, who was
my own sponsor at the Toronto Gen
eral Hospital, undertook the first re
section for lung cancer at that hos
pital within a year of Dr. Evarts
Graham’s initial pneumonectomy. He
demonstrated
remarkable
insight
when, in 1941,' worried about the
large number of explorations per
formed for nonresectable disease in
the attempt to find lesions that were
suitable for excision, he expressed the
opinion in the form of a challenge
that it should be possible to define
more clearly the boundary between
operable and inoperable cases.
Subsequently, in 1957, Dr. Graham
exhibited his own brand of foresight
when he commented on the signif
icance of the relation between smoking

and lung cancer. These comments
were made shortly before his own
death from that disease. He posed
two more challenges2 to the profes
sion:
1. “The more important part is to
do away with the carcinogenic agent
which is responsible for the disease
in the first place.”
2. “The other part is to try and get
those patients earlier who permit their
cancers to develop in spite of the very
strong evidence already at hand that
heavy cigarette smoking is an im
portant etiologic factor.”
To digress for a moment: It was
while I was working on Dr. Graham’s
service after the war that, frustrated
by his inability to affect the disease
by treating it as a sex-linked pheno
menon, he asked me to find out what
was causing the epidemic. It was
in 1947 that the evidence was
eventually collected which indicated
that cigarette smoking played a role
in the pathogenesis of lung cancer.
Dr. Graham, a chain smoker, scorned
the purely statistical evidence but,
several years later, supported a fur
ther study and did then accept the
relation as factual. He promptly
stopped smoking completely but with
in a year succumbed to inoperable lung
cancer— surely a quirk of fate that
resulted in the loss of one of the truly
great surgeons of our time.
Let us then initiate this discourse
from the three challenges presented to
us by these two pioneers at the time
when thoracic surgical practice was
passing from the pioneer era into the
modern era of technical capability.
The importance of these challenges
can scarcely be overstated, because we
had, for so long, failed miserably to
solve the last two challenges effect
ively, despite steadily increasing atten
tion to the problem. None the less
there have been accomplishments
which I should like to review with you
before discussing those that remain
for future attention.
The need to view the current situa
tion with concern is clearly apparent
when one considers the steady increase
in the prevalence of lung cancer and
the alarming increase in deaths from
lung cancer so clearly indicated in the
national data for 1980 in the United
States3 and in the Ontario statistics.
Our experience at the Toronto Gen
eral Hospital reflects these observa
tions. It has been my privilege to
review this experience and report on
the findings since Dr. Shenstone ini
tially asked me to do so in 1939. The
data now cover more than 40 years
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(Table I). That 370 patients—more
than 1 new patient every day—-are
seen currently at this one hospital each
year must cause not only concern but
frank alarm. Thoracic surgeons are
acutely aware of the increasing rate
of new cases of lung cancer since two
of every three patients are referred to
them for definitive therapeutic pro
posals (Table I).
The Accomplishments

What then are some of the accom
plishments?
Dr. Shenstone’s Challenge

There has been a steady improve
ment in operability and resectability
rates. The gap between operability and
resectability has narrowed to an ac
ceptable figure of 3% to 4% (Table
II). We have, therefore, met success
fully the challenge presented by Dr.
Shenstone.
This improvement has been due to
recognition of the biologic factors that
determine curability and adherence to
the principle of individualizing treat
ment according to the tumour-host
“equation” in effect at the time of
treatment. The manner in which the
therapeutic decision can be finalized
has been described4 as a four-stage
process:

1. Assessment of curability— the
biologic aspect.
2. Determination of resectability—
the technical aspect.
3. Evaluation of the tumour-host
equation-—is the disease curable (i.e.,
is it biologically favourable)? and can
the local (and regional) disease be
excised completely (i.e., is it techni
cally favourable)?
4. Therapeutic individualization—a
little operation for “little" disease,
since one is dealing with a vital organ
and a big operation for “big” disease,
provided it is biologically favourable.
Technical advances permit radical pro
cedures if the disease allows salvage.
To date, we have found no better
method.
Dr. G raham ’s Challenges

Unfortunately, the challenges posed
by Dr. Graham have not been met
successfully. They were designed to
lower the toll taken by the disease.
This we have not affected signif
icantly, although slow improvement is
being made.
I. Current Experience

It is obvious that, despite rapidly
accumulating experience with an in
creasing number of patients, the im
provement has not met the necessary
goals. To illustrate this I have re

viewed 450 cases (Table III). These
patients represent a series of un
selected consecutive admissions to my
own service over a 10-year period up
to 1976. They provide an opportunity
to assess present results.
This was a representative group
pathologically (Table IV) reflecting
the spectrum of diseases currently seen
in North America. Although 64% had
squamous or undifferentiated lesions,
surprisingly 16% were described as
having small cell anaplastic cancers
(oat cell type).
The results were not impressive.
The resectability rate was still only
43.5% (Table III). Although a 5-year
survival rate of 42% for patients who
had resection (Fig. 1) sounds en
couraging the overall salvage rate of
only 18.3% (Fig. 2) cannot be ac-

T a b l e 111— C h a r a c t e r i s t i c s o f P r i m a r y
R e f e r r a l P a t ie n t s w it h B r o n c h o g e n ic
C a r c i n o m a (4 5 0 C o n s e c u t i v e U n s e l e c t e d
P a t ie n t s )

C h a r a c t e r is t ic
C o m p le t e f o l l o w - u p
E x c lu d e d ( i n v e s t i g a t i o n
in c o m p le t e )
In o p e r a b l e
N o n r e s e c t a b le
R e s e c ta b le
P o s t o p e r a t iv e m o r t a lit y
S u r v iv a l > 1 y r

Num ber

(%)

440 (9 8 )
8
226 (5 2 .3 )
18 ( 4 . 2 )
188 ( 4 3 . 5 )
6 (3 )
136 (7 2 )

T a b le 1 - A d m i s s i o n s f o r L u n g C a n c e r to T o r o n t o G e n e r a l
H o s p i t a l fr o m 1 934 t o 1 9 7 6

A d m is s io n s
P e r io d
1934
1946
1949
1953
1957
1965
1 966
1969
1973

-

1945
1948
1952
1956
1964

and 1968*
- 1972
- 1976

T o ta l no.

A n n u a l no.

S u r g i c a l r e f e r r a l, %

508
161
349
655
952
160
364
1252
1481

42
54
87
164
119
160
182
313
370

56 - 59)
7 2 - 79 67
6 1 -6 3

FIG. 1— Five-year survival of 295
patients with bronchogenic carcinoma.

*1 9 6 7 r e c o r d s u n a v a il a b le .

T a b le I I — R e s u l t s o f T r e a t m e n t in P a t i e n t s w i t h L u n g C a n c e r A d m it t e d
to T o r o n t o G e n e r a l H o s p it a l

5 - y r s u r v iv a l, %

P e r io d
1934 - 1952
1954 - 1957
1965
1966 - 1976

N o. of
p a t ie n t s
1018
408
160
450

O p e r a b ili t y , %

R e s e c t a b il it y , %

R e s e c ta b le
cases

O v e r a ll
s a lv a g e

14
24.7
3 7 .5
43.5

2 7 .7
3 4 .6
39
42

3
9
15
18.3

34
37
40.6
47.7

• C o n s e c u t iv e u n s e l e c t e d p e r s o n a l r e f e r r a ls .
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FIG. 2— Overall salvage rate, over
four decades, of patients with broncho
genic carcinoma admitted to Toronto
General Hospital.
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cepted when death is primarily due to
tumour—either local recurrence or
distant dissemination (Table V). If,
in the 80% who die, most deaths re
sult from the disease itself, other
methods of management are obviously
mandatory. Thus the unresolved chal
lenges remain current indeed. What
has been done to improve the re
cord?
2. Impact o f Therapeutic
Innovations
Although the steady improvement
in overall salvage is encouraging (Fig.
2) the pace of change is unacceptable
despite innovative improvements in
patient management. The impact of
these therapeutic innovations can be
summarized as follows:
Significance of superior mediastinal
adenopathy.—My interest in the su
perior mediastinal nodes was stimul
ated by a wave of enthusiasm during
the 1950s for a procedure called a
radical pneumonectomy— a procedure
in which an extended resection was
performed including a block dissec
tion of the ipsilateral superior media
stinum in continuity with an intrapericardial resection of the root of the
lung. Admittedly, the technical ele
ments were simplified and the opera
tion therefore appeared attractive.
However, when the procedure was
used in 23 patients with palpable— and
therefore gross— superior mediastinal
adenopathy not a single patient sur
vived 2 years (Table VI).
These results had to be compared
with isolated reports of long-term sur
vival following the same radical proce
dure and it seemed obvious that a
more detailed study of the nature of
superior mediastinal adenopathy was
necessary to clarify the issue.
Quite fortuitously, at this time Dr.
F.G. Pearson returned from post
graduate training in Europe with
knowledge of Carlen’s maneuver of
mediastinoscopy which allowed pre
operative staging of mediastinal dis
ease and differentiation between gross
extranodal involvement and micro
scopic intranodal spread and also be
tween ipsilateral and contralateral dis
ease. It seemed logical to assume that
the long-term survivors would come
from the group with the least disease
(e.g., ipsilateral microscopic intranodal
dissemination) in keeping with similar
observations of the significance of
axillary adenopathy in mammary car
cinoma. For example, in that disease,
patients harbouring microscopic intra
nodal metastases affecting only nodes
in the lower third of the axilla have
552

been found to have survival and local
recurrence rates as good as those of
patients with true stage I disease.
A study of radical combination
treatment with preoperative irradia
tion was therefore undertaken in this
more favourable group of patients
with superior mediastinal adenopathy
that was ipsilateral, microscopic and
intranodal. Indeed a 5-year salvage
rate of 31 % was achieved although
long-term survivors were found only in
the group with squamous cell carcino
ma (Table VI). The fact that only 16
patients have been found to harbour
disease suitable for completion of this
type of treatment unfortunately means
that this form of therapy can have
little effect on the overall salvage.
The “little” operation for “little”
disease.— Since cigarette smoking
plays an important role in the patho
genesis of chronic obstructive lung
disease and coronary artery disease,
many patients with lung cancer will
have a degree of cardiorespiratory

functional impairment that would
make consideration of pneumonectomy
unwise although they might well toler
ate a lesser procedure.
Examination of the role of limited
resection in these compromised pa
tients was obviously warranted. A sub
stantial 5-year salvage rate was ob
tained: if a potentially curative resec
tion was possible, 18% of these pa
tients were alive and free of disease
5 years after resection.5
This result led us to explore the
value of sleeve resection in the re
latively uncompromised host. In these
more favourable cases a 5-year sur
vival rate of 36% was obtained when
the resection was of a potentially cura
tive type. This must be compared with
an overall 5-year survival rate of 64%
after pneumonectomy and a potentially
curative resection. However, the ac
tuarial survival rates were similar for
both procedures reflecting the fact that
more patients with the limited resec
tion suffered from associated life-en-

Table I V - Pathological Classification of Bronchogenic Carcinoma
Toronto General
Hospital, %

Type
Squamous
U ndifferentiated
(large ce ll)
Oat cell
Adenocarcinoma
Bronchioloalveolar
Mixed
Other

Cumulative
(N orth Am erica), %

48

42

16
16
11
4
2
3

22
18
10
4
4

Table V— Significance of Cell Type in Death from Bronchogenic Carcinoma
(Figures Are Percentages)

Cause of death

Squamous
carcinoma

Other diseases
Tumour
Recurrence
Dissemination

25*
72
36
36

Undifferentiated
(large cell)
Oat cell Adenocarcinoma Bronchioloalveolar
2
98
43
55

2
98
16
82

12
88
30
58

10
90
40
50

*N ot specified in 3% .

Table V I— Treatm ent and Results in Patients w ith Lung Cancer
Who Had Mediastinal Adenopathy
Treatment
Radical pneumonectomy
(prior to mediastinoscopy)
Preoperative radiotherapy*
Resection
(mediastinoscopic staging)

Number
23
32
22
16
3
3

5-yr survival
0 (2 yr)

(26 squamous carcinoma)
squamous carcinoma
adenocarcinoma
small cell carcinoma

5 (31% )
0 (2 yr)
0 (2 yr)

*10 patients had radiotherapy only; 1 died.
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dangering diseases although they were
not compromised to the point where
pneumonectomy was contraindicated.5
Although these results appear en
couraging, only 70 patients were sub
jected to the limited resection over a
12-year period.5 This means that the
procedure was used on only six pa
tients a year, so the results would
again have little impact on the salvage
of the 370 patients now admitted an
nually.
Adjuvant therapy.— From the ex
perience with the most recent series
it is apparent that the patient
with lung cancer who dies, re
gardless of the operability or resect
ability of the disease, succumbs
primarily to the tumour: there is only
a moderate preponderance of dissemi
nation as the major cause of death
but local recurrence plays an impor
tant role in the outcome as well. Ob
viously, although local treatment
remains the focus for controlling local
disease, supplementary measures are
required to manage the metastatic
phenomenon more effectively.
In the very first study of adjuvant
chemotherapy in solid tumours (one in
which we were fortunate enough to
participate) the use of a single drug
(nitrogen mustard intrapleurally and
systemically) did indeed increase
longevity for a minor subgroup
of patients having small tumours
and regional adenopathy. It is now
considered illogical to use a single
drug in a short course of chemother
apy.
More logical protocols for adjuvant
chemotherapy using a combination of
drugs and prolonged therapy4 as well
as other protocols involving radio
therapy or immunotherapy have un
fortunately not yet produced the anti
cipated improvement in recurrence
or death rates. None the less further
investigation of these adjuvant meas
ures is clearly in order. There is al
ready a suggestion that adjuvant ther
apy of this type may be beneficial
in more advanced although resectable

adenocarcinoma or large cell undif
ferentiated cancers.
Of more immediate importance is
the evidence that combination ad
juvant therapy has a significant im
pact on patients suffering from oat
cell carcinoma.
Small cell anaplastic carcinoma (oat
cell).—Special attention has been di
rected to the oat cell component of
malignant lung disease because of the
increasing frequency with which it is
being recognized and because of the
extent of the disease when it produces
symptoms as indicated by the very
high inoperability (92%) (Table VII)
and death rates (98% ) (Table V).
It is encouraging to note the high
response rate (Table VIII) and excel
lent performance status (Table IX)
achieved by combination chemother
apy in 147 patients treated at the
Toronto General Hospital.6 The rates
of local and intracranial recurrence
provide the rationale for the use of
radiotherapy at these sites (Table X).
The intracranial disease is sequestered
from systemic therapy, the rapidity
of response to the treatment program
is striking and the appearance of
long-term survivors encouraging and
reassuring. Currently, approximately
20% of such patients can be expected
to survive longer than 2 years.
Current Challenges for the
Medical Profession

Although these innovations may be
of great importance to individual pa
tients, the numbers affected and the
survival achieved will unfortunately

Table V III Response to Chemotherapy
and Radiotherapy of 147 Patients w ith
Small Cell Anaplastic Lung Carcinoma
Limited
disease

Response

Extensive
disease

Complete
16 \ 83% (60% after
Partial
39 / radiotherapy)
No response 11

4s } 65%
28

Total

81

66

have little or no impact on the overall
salvage rate. If we are to affect the
increasing prevalence and mortality
other approaches to management are
required.
Many problems and failures con
tinue to plague us (Table XI). We
have not succeeded in eradicating the
disease. We have not found ways to
recognize lung cancer at an earlier and
more favourable stage. We now have
no recourse but to concentrate on (a)
early diagnosis by screening and (b)
prevention of disease.
Table IX — Perform ance Status
of 147 Patients w ith Small
Cell Anaplastic Lung
Carcinoma afte r Chem otherapy and
Radiotherapy
Performance
status*
0
1
2
3
Total

Lim ited
disease

Extensive
disease

15
47
4
0

11
57
10
3

66

81

‘ Standard scale used by Eastern Cooperati
ve Oncology Group; 0 = normal a c tivity, 1 =
symptomatic but am bulatory, 2 = < 5 0 %
bedridden, 3 = > 5 0 % bedridden.

Table X — Incidence and Site of Tum our
Recurrence in 55 Patients w ith Lim ited
Disease Who Responded to Chem otherapy
and Radiotherapy
Site

Incidence, %

Local
Brain
Bone

22
25
10

Table X I— Lung Cancer: the “ Problem s”
and the "F a ilu re s ”
Preventable disease — smoking remains
acceptable social custom
Prevalence increasing
M o rtality increasing
Early recognition not common
Results of treatm ent unacceptable

Table V II— Significance of Cell Type in Bronchogenic Carcinoma (Figures Are Percentages)

S e x -m a le
Inoperable
Extrathoracic disease
Mediastinoscopy positive
(superior mediastinal
adenopathy present)
Resectable
Curative resection

Squamous
carcinoma

U ndifferentiated
(large cell)

Oat cell

Adenocarcinoma

Bronchioloalveolar

92
39
27
42

84
60
37
44

81
92
24
68

74
52
42
60

72
28
40
80

58
45

31
19

7
4

39
30

61
44
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Obviously the challenges posed by
Dr. Graham almost 25 years ago have
not been resolved.
The Hope for Earlier Diagnosis
by Screening
How can we accept such a poor
record when the clinical spectrum of
the disease (Table XII) indicates the
potential salvage with earlier recog
nition and prompt treatment? Al
though this possibility was demon
strated as early as the 1950s when
the presence of a clinical spectrum
was recognized, little progress has been
made. Several facts underscore the
difficulty of obtaining enthusiastic sup
port for screening programs even
though the disease lends itself well to
screening techniques:7 (a) it sloughs
malignant cells from its earliest ap
pearance (carcinoma in situ), (b) it
produces warning symptoms (e.g., he
moptysis, obstructive pneumonitis),
(c) obstructive phenomena can be re
cognized radiologically before the ap
pearance of a radiologically detectable
shadow and (d) asymptomatic peri
pheral lesions can be detected radiolo
gically.
Unfortunately earlier assessments
of survey roentgenograms or sputum
cytology were discouraging. However,
recent re-evaluations have been much
more encouraging.
1. Radiologic Screening
It is the frequency of screening that
determines the value of this method.
The experience of Saito, Sakuma
and Kakita in Tokyo® can be com
pared with the findings of Boucot and
Weiss from the Philadelphia mass
survey” to put this factor in clear
perspective (Table XIII).
2. Combined Radiologic and
Cytologic Screening
The Mayo lung project10 in which
high-risk smokers were screened
radiologically and by cytologic exami
nation of pooled sputum samplings at
intervals of 4 months and compared
with a control group subjected to an
annual clinical examination alone
clearly indicates the value of frequent
screening and the primary importance
of the radiologic studies. The tumour
is recognized at an earlier stage and
there is a definite increase in the
number of curative resections (Table
XIV). One would therefore expect the
number of survivors to be greater.
However, the high number of deaths
(over 50%) from cardiovascular dis
ease minimizes the long-term impact
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of these improvements. Consequently,
the disease must he detected early
enough to overcome the competing
mortality risk of other cigarette-related
diseases, particularly coronary artery
disease. This means we must look for
still earlier stages of lung cancer as
exemplified by radiologically occult
disease. For recovery of these patients
greater emphasis will have to be
placed on cytologic screening.
3. Cytologic Screening
Recent evaluations have helped to
dispel the sense of frustration that
coloured earlier reports. At a time
when only bronchography and the
rigid bronchoscope were available for
examination of the bronchial tree it
was difficult to locate the occult
lesions identified cytologically.
With the introduction of the flexible
bronchoscope it became possible to
study the individual segments of the
lungs in the search for radiologically
occult lesions. It is now rare for
these lesions not to be located

within 3 months of the initial cytologic
report of the presence of malignant
cells.
What dividends have been declared?
Definition of carcinoma in situ and
microinvasive cancer.—The skilled
cytologist, who has become an integral
part of the health care team, can now
identify the presence of carcinoma in
situ or microinvasive cancer and not
only frankly invasive disease. This dif
ferentiation has enormous clinical
significance for the practising phy
sician and surgeon.
Patients who have malignant cells
of the noninvasive type and who suc
ceed in giving up cigarette smoking
may slough away the carcinoma in
situ once the stimulus for malignant
change is withdrawn, thereby in effect
curing themselves of their disease
(Table XV). This was noted in seven
patients in our original series. They
represented a group of patients in
whom localization of the malignant

Table X III—Value of Radiologic Screening
in Bronchogenic Carcinoma*
Table X II—Clinical Spectrum of
Bronchogenic Carcinoma
Clinical syndrome

Interval

5-yr survival, %

Symptomatic disease
Coin lesion
Curative resection
Asymptomatic
Semioccult disease
Occult disease

5-8
40
40
52
70
100

Semiannual
Annual
> 1 yr

Resectability,

5-yr survival,

%

y0

100
54
39

54.5 (12f)
22 (4 t)
0

‘ Data obtained from reports of Health Con
trol Centre, Tokyo Metropolitan Govern
ment 1976.
(Comparative figures from Philadelphia
mass survey 1972.

Table X IV —Dividends of Repetitive Screening in Bronchogenic Carcinoma*

Technique
Radiology
Cytology
(alone)
Clinical
(alone)

No. of
patients (% )

Screening
interval

Number

Curative
resection

3-yr
survival, %

4 mo

84

2 out of 3
(85% stage 1)

50

annual

56
(symptoms 2 out of 3)

112 (80) 1

\

21 (15) ]
7 (5)

< 1 out of 3

<20

‘ Data from Mayo lung project (9223 men), 140 “ new” cases.

Table XV—Sputum Cytology Changes in Continuing Smokers
with Moderate or Marked Dyskaryosis*
Cytologic changes
Dyskaryosis

No. of
patients

Moderate
Marked

44
43

Total

87

Marked dyskaryosis
7

__ y

--------- y

Malignant
cells
3
3
6 (7%)

*Exsmokers: 7 with malignant cells had no further "positive” samplings.
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lesion proved impossible on the in
itial investigation (before the advent
of the fiberoptic bronchoscope). If the
lesion can be located excision is of
course warranted because of the pos
sibility that invasive carcinoma may
coexist with the noninvasive form. To
determine whether this might be true
for microinvasive cancers requires fur
ther study. The observation probably
explains— in a much larger group of
patients— why the appearance of a
second primary cancer is so infrequent
in cigarette smokers who give up their
habit following excision of an initially
invasive cancer. Presumably the other
areas of multicentric disease, which
might logically be anticipated in the
bronchial mucosa of these smokers,
have not reached the stage of frank
invasion before the nourishing insult
is withdrawn.
Definition of hazardous reactive
epithelial change.—Those who show
an earlier stage of reactive epithelial
change (moderate or marked dyskaryosis) may evade the steady progres
sion to malignant disease if they stop
smoking. In contradistinction, those
who continue smoking may stimulate
steadily increasing change to malig
nant epithelium. There was a 7% (6
of 87) yield of samplings positive for
malignant cells when continuing
smokers who showed significant
dyskaryosis were followed up to 4
years and the incidence was steadily
rising at that time (Table XV). In ex
smokers the dyskaryotic changes sub
sided. The implications for preventive
therapy are obvious.
Radiologically occult disease.—Cy
tologic screening, therefore, plays an
important role in our attempts to de
tect changes at the stage when cura
tive therapy is possible. In the current
Baltimore study11 the 3-year survival in
patients with truly occult disease
stands at 100% and remains at 70%
in stage I (TtN0) cases even though
invasive disease is found.
Similarly, our own experience with

radiologically occult disease has not
shown a single death from the malig
nant disease in 23 patients from a
nonindustrial population (Table XVI).
Industrial screening.—A compari
son with screening in industry shows
some interesting differences. The re
sults from our initial screening pro
grams (Table XVII) had such an un
rewarding yield (0.1%) of favourable
cases that it was not thought econ
omically practical to translate these
studies into programs for the general
public (Table XVIII). It was altern
atively proposed in 1966 that “screen
ing of asymptomatic cigarette smokers
should be directed at that segment of
this high risk population in which
cigarette smoking acts in concert with
some other significant form of at
mospheric pollution, industrial or
otherwise”.7
The nickel industry was chosen for
further study and, by 1978, 268 miners
had been screened with a yield of 12
cancers (4.4%) including one case of
paranasal sinus cancer and one of
laryngeal cancer.12 These miners had
all been exposed to smoking and to
atmospheric pollution within the plant.
Eight additional cases can now be
added to this series although their
follow-up information is too recent
for inclusion in the overall data. Our
experience with the nickel industry—
the high number of oat cell cancers,
the multiple tumours, the recurrences
and the deaths from the disease—
clearly differs from the nonindustrial
experience (Table XVI).
Regional screening.— A continu
ing search for more producive
target groups is obviously warranted
(Table XIX). Such groups will
be found somewhere, between the
two extremes. Our experience in 1978
and 1979 raises again the hope for
more worthwhile dividends in a com
munity with continued screening pro
grams. The practice of routine screen
ing of employees working in a refinery
has stimulated interest within the re

gional community in combined radiol
ogic and cytologic studies and has en
couraged referral of smokers from the
community for similar studies. D ur
ing this short time five radiologically
occult lesions have been detected,
three from the plant workers and two
from the community population. The
lesions have all been of squamous
origin and only one showed an intralobar adenopathy. All were located by
fiberoptic bronchoscopy during the
original investigation; further study
necessitated a delay of therapy in
one patient. All are currently free of
disease. These cases reflect the entire
gamut of radiologically occult disease
and were managed as follows:
Case /.—A patient with occult dis
ease was treated by sleeve resection of
the upper lobe of the right lung be
cause of chronic obstructive lung dis
ease. A preoperative biopsy specimen
of the right upper lobe showed malig
nant cells. There was carcinoma in
situ at the bronchial suture line. The
patient stopped smoking and no fur
ther treatment was required. Repeat
bronchoscopic biopsy has shown no
residual disease over 3 years.
TableXVIl— Features of Cytologic Screening
for Lung Cancer in 2799 High-Risk Smokers
Feature

Number ( % )

“ Negative”
Significant dyskaryosis
“ Positive”
Lesion located
Potentially curative resection

2575
205
19
7
3

(92)
(7.3)
(0.7)
(0.3)
(0.1)

Table X V III — Initial Conclusions from
Study of Cytologic Screening for Lung
Cancer (1966)
Economically impractical because
(a) Adequate sampling unlikely
(b) Sequential examinations unaccept
able
(c) Yield of “ positive” samplings unsatis factory
(d) Localization frequently impossible
(e) Incidence of favourable cases disap
pointing

Table XVI —Cytologically Detected Lung Cancer in Patients with
Radiologically Occult Disease

Characteristic
Resection
Pathology
Multicentric cancer
Second primary cancer
Adenopathy
Recurrent cancer
Death from lung cancer

Nonindustrial
population

Nickel industry
screening program*

23
96% squamous carcinoma
0
0
0
0
0

10
> 4 0 % small cell carcinoma
1
2
1
2
1

*268 miners screened: 12 (4.4%) had lung cancer. Sinus carcinoma and laryngeal carcinoma
were also detected.

Table X IX — Initial Recommendations from
Study of Cytologic Screening for Lung
Cancer (1966)
Choose target groups more specifically
Smoking in conjunction with other car
cinogenic exposure
Industrial risks
Atmospheric pollution
Semioccult disease (radiologically occult)
Hemoptysis
Obstructive (stasis) pneumonitis
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Case 2.—Suspicious cells (i.e., not
diagnostic of carcinoma) were found
in the sputum of this patient with an
occult lesion. The lesion was visualized
bronchoscopically below the orifice of
the middle lobe of the right lung. At
thoracotomy a palpable lesion was
found with one local node showing
metastatic disease. Lobectomy of the
right and middle lower lobes was car
ried out. There was residual carci
noma in situ at the bronchial stump.
The patient stopped smoking. Repeat
bronchoscopic biopsy showed no resi
dual disease at 1 year.
Case 3.—This patient had a semi
occult lesion with hemoptysis. A tiny
lesion (anterior basic segment) of the
right lung was visualized broncho
scopically. A biopsy specimen showed
malignant cells. Right lower lobe
lobectomy was performed. The patient
is well l'/i years after operation.
Case 4.—A patient with a semi
occult lesion had obstructive (stasis)
pneumonitis. Microinvasive carcinoma
was found at the bronchial stump of
an initial left upper lobe lobectomy.
Pneumonectomy was performed. The
bronchial stump was free of disease,
but there was extensive “carpet” tu
mour within the upper lobe bronchus
and its subdivisions. This patient re
mains well at Vh years.
Case 5.—The patient had a chronic
granulomatous lesion at the apex of
the right lung, unrelated to bilateral
occult disease (left upper lobe, right
middle lobe). The patient continued to
smoke cigarettes and the carcinoma in
situ progressed to invasive cancer as
follows: On May 16, 1979 the pa
tient was asymptomatic but sputum
cytology showed the presence of squa
mous carcinoma. Fine needle biopsy
of the right upper lobe lesion showed
no evidence of malignant disease. On
June 4. 1979, brushings from the left
upper lobe (LB 1 and 2) showed squa
mous carcinoma (invasive type). On
Aug. 8, 1979 brushings LB 1 and 2
again showed invasive squamous car
cinoma and brushings from the right
middle lobe (RB 4) showed in-situ
squamous carcinoma. One week later
similar brushings again showed squa
mous carcinoma in situ. On Aug. 21,
1979 a left upper lobectomy was car
ried out. Microinvasive squamous car
cinoma, LB 1 and 2, was found. Cy
tologic examination of the sputum on
Dec. 11 showed in-situ squamous car
cinoma. On Jan. 22, 1980 brushings
from RB 4 showed microinvasive
squamous carcinoma and on Jan. 28,
1980 right middle lobe lobectomy de
monstrated the presence of microin
vasive squamous carcinoma of RB 4
(extensive in situ squamous carcinoma
—'“carpet” tumour). Brushing, wash
ing and biopsy findings of all other
segments showed no carcinoma.
Reasonably good results can be ob
tained so we must learn how to use
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these screening techniques to maxi
mum advantage. The Mayo Clinic lung
project suggests that the cost is not
prohibitive. With increasing use the
dividends and the cost experience are
bound to improve and once this point
has been reached more enthusiastic
support can be anticipated. The im
portance of the challenge will permit
nothing less.
Prevention of Disease
Although I hesitate to belabour this
point we simply cannot ignore the fact
that lung cancer is largely preventable.
The toll taken in illness, disability and
premature death is one of the major
tragedies of our time.
If the medical profession can make
a greater commitment to prevention
the impact would assuredly be dra
matic since the public continues to
look to the profession for example,
leadership and advice in all matters
of health.
Doctors’ advice to abstain carries
more influence than any other single
factor in a smoker’s decision to give
up his habit. This advice may be
offered in two different settings: (a)
office encouragement of smoking pa
tients to stop and (b) by smoker par
ticipation in group therapy. In the
office the advice cannot be restricted
to facts alone but must include an ex
planation of the steps to be taken in
ensuring success. The patient primarily
wants to know how to stop. Certain
fundamentals can be reiterated: identi
fy the smoking pattern, isolate the
smoking habit, develop alternatives to
smoking and, the final step, confirm
nonsmoking status. When group ther
apy is carried out in properly con
structed groups which are small and
homogeneous and when repetitive
courses are provided, successful total
abstention at the end of a year can
be anticipated in over 50% of the
participants.13 The effort is therefore
eminently worthwhile.
Admittedly the sentimental recol
lection of the physician as the person
who was “all things to all people” is a
thing of the past. None the less, al
though our professionalism now pos
sesses a keener insight and a sharper
edge, we can no longer evade the de
manding responsibility of protecting
the health of the public as well as that
of treating the ill.
We, as physicians, may resent the
additional load that this role implies
since the traditional view still persists
in many areas that provision of relief
from symptomatic disease fulfils our
responsibilities. Today medical re
sponsibilities cannot end there. Health
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promotion has become a major duty
for the physician and failure to use a
real opportunity to dissuade the
smoker from continuing his habit can
no longer be accepted.
Implications for the Future
These observations imply a subtle
change in the philosophy of practice
in the years to come.
In the recent past the changing
nature of the physician-patient rela
tionship led to a reappraisal of the
profession by the public— a reap
praisal currently not entirely to our
credit. Quite obviously most of the
blemishes which are considered to sul
ly our reputation are related to m at
ters beyond our control. Too little
has been made— at least in the public
mind— of the enormously important
advances that have been made as the
direct result of professional interest
in marshalling new information and
applying it to the welfare of the pa
tient. Public questioning of profes
sional competence and judgement
should no longer go unchallenged.
Nevertheless, the public continues
to look to the profession for leader
ship in all matters of health. This
poses an undeniable challenge to
provide “care” at all stages of disease.
The public has a right to this care
from the profession. We, in turn, must
keep reminding ourselves that we treat
patients and not diseases. Frequently
we seem to forget this in the face of
the overwhelming deluge of new
discoveries and treatment resources
with which we have to keep abreast.
In attending to the needs of pa
tients with malignant disease, this
“care” must encompass the entire dis
ease spectrum from carcinogenesis to
terminal care. The local lesion is in
deed but an incident in the natural
history of the disease. In accomplish
ing this purpose, a team approach is
mandatory. Physicians of all disci
plines must be involved since they
must deal with all stages of the natural
history of the disease. Actually, if
maximum benefits are to be achieved,
the team approach will involve the
public sector as well as the profes
sional disciplines. Development of this
team concept may in fact anticipate
the real golden age of surgery.
If our social system is to work ef
fectively in this type of interplay, the
advantaged or the endowed must play
a major role in ensuring the welfare
of the disadvantaged or the unen
dowed. This means that the medical
profession must assume responsibilities
that are supplementary to the tradi-
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tional role of the physician in dealing
with established symptomatic disease.
Let us then briefly review the
natural history of lung cancer and the
manner in which professional respon
sibilities are designed to fit the needs
of the sequential changes in the dis
ease spectrum.
• At the stage of carcinogenesis,
prevention, because it is feasible, re
presents the most exciting future pro
spect.
• Once the primary lesion is estab
lished it must be recognized early
(while it is biologically favourable for
treatment) and treated promptly, (a)
Practical screening measures for high
risk groups must be implemented and
(b) treatment must be individualized,
based on the tumour-host equation
that is defined by the biologic and
technical staging of the disease.
• The situations in which the tu
mour-host interplay makes dissemina
tion probable have to be recognized
and systemic therapy for the occult
systemic disease should be used.
• When the terminal stage is
reached the patient must not be de
serted. Medical “care” becomes even
more important. The patient in this
situation deserves active quality care
by a team of dedicated practitioners
of the art provided with the equip
ment and facilities with which to pro
duce this service.
How can we fail but respond to

these exciting challenges when current
knowledge shows us the prospect of
meeting the challenges effectively? By
demonstrating our real concern for the
welfare of the public, we can correct
the misconceptions that colour the
manner in which we are all too fre
quently viewed by them. Once our
motives are no longer suspect a true
partnership between the public and
the profession can again flourish, as
trust replaces suspicion, confidence
replaces doubt and the patient-doctor
relationship regains its humanitarian
basis.
Dr. Gallie would applaud such a
happy turn of events. He frequently
referred to his belief that the profes
sion should primarily be concerned
with the health of the public,14 im
plying this to be preferable to the
treatment of symptomatic disease. He
would be excited and enthusiastic
about these prospects and without hesi
tation would wish us well—with the
unfailing and always sincere toast to
our success!
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Items 539-542
(A)
(B)
(C)
(D)

Medullary carcinoma of thyroid gland
Pheochromocytoma
Malignant sacrococcygeal teratoma
Metastatic carcinoid tumor
(E) Carcinoma of sigmoid colon

539. Elevated a-fetoprotein
540. Elevated serum calcitonin
541. Elevated urinary catecholamines
542. Elevated urinary 5-hydroxyindoleacetic acid (5-HIAA)
For each numbered phrase above, select the one lettered heading that is
most closely associated with it. Each lettered heading may be selected once,
more than once, or not at all.
For the critique of Items 539-542 see page 595 of this issue.
(Reproduced by permission from SESAP 111 Syllabus: Surgical Education
and Self-assessment Program No. 3. For enrolment in the Surgical Educa
tion and Self-assessment Program No. 3, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Suppressive Therapy for Postirradiation Thyroid Nodules
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From the thyroid screening program
at the Roswell Park Memorial Institute
in Buffalo, New York, 85 patients
with thyroid nodules who had received
previous irradiation to the head and
neck were identified. The diagnosis
was confirmed microscopically by
needle aspiration cytology and the
patients were treated with thyroid
replacement therapy. In 24 patients,
the nodules disappeared completely;
a partial response (more than 50%
reduction in size) was seen in 26;
11 patients were improved (20% to
50% reduction in size); 14 had stable
disease (less than 20% reduction in
nodule size) and in 10 the condition
progressed (an increase of more than
20% in nodule size). Six of 21
patients who underwent operation
had well differentiated tumours. The
number of cases of Hashimoto’s
thyroiditis (14) was high.
Suppressive therapy w ill separate
those patients whose nodules will
disappear completely and who will
thus be spared operation. Continued
follow-up of such patients is essential.
All other patients should be offered
operation since thyroid nodules are
malignant in 30% of cases.
A partir du programme de depistage
des maladies thyroi'diennes du Roswell
Park Memorial Institute de Buffalo,
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etat de New York, on a identifie
85 porteurs de nodules thyroidiens qui
avaient prealablement recu une
irradiation de la region de la tete et
du cou. Le diagnostic fut confirme
au microscope par cytologie a
I aiguille et les malades regurent une
thyrotherapie suppletive. Chez 24
patients, les nodules disparurent
completement; 26 autres patients
montrerent une reponse partielle
(avec une reduction de plus de 50%
de la taille des nodules); 11 malades
furent ameliores (reduction de taille
de 20 a 50%); 14 presentment
une maladie stable (moins de 20%
de reduction de la taille des nodules)
et la pathologie evolua chez 10
(augmentation de plus de 20% de la
taille des nodules). Six des 21 patients
qui subirent une operation montrerent
des tumeurs bien differenciees. On
observa un nombre eleve de
thyroidites chroniques de Hashimoto.
Un traitement suppressif permettra
de separer les malades dont les
nodules disparaitront completement
et qui pourront done eviter I'operation.
Une surveillance continue de ces
patients est essentielle. Tous les autres
patients devraient se voir offrir
I'operation puisque les nodules
thyroidiens sont malins dans 30%
des cas.

The treatment of thymic enlargement
in infancy by external irradiation was
first reported in 1907' and was enthu
siastically received because the mor
tality for thymectomy was over 50%.
For the next 50 years, external irra
diation to the head, neck and upper
thorax was common for a variety of
other benign conditions including ton
sillitis, cervical lymphadenitis, acne
vulgaris, tinea capitis and vascular
malformations. In 1950, Duffy and
Fitzgerald2 drew attention to the
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association of thyroid carcinoma with
previous thymic irradiation. Since then
numerous studies have confirmed the
increased prevalence of benign and
malignant thyroid disease occurring
many years after irradiation. It is
estimated that for every rad of radia
tion there will be two to five more
cases of thyroid cancer per million
people annually.3 Many screening pro
grams have been initiated and our own
results with such a program have been
reported.4
Many authorities believe all patients
at high risk for goitre should receive
suppressive therapy with thyroactive
agents. Our preliminary data have
indicated that the response of nodular
goitre to suppressive therapy is sim
ilar in irradiated and nonirradiated
glands.5 The present study was under
taken to evaluate this question further
and to compare the effectiveness of
liothyronine (T3) with desiccated thy
roid in shrinking nodular goitre.
Patients and Methods
During its first year, 735 patients
were studied as part of the Roswell
Park Memorial Institute (RPMI)
screening program. Physical examina
tion of the head and neck was per
formed together with a complete
blood count and SMA 12 biochem
ical analysis. The erythrocyte sedi
mentation rate was measured and the
serum thyroxine (T4) level was estim
ated by radioimmunoassay.
For patients with palpable thyroid
abnormalities, 6-hour uptake and thy
roid imaging were performed using
iodine-123 and a scintillation camera
with a pinhole collimator. Additional
laboratory tests included radioimmu
noassay for serum triiodothyronine
(T3), thyroid-stimulating hormone
(TSH), circulating thyroglobulin and
thyroxin-binding globulin (TBG) and
CANADIAN JOURNAL OF SURGERY

measurement of antithyroglobulin and
antimicrosomal antibodies. All patients
underwent indirect laryngoscopy. With
informed consent, needle aspiration
was performed in most patients as
previously described.6 Single or mul
tiple nodules and diffuse enlargements
were aspirated at the first visit and
aspiration was repeated if cells were
not obtained or were suggestive of
malignancy. Patients participating in
the study were stratified according to
the site irradiated (for conditions of
the thymus, tonsils and adenoids, for
acne and for miscellaneous condi
tions), and were randomized to re
ceive either liothyronine (T3) (50 u.g/
d) or desiccated thyroid (120 m g/d).
Increased dosage was permitted after
2 months of treatment if the TSH level
failed to decrease to less than 0.3 uU/
ml (normal less than 4.6 txU/ml).
Decreased dosage of 50% was also
permitted when signs of thyrotoxicity
were present. Patients were seen by
the same investigator at monthly in
tervals for 6 months. All nodules were
measured in two dimensions and the
product of the measurements was
calculated for comparison with the
baseline value. Complete response was
defined as complete and sustained
disappearance of the nodule and par
tial response as a decrease of more
than 50% in the calculated nodule
area. Improvement was considered to
be a 20% to 50% decrease in area
and stable disease any reduction less
than 20%. The nodule was considered
to have progressed if there was an in
crease of more than 20% of the base
line size.
Patients whose nodules had disap
peared were maintained bn suppressive

therapy. All others were offered
operation.
Of the 735 patients examined, 159
(21.6%) had palpable nodules. Of
these, 90 patients agreed to participate
in this study. Eighty-five of the 90
patients were available for re-evalua
tion at the end of the first year. There
were 29 men and 56 women. The
mean age was 39 years (range 16 to
72 years).

blind study of suppressive therapy for
nontoxic goitre, found a significantly
better response to T3 than to T4.
We did not find any difference
between liothyronine (T3) and de
siccated thyroid in this study (Table
I). When these studies are considered
together, 28 (70%) of 40 irradiated
patients and 40 (73%) of 55 nonirradiated patients treated with T3
showed a decrease in nodule size of
more than 20%. Complete remission
in patients treated with T3 is not sig
Results
nificantly higher in the irradiated
As shown in Table I, there was no group (11 of 40) than the nonirdifference in response between liothy radiated group (6 of 55) (P = 0.075,
ronine and desiccated thyroid. Twen X2 analysis). However, when the two
ty-four patients (28.2%) achieved a groups of patients are compared re
complete response and 26 (30.2%) gardless of the type of suppressive
achieved a partial response. Operation therapy, a complete response in the
was recommended for all 61 patients irradiated group (24 of 85) was sig
who did not have a complete response. nificantly (P < 0.005) more frequent
Twenty-one patients consented. One than in the nonirradiated group (13 of
patient with a partial response was
114). Patients in the nonirradiated
found at operation to have a follicular group were a mean of 9 years older
carcinoma and three with stable dis than those of the irradiated group;
ease had papillary carcinomas; two part of the difference may be due to
patients with progression were also this, as it is possible that they had a
found to have papillary carcinomas greater bulk of disease.
(Table II). One of these patients had
It is postulated that, following irra
had an initial transient complete re diation, chromosomal and other
sponse. Histologically many glands damage occurs within thyroid cells
showed more than one abnormality. and, with hypofunction of the gland,
Eight (38%) of the 21 patients had continued stimulation by TSH pro
histologic changes typical of Hashi- motes
hyperplasia,
adenomatous
moto’s thyroiditis and 7 (33%) had change and ultimately carcinoma.8'9
nonspecific thyroiditis. Of the 24 pa These thyroid tumours, therefore, ap
tients who achieved a complete re pear to be endocrine dependent and
sponse 6 had significantly elevated for more than 40 years thyroid car
antimicrosomal and antithyroglobulin cinoma has been known to regress in
titres.
patients given desiccated thyroid.10 In
a review of 19 patients with metastatic
Discussion
papillary carcinoma, 12 responded for
Shimaoka and Sokal,7 in a double 5 to 16 years (mean 11 years).11 Re
sponse was best in patients under 40
years
of age who had received radia
Table I—Suppressive Therapy: Liothyronine (T 3) versus Desiccated Thyroid (D T)
tion therapy to the neck for benign
disease. Similar results were noted
No. of patients
by DePapp, Pincus and HempelTotal no.
Result
DT
of patients
T3
mann,12 who observed responses of
both benign and malignant nodules.
Complete response (100% regression)
11
13
24
Most malignant nodules, however, re
Partial response (> 5 0 % regression)
11
15
26
main unchanged or increase in size.13-14
Improvement ( > 20% regression)
6
5
11
Stable disease ( ^ 20% regression)
7
7
14
All of our patients who achieved
Progression (> 2 0 % )
5
5
10
a complete response were maintained
Total
on thyroid hormone and are being
40
45
85
followed up at 3- to 6-month intervals.
One patient who achieved a complete
response initially but whose disease
Table II--Histologic Findings in Thyroid Nodules
then progressed was found to have
carcinoma, reaffirming the impor
Other
Suppressive
benign
Total no.
tance of close follow-up in this group
agent
Carcinoma
Thyroiditis
Fibrosis
conditions
of patients
of patients. Operation was performed
in 21 patients and in 6 (28.6%) a
4
7
t3
6
6
11
DT
2
8
9
7
10
malignant lesion was found. All tu
mours were well differentiated.
Total
6
15
15
13
21
Of the 24 patients who achieved
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a complete response, 6 (25%) had
laboratory and cytologic findings com
patible with Hashimoto’s thyroiditis.
Of the 21 who underwent operation, 8
(38.1%) had histologic changes ty
pical of Hashimoto’s thyroiditis and
7 (33.3%) showed nonspecific lym
phocytic thyroiditis, but did not have
typical findings of Hashimoto’s dis
ease. This condition appears to be a
late sequel to irradiation and may
coexist with carcinoma.
We conclude that patients in whom
thyroid nodules develop following
irradiation exposure to the head and
neck are sensitive to thyroid suppres
sion therapy. All patients who do not
have a complete remission should be
offered operation, as the incidence of
malignant change in a screened popu
lation such as ours approximates 30%.
Many patients who may harbour min
imal carcinoma (less than 1 cm in dia
meter) in their thyroid gland decline
operation; they should be treated with
suppressive agents and followed up
closely. There is a high rate of
Hashimoto’s thyroiditis and some
patients with this condition also re
pond to thyroid suppression. Patients
in whom a benign lesion has been
found at operation and who have
residual thyroid tissue should remain
on suppressive therapy indefinitely in
an attempt to prevent new lesions de
veloping in the thyroid remnant.
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Does Vascular Steal Occur following Femorofemoral
Bypass Grafting?
R.W. L andymore,

md,

C.E. K inley ,

md, frcs[c] and

A.E. M arble,

r
Vascular steal has been reported
following aortoiliac and crossover
femoral vascular reconstruction.
Although the steal phenomenon has
been described in clinical situations
some have denied its existence. The
authors attempted to determine
whether or not vascular steal occurs
after femorofemoral bypass operation.
Fifteen adult mongrel dogs under
went femorofemoral bypass grafting.
Stenosis of the iliac artery was
simulated with a specially designed
device. Blood flow was measured with
the femoral graft open and closed in
combination with superficial femoral
and deep femoral artery obstruction
in the donor and recipient circulations.
There was no statistically significant
decrease in flow to the donor leg in
any situation. Thus the authors
conclude that vascular steal does not
occur following femorofemoral bypass
operation.
Un detournement de I'apport circulatoire a ete signale a la suite de la
reconstruction vasculaire de I’aorte
iliaque avec entrecroisement de la
femorale. Bien que le phenomene de
detournement ait ete decrit dans
des situations cliniques, certains en
ont nie I'existence. Les auteurs ont
tente de determiner si oui ou non
un detournement de I'apport circulatoire survient apres une operation
de pontage femoro-femoral.
Quinze chiens batards adultes
subirent un pontage femoro-femoral.

From the division of cardiovascular
surgery, Dalhousie University,
Halifax, NS
Accepted for publication Oct. 16, 1979
Reprint requests to: Dr. C.E. Kinley,
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Une stenose de I'artere iliaque fut
simulee a I’aide d'un appareil
specialement concu a cette fin. Le
debit sanguin fut mesure dans la
circulation des vaisseaux donneur et
recepteur alors que la greffe femorale
etait ouverte ou fermee, en association
avec une obstruction superficielle ou
profonde de I’artere femorale. O n n'a
enregistre aucune diminution statistiquement significative du debit vers
la patte donneuse dans aucune
situation. Les auteurs concluent done
qu'il n'y a pas de detournement de
I'apport circulatoire a la suite
d’un pontage femoro-femoral.

Vascular steal is a concept that has
been used to account for the onset of
ischemic symptoms resulting from re
distribution of blood flow in two ad
jacent vascular beds. Following
femorofemoral bypass grafting blood
flow is diverted to the ischemic limb
at the expense of the donor circula
tion.
Although the steal phenomenon
has been reported following cross
over femoral bypass,12 some3,4 have
denied its existence.
The purpose of this study was to
determine whether or not vascular
steal occurs following femorofemoral
bypass grafting.

m eng, p eng

The surgical preparation is illus
trated diagrammatically in Fig. 1.
Blood pressure was monitored with
a no. 6 French arterial catheter in
serted through the left carotid artery
and positioned in the distal abdomi
nal aorta. Venous pressure was moni
tored with a second no. 6 French
catheter inserted through the left
external jugular vein and positioned
in the proximal inferior vena cava.
These catheters were connected to a
P23dB Statham transducer and a
Statham SP1400 pressure monitoring
unit (Statham Instruments, Oxnard,
Calif.). Blood flows were measured
by means of the Statham SP2201
electromagnetic flowmeter and asso
ciated flow probes (Statham Instru
ments). The instruments were cali
brated using the procedure outlined
by Marble and Paasche.5 Blood pres
sure was maintained with intravenous
infusions of Ringer’s lactate solution.

Materials and Methods

Anesthesia was induced in 15 adult
mongrel dogs (weight 24 to 33 kg)
with a combination of fentanyl citrate
and droperidol. Anesthesia was main
tained with the aid of endotracheal
intubation and a model 607 Harvard
volume respirator (Harvard Appa
ratus Co., Millis, Mass.) with room
air.

FIG. 1—Dog preparation. A = aorta,
Cl = common iliac artery, CF = com
mon femoral artery, PF = deep femoral
artery, II - internal iliac artery and
SD = stenosing device.
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The animals also received heparin (1
mg/kg body weight) intravenously.
The iliac and femoral arterial sys
tems were exposed through bilateral
extraperitoneal
inguinal incisions.
Crossover grafts were created utiliz
ing a 5-mm double velour-knitted
Dacron prosthesis. An end-to-side
anastomosis was carried out between
both common femoral arteries using
continuous 5-0 Prolene suture. The
graft was brought out externally to
avoid any possibility of kinking that
might occur in a subcutaneous tun
nel. Iliac stenosis was simulated with
a specially constructed plastic occlud
ing device (Fig. 2), designed to pro
duce 75% reduction of luminal area
and constructed in accordance with
the mathematical relation between
critical stenosis and reduction in dis
tal flow described by Young, Cholvin
and Roth.6 Obstruction of the super
ficial femoral artery, deep femoral
artery and graft was simulated with
bulldog clamps. Blood flows were
measured before and upon comple
tion of the crossover femoral graft
to ensure that blood flow was not
obstructed because of poor surgical
technique. The occluding device was
then inserted into the left common
iliac artery to simulate unilateral iliac
stenosis. Blood flow was recorded
with combinations of superficial fe
moral and deep femoral artery ob
struction with the crossover graft
open and closed.
The paired Student’s f-test was
used to determine statistical signifi
cance and results were reported as
mean values with their associated
standard errors.

indicating that the operative proce
dure had not jeopardized the flow
distal to the graft. Flow in the left
common femoral artery was signifi
cantly reduced (P < 0.01) following
construction of left iliac stenosis.
Table II sets forth mean flow
measurements obtained following
crossover femoral grafting with com
binations of superficial femoral and
deep femoral artery obstruction. In
each case flow was measured with
the graft open and closed to deter
mine if vascular steal occurred in the
donor leg. No statistically significant
reduction in flow to the donor leg
occurred following crossover femoral
grafting with any of the combinations
of superficial femoral and deep
femoral artery obstruction, indicating
that vascular steal was not present.
Femorofemoral bypass for unila

teral iliac stenosis resulted in in
creased flow to the recipient leg in
each case. The increase in perfusion
was statistically significant when
crossover grafting was associated with
obstruction of the superficial femoral
artery (P < 0.01) and obstruction
of the combined superficial and deep
femoral arteries (P < 0.05) in the
donor leg.
Discussion
Crossover grafting was first de
scribed by McCaughan and Kahn7
in 1960 to treat poor-risk patients
with unilateral iliofemoral occlusive
disease. Since their original descrip
tion the procedure has been widely
used.1-3-8-9
Traditionally, aortoiliac occlusive
disease has been managed surgically

T a b le 1— P ro file o f D og P re p a r a tio n

T im e o f m e a s u re m e n t

C om m on fe m o ra l
a rte ry

F lo w , m l/m in
(m e a n ± S E M )

R ig h t
L e ft

177 ± 13
176 ± 15

R ig h t
L e ft

181 ± 17
187 ± 20

R ig h t
L e ft

204 d= 18
100 ± 13

B e fo re g r a ftin g
A f t e r g r a f t in g g r a f t c lo s e d
A f t e r g r a f t in g g r a f t c lo s e d an d le f t
ilia c a r t e r y s te n o s e d

* W e ig h t, r a n g e 24 to 33 kg (m e a n 28.6 k g ); h e m o g lo b in v a lu e , ra n g e 11 to 47 m g /d l (m e a n 13.1
m g /d l) ; p a c k e d -c e ll v o lu m e , ra n g e 3 4 % to 4 4 % (m e a n 3 9 .5 % ).

T a b le I I - F lo w M e a s u re m e n ts fo llo w in g C ro s s o v e r G ra ftin g
F lo w , m l/m in (m e a n d= S E M )

Results

R ig h t com m on fe m o r a l a r t e r y

The initial flow measurements are
illustrated in Table I. Before the
crossover femoral graft was con
structed there was no significant dif
ference in flow to the two extremities.
This was also true after grafting.

H e m o d y n a m ic s ta tu s
S u p e rfic ia l fe m o r a l
a r t e r y o b s tr u c tio n ,
d o n o r leg
S u p e rfic ia l fe m o r a l
a r t e r y o b s tru c tio n ,
r e c ip ie n t le g
S u p e rfic ia l fe m o r a l
a r t e r y o b s tru c tio n ,
b o th legs
S u p e rfic ia l fe m o r a l
a r t e r y o b s tru c tio n ,
d o n o r leg a n d d eep
fe m o ra l a r t e r y s te n o s is ,
d o n o r leg
S u p e rfic ia l fe m o r a l
a r t e r y o b s tru c tio n ,
r e c ip ie n t le g an d
d e e p fe m o ra l a r t e r y
s te n o s is , d o n o r leg
B ila te r a l s u p e r fic ia l
fe m o r a l a r t e r y
o b s tru c tio n a n d d eep
fe m o r a l a r t e r y s te n o s is ,
d o n o r leg

L e ft com m on fe m o ra l a r t e r y

G ra ft closed

G r a ft open

G r a ft c lo s e d

G r a ft open

40 ± 6

40 =fc 7

132 d= 26

170 ± 23

160 ± 19

158 ± 19

34 ± 7

44 ± 6

43 ± 7

44 ± 7

40 ± 8

56 ± 7

28 ± 8

28 ± 6

105 ± 18

116 ± 18

110 ± 22

100 ± 18

25 ± 9

38 ± 12

22 ± 8

25 d= 7

29 ± 8

42 =fc 16

FIG. 2— Iliac stenosing device.
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by replacing the obstructed seg
ment with a unilateral or bilateral
Dacron prosthesis with good relief of
symptoms and with average long
term patency rates of 80% .1014 How
ever, these operations result in a
higher morbidity and operative mor
tality3 compared with low-risk cross
over femora] bypass operations.
Originally, the use of crossover
grafts was restricted to high-risk pa
tients who were considered unable to
withstand a major surgical proce
d u re .'" '5 Recently the indications for
this operation have been expanded
and some3,8 are now suggesting that
crossover grafting should be used as
the initial procedure of choice.
With the widespread use of recon
structive vascular procedures in the
management of peripheral vascular
insufficiency there have been nu
merous reports alluding to the pres
ence of vascular steal.1’*'15' 1" The
phenomenon was first described in
patients following aortoiliac recon
struction"'15'7'"1 to explain the sudden
onset of mesenteric ischemia in the
early postoperative period. Vascular
steal was attributed to a sudden redis
tribution of flow to the extremities at
the expense of the mesenteric circula
tion.
Although vascular steal has been
reported following femorofemoral by
pass,20'22 some authors3’4 have ques
tioned its existence. Ehrenfeld. Harris
and Wylie4 failed to demonstrate it
in dogs with unilateral iliac stenosis
following crossover grafting. No at
tempt was made in this study to de
termine the effect of significant out
flow tract obstruction on the redistri
bution of blood flow. If a steal phe
nomenon does exist, it would be more
likely to occur in a situation in which
the vascular resistance is higher in the
donor than in the recipient circula
tion. Femorofemoral bypass in this
situation conceivably results in in
creased flow to the recipient circula
tion at the expense of the donor cir
culation because blood flow is always
distributed to the vascular bed with
the lowest resistance.
Our study was designed to deter
mine the effect of serious peripheral
vascular occlusive disease in the
donor circulation on blood flow fol
lowing crossover vascular reconstruc
tion. From combinations of outflow
tract obstruction in the donor and
recipient circulations with associated
unilateral iliac artery stenosis we
found no statistically significant re
duction in blood flow to the donor
leg after crossover grafting. Acute
ischemia in the donor limb after by

13. M o zersk y

DJ,
Sum ner
DS,
DE: Long-term results
of reconstructive aortoiliac surgery.
Am J Sura 123: 503, 1972

pass surgery that has been reported
by others1,17 might be explained by
the fact that the donor circulation
was jeopardized at the time of opera
tion. Our results suggest that the
acute ischemia observed in the donor
limb following femorofemoral bypass
is not truly representative of vascu
lar steal.
We conclude that vascular steal
does not occur as a result of fem oro
femoral bypass operation.

15. T r ip p e l OH, J u r a y j MN, M id e l l
Al: The aorto-iliac steal: a review
of this syndrome and a report of
one additional case. Ann Sura 175:
454, 1972

We thank J.A. Love and A. Fenton
for their technical assistance and Mrs.
Sandra Martin for preparing the manu
script.

16. Bo l e PV, M unda RT, C arbonaro
T, et al: Aortofemoral steal: hemo
dynamic deprivation in mesenteric
artery. J Cardiovasc Sura (Torino)
15: 486, 1974
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Complications of Ventriculoatrial and
Ventriculoperitoneal Shunts in a New Children’s Hospital
L.P.

I van,

md, frcs[c], facs,*

At a new children's hospital between
1974 and 1978, 125 patients underwent
243 shunt procedures performed by
six neurosurgeons. In spite of diverse
techniques used, the overall results
were acceptable. Seventy-seven
patients required 118 shunt revisions.
The mortality related to the shunt
procedures of 7.2% and the infection
rate of 14.4% were comparable to
those of other series reported during
the same period. Ventriculoatrial
shunts, although fewer in number,
required fewer revisions (20 revisions
of 18 shunts) than ventriculoperitoneal
shunts (97 revisions of 58 shunts)
for which the variation in technique
was larger. A sharp decline in the
complication rate was noted during
the last year of the study.
Entre 1974 et 1978, dans un nouvel
hopital pour enfants, 125 malades
ont subi 243 operations de derivation
pratiquees par six neurochirurgiens.
En depit du fait que des techniques
diverses ont ete utilisees, les
resultats d’ensemble sont acceptables.
Soixante-dix-sept patients ont
necessite 118 revisions. La mortalite
reliee a I'operation de derivation
a ete de 7.2% et le taux d’infection
de 14.4%: ceci est comparable aux
taux signales dans d'autres series
au cours de la meme periode. Les
derivations ventriculo-auriculaires,
bien que moins nombreuses, ont
necessite moins de revisions (20
revisions pour 18 derivations) que les
derivations ventriculo-peritoneales
(97 revisions pour 58 derivations) pour
lesquelles les variations de techniques

S.H.

Choo,

md | and

E.C.G.

V entureyra, md, frcs[c]J

ont ete plus nombreuses. Une baisse
nette du taux d’infections a ete
observee au cours de la derniere
annee de I’etude.

Infection and blockage are the major
problems of cerebrospinal fluid shunt
ing procedures. This report studies
the use of both ventriculoatrial and
ventriculoperitoneal shunts in 125 con
secutive patients with hydrocephalus
admitted to a new children's hospital
during the first 4 years of its opera
tion. A standardized antibiotic regi
men and operative protocol allowed
some reduction in the rate of infec
tious complications during the last
year of the study.
Patients

Between Aug. 1, 1974 and July 31,
1978, 125 patients with hydrocephalus
(68 boys, 57 girls) were treated by six
neurosurgeons at the Children’s Hos
pital of Eastern Ontario in Ottawa.
Their ages ranged from newborn to
16 years. The follow-up was for a
minimum of 10 months. One third of

the patients were newborn infants with
associated myelomeningocele.
One hundred primary ventriculo
peritoneal shunts were placed (group
1) and 24 primary ventriculoatrial
shunts were placed (group 2). One
patient with a lumboperitoneal shunt
done in another centre was later ad
mitted to the Children’s Hospital of
Eastern Ontario for shunt revision.
Causes

Aqueduct stenosis was the cause of
hydrocephalus in 16 cases (13%)
while brain tumour accounted for 13
cases (10%) (Table I). In 36 cases
(29%) there was a communicating
hydrocephalus of undetermined cause.
Associated myelomeningocele was
present in 44 children (35%).
The need for a shunting procedure
was determined by the patient’s his
tory and clinical evidence of hydro
cephalus. The diagnosis was confirmed
by ventriculography or pneumoence
phalography, or both. These tests have
since been replaced by computerized
tomography.
The types of valve mechanism used

T a b le 1 - -Causes o f H y d ro c e p h a lu s (125 P a tie n ts )

Cause
H y d ro c e p h a lu s w ith
m y e lo m e n in g o c e le
C o m m u n ic a tin g h y d ro c e p h a lu s
cause u n d e te rm in e d
A q u e d u c t s te n o s is
B ra in tu m o u r
M e n in g itis
T ra u m a
N o n n e o p la s tic c y s t
V a s c u la r m a lfo rm a tio n in
p in e a l re g io n

V e n tr ic u lo a tr ia l
shunt

Lum bo
p e rito n e a l
shunt

33

11

—

28
12
12
4
4
5

7
4
1

—

V e n tr ic u lo p e rito n e a l
shunt

—

—
—

1
—

1

—
—

T o ta l

44
36
16
13
4
5
5
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for shunting are shown in Table II.
The figures indicate only the neurosur
geons’ preference. No “Unishunts”
were used, although the Raimondi
peritoneal catheter with a flushing
device attached to a ventricular catheter was next in popularity to the
Holter valve.
Table I I I — Causes of Failure of Ventriculoperitoneal Shunts (58 Patients)

r

K

►

^

*

r1

*

A

Y

Y

No. of
revisions

Cause of failu re*
Obstruction of ventricular
catheter w ith choroid plexus,
brain tissue, detritus
Retraction of peritoneal
catheter from peritoneal
cavity
Disconnection of catheter
from flushing device
Obstruction of peritoneal
catheter with omentum, fibrin
Shunt infection
Revision of medium pressure
to low pressure valve
Leakage of shunt tubing
Skin erosion
Kinked tubing
Valve malfunction
D istal catheter encysted in
peritoneal cavity
Shunt malfunction, undefined
cause

10

Total

97

36
11
9
9
6
5
3
2
2
3
1

Results

During the 4-year study period
there were 118 shunt revisions in 77
patients. In 58 group 1 patients there
were 97 failures requiring revision of
the shunt. The reasons for failure are
analysed in Table III. The most com
mon reason (in 36 instances) was ob
struction at the ventricular end of the
shunt caused by choroid plexus,
brain tissue or detritus. On the other
hand, obstruction at the peritoneal end
accounted for only nine failures re
quiring revision; retraction and dis
connection of the peritoneal catheter
accounted for 20 failures in this
group.
There were 20 failures in group 2
necessitating revision in 18 patients
(Table IV). In 13 of these revision
procedures, the shunt was converted
to a ventriculoperitoneal shunt. No
ventricular obstruction was docu
mented.
The revision rate for groups 1 and
2 was 58% (58 of 100) and 75%
(18 of 24), respectively, but the 18
ventriculoatrial shunts needed only 20

Table V I— Infecting Organisms in
Group 1 Patients

*1 revision of lumboperitoneal to ventriculoperitonea! shunt.

No. of
patients*

Organism
Table IV — Causes of Failure of Ventriculoatrial Shunts (18 Patients)

Staphylococcus epidermidis
Staphylococcus aureus

5
3
3
1
1

Mixed organisms

Escherichia coli
No. of
revisions

Cause of failure
►-

Y

Yv

Y

r

y

’ In 1 patient no organism was cultured.

Proximal migration of atrial
catheter from atrium
A trial end blocked
A trial catheter disconnected
from flushing device
Malposition of ventricular
catheter in the subarachnoid
space
Shunt nephritis
Meningitis
Overdrainage of cerebrospinal
fluid from low pressure valve
Shunt malfunction, undefined cause
Total

a-hem olytic streptococcus

6

revisions while the 58 ventriculoperi
toneal shunts required 97 revisions.
The only lumboperitoneal shunt was
converted to a ventriculoperitoneal
shunt.
The frequency of shunt revisions
per patient is shown in Table V. The
follow-up in these patients ranged
from 10 to 48 months (average 24
months). Forty-eight patients (38%)
had no complications as a result of
the shunt procedure.
There were 14 (14%) shunt infec
tions among the group 1 patients and
4 (16.7% ) in group 2. The overall in
fection rate was 14.4%. The organisms
cultured from group 1 patients are
listed in Table VI. Staphylococcus epidermidis was the predominant infect
ing organism in both groups. In group
2, three patients had chronic bactere
mia; in two the infection was as
sociated with shunt nephritis. There
was one case of meningitis. In one
patient the infecting organism was
//-hemolytic streptococcus, Lancefield
group A, and in three it was S. epidermidis. The nature of the infections in
group 1 is shown in Table VII.
The culture and sensitivity results
showed that the S. epidermidis and
Staphylococcus aureus were sensitive
to cephalosporin and /3-lactamase pe
nicillin (Table VIII).
Routine antibiotic prophylaxis with
either cloxacillin or cephalosporin was
instituted in early 1977 and there was
a notable decline in the number of
shunt infections thereafter (Table IX).
Miscellaneous Complications
Inguinal hernia developed in three
patients who subsequently underwent
herniorrhaphy.

2
3
1
2
1
2
3
20

Table IX — Incidence of Shunt Infection

Table V II— 'T ype of Infection in
Group 1 Patients
No. of
patients

Nature of infection
V entriculitis
Abdominal wound
Meningitis
Cerebral abscess
Gut perforation with peritonitis
Septicemia
Shunt tubing

5
2
2
2
1
1
1

No. in fe ctio n s/
admissions
for su rg ery)

Period
August 1 9 7 4 -July
August 1975 - July
August 1976-J u ly
August 1977-J u ly

1975
1976
1977
1978

5/37
8/29
4/59
1/55

*14 ventriculoperitoneal shunts, 4 v e n tri
culoatrial shunts.
fl8 0 admissions for 125 patients.

Table V - Frequency of Shunt Revisions
No. of
revisions

No. of
patients

Total no.
of revisions

0
1
2
3
4
6

48
51
18
3
4
1

0
51
36
9
16
6

Total

125

118

Table V III— Sensitivity of Organisms to Antibiotics
Organism
S.

epidermidis

S. aureus

A ntibiotic

Sensitive

Resistant

Cephalosporin
^-lactam ase penicillin

7
8

1
0

Cephalosporin
(1-lactamase penicillin

3
2

0
1
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The ventricular catheter was dis
lodged and lost in the lateral ventricle
in two patients; in one of these a
craniotomy was necessary to remove
the catheter because of persistent in
fection.
One patient had a thalamic hemor
rhage resulting from a revision proce
dure.
Two patients had shunt nephritis 10
and 12 years respectively after the in
sertion of the initial ventriculoatrial
shunt.
Fourteen patients died, 9 from
complications directly related to the
shunt procedure. The other five deaths
were related to the condition for which
the shunt was initially inserted. The
mortality from shunt complications
was, therefore, 7.2%, but the overall
mortality was 11.2%. Of the nine
deaths from shunt complications eight
occurred in group 1 (Table X). Five
deaths were directly related to shunt
infections which accounted for 55%
of the deaths from shunt complica
tions.
Discussion

Despite the repeated labelling of
shunting procedures as nonphysiologic
by Scarff1,2 and despite new attempts
to revive fenestration of the third
ventricle,3,4 most neurosurgeons treat
hydrocephalus by ventriculoatrial or
ventriculoperitoneal shunting.5'8 Be
cause of the simplicity of the ventri
culoperitoneal shunt, the majority of
neurosurgeons, including our own,
prefer this method.8,9
In our patients ventricular catheters
blocked more frequently with ventri
culoperitoneal shunts than with ven
triculoatrial shunts. This finding is in
contrast to the observations of Little,
Rhoton and Mellinger.8 On the other
hand, we had fewer obstructions of
the peritoneal catheter than did
others.5,9 The development of in
guinal hernia was also less frequent
than in other series.5
Two cases of shunt nephritis, con
firmed by renal biopsy, were clearly
related to ventriculoatrial shunt infec
Table X

tion with S. epidermidis. This compli
cation, rare in all series,10 responded
to treatment promptly.
Our overall infection rate of 14.4%
is high and was probably related to
the fact that neither the operative
technique nor the use of prophylactic
antibiotic therapy was uniform until
1976 when the shunt operation was
done by fewer surgeons, with a result
ing decline of shunt infections. Al
though some authors do not find anti
biotics useful," we believe that stan
dardized technique12 and routine use
of antibiotic prophylaxis reduce in
fection and mortality.7'13'15
Our overall mortality from shunt
complications of 7.2% is comparable
to that of other series.6 The majority
of those who died had infectious com
plications, confirming the findings of
Raimondi, Robinson and Kuwamura.9
Overall the results of our series were
good and compare favourably with
some series,9 '8 but the relatively small
number of procedures done by the in
dividual neurosurgeons makes com
parative evaluation of different tech
niques impossible. The lower revision
and mortality rates of ventriculoatrial
shunting, however, are probably signif
icant and confirm the findings of Ivan
and associates,7 who reported their
favourable impression of these shunts
in 1968.
In 1976 we began a more stand
ardized approach to primary shunts
and to the management of complica
tions. We believe that the sharp
decline of infections is the result of
these changes.
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M ortality Related to Shunt Complications

Correction
Shunt type
Ventriculoperitoneal

V en tricu lo a trial

Cause of death

No. of deaths

Septicemia
V entriculitis
Meningitis
Thalam ic hemorrhage
Sagittal sinus thrombosis
Blocked shunt
Meningitis

2*
1
1
1
1
2
1

*Both patients had a myelomeningocele.
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On page 487 of the September 1980
issue, in the article “Effect of Actino
myces israelii on human peripheral lym
phocytes”, the fourth sentence of the
abstract reads: “Skin reactivity to various
standard antigens was depressed in all
seven patients.” This sentence should
have read “Skin reactivity to various
standard antigens was depressed in each
of the patients.”
THE CANADIAN JOURNAL OF SURGERY

Myocutaneous Flaps: the Saskatoon Experience
B rian J. M iller,
The purpose of this study was to
determine the results of myocutaneous
flap procedures performed in three
Saskatoon hospitals between 1977
and 1979.
Twenty-two flap procedures were
performed on 17 patients. Eleven
patients were suffering from decubitus
ulcers and 6 had other wounds.
Myocutaneous flaps have a place
in the early surgical management of
decubitus ulcers. Fluorescein given
intravenously in some patients during
operation was used to assess flap
viability; 4 out of 10 flaps required
trimming as a result.
The myocutaneous flap technique
provides rapid and durable closure for
a wide variety of tissue defects
which are otherwise difficult to cover.
Cette etude a pour but de determiner
les resultats des greffes de lambeaux
myo-cutanes pratiquees dans trois
hopitaux de Saskatoon entre
1977 et 1979.
Vingt-deux de ces greffes ont ete
effectuees chez 17 patients. Onze
patients souffraient d'ulceres de
decubitus et 6 presentaient d'autres
blessures. Les greffes myo-cutanees
peuvent etre envisagees tot dans le
traitement chirurgical des ulceres
de decubitus. Chez quelques patients,
I'administration intraveineuse de
fluoresceine durant I'operation servit
a evaluer la viabilite des greffons;
en consequence, 4 greffons sur 10
necessiterent des modifications.
La technique de greffe myo-cutanee
assure la fermeture rapide et durable
d’une grande variete d'imperfections
de la peau qui sont autrement
difficiles a couvrir.
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The purpose of our study was to re the patient with the scapular sarcoma.
view the results in patients who under
Fluorescein (10 to 15 mg/kg) was
went myocutaneous flap procedures injected intravenously at operation to
in three Saskatoon hospitals between
November 1977 and July 1979 to de
termine how successful this technique
is for wounds that are difficult to
manage.
The preservation of an island of
skin by elevating it along with the
underlying muscle was described by
D’Este in 1912.' The concept did not
become popular until McCraw defined
more than 20 independent myocuta
neous vascular territories2 and, in
1976, first coined the term myocuta
neous flaps.3 Many applications have
been found for these flaps in recon
structive surgery since then. They have
certain advantages over other local
flaps; safe length-to-base ratios of
up to 5:1 may be achieved; excellent
padding is provided by the carrier
muscle over pressure areas; delaying
procedures are unnecessary in most
cases and the majority of operations
may be performed in one stage.
Patients and Methods

Myocutaneous flaps have been used
in reconstructive surgery at the three
main Saskatoon hospitals since No
vember 1977. In the first 18 months of
our experience 22 flap procedures
were performed on 17 patients (15
men, 2 women), whose ages ranged
from 19 to 68 years (average 45
years).
A variety of conditions were
treated. Sixteen decubitus ulcers (9
ischial and 7 trochanteric) were treated
in 11 patients who were paraplegic or
quadriplegic. Two patients had chronic
tibial osteomyelitis with sinus forma
tion and ulceration. There was one
case each of electrical burns of the
knee, severe frostbite of the knee,
pharyngeal fistula following pharyngolaryngectomy for carcinoma and
recurrent sarcoma of the left scapular
area.
The flap chosen to close each de
fect was the one whose arc would
cover the wound in question. Eight
rectus femoris flaps, six gracilis flaps
and two biceps femoris flaps were per
formed for decubitus ulceration. Four
gastrocnemius flaps were used for
the wounds around the knee (Fig. 1).
The patient with a pharyngeal fistula
was treated with a sternomastoid flap.
A latissimus dorsi flap was used for

Fig. lb
FIG. 1—(a) Right knee of 24-yearold man who sustained electrical burn.
Patella is necrotic, (b) After excision of
patella, lateral gastrocnemius flap is
elevated and laid over open knee joint.
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check the circulation in 10 of the 22
flaps (Fig. 2). As a result 4 of the 10
flaps required some trimming of skin
and muscle.
Follow-up was from 6 months to 2
years (average 9 months). Entry of
patients to our series was terminated
18 months after the first myocuta
neous flap procedure had been done,
to allow recognition of complications
in the collected cases.
R esults

a different area in one patient, minor
flap necrosis in four patients and
wound infection in one. In no patient
was there complete loss of a flap.
Three out of four cases of minor
necrosis of the flap postoperatively
occurred in patients whose flap cir
culation was not checked by fluor
escein injection. One rectus femoris
flap that was checked by fluorescein
underwent partial necrosis. The viabil
ity of this flap was probably com
promised by edema of the pedicle 2

days after operation because the ische
mic area was greatly diminished by
prompt removal of some of the skin
sutures (Fig. 3). In one patient who
was quadriplegic, diabetic and very
obese two of three myocutaneous flaps
ulcerated in less than 4 months. The
patient who underwent coverage of
the pharyngeal fistula with a sternomastoid flap had necrosis of the tip of
the flap 10 days after operation and
the fistula recurred. Six months after
operation the fistula had not healed.

All 17 patients in the series are
alive and have been available for fol
low-up. The average time that elapsed
before patients with decubitus ulcers
could bear weight on their flaps was
4 weeks.
Early complications included for
mation of a hematoma in two patients,
minor dehiscence of the suture line in
three, further decubitus ulceration in

Fig. 2a

Fig. lc
F IG . 1— (c) F our weeks after o pera
tion patient is well mobilized with little
functional disability resulting from flap.
570

Fig. 2b
FIG . 2— (a) Rectus fem oris flap elevated to close excised trochanteric decubitus
ulcer, (b) Luminescence under ultraviolet light after intravenous injection of
fluoroscein reaches tip of flap indicating that its blood supply is adequate.
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T he other 15 patients have good re
sults to date.
Split-skin grafting of donor sites
was required in four out of eight rec
tus femoris flaps, three out o f four
gastrocnem ius flaps and in both the
latissimus dorsi and the sternom astoid
flaps. T he need for grafting of the
donor site depended on the patient's
degree of obesity and the anatom ic
location of the flap. N o gracilis flap
required a donor site split-skin graft.

T he use of m yocutaneous flaps to
close decubitus ulcers has not yet

been recom m ended as an initial p ro ce
dure despite their reported effect
iveness. This is because elevation of
the m yocutaneous flap may interfere
with the design of other simpler local
flaps should the m yocutaneous flap
fail. T he average time between onset
of ulceration to closure by the m y o 
cutaneous flap procedure in our series
was 2 '/x years (range 1 month to 7
years). O f the 11 patients with de
cubitus ulcers, the 5 most recent have
had m yocutaneous flaps as the initial
procedure. The first six patients in
ou r series had had an average o f nine
procedures before a m yocutaneous
flap was used. O ur experience with

Fig. 3a

Fig. 3b

D iscussion

Fig. 3c
Fig. 3d
FIG . 3— (a) Trochanteric decubitus ulcer 10 cni in diam eter in 37-year-old p a ra 
plegic. (b) Island of skin is elevated on rectus fenioris muscle to provide coverage.
(C) Twenty-four hours after operation there is partial necrosis of flap . Pedicle
was decompressed as soon as this was recognized, (d) N o further necrosis took
place after rem oval of sutures over pedicle. Result 3 weeks later after local debride
m en t and sp lit-sk in n g ra ftin g is sa tisfa c to ry .
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these flaps has been encouraging. W e
tend now to use them earlier fo r d ec u 
bitus ulceration than previously. O ur
success can be attributed to good re 
habilitation program s as well as to
surgical technique.
T he possibility th at an in n erv ated
m yocutaneous flap may cause w ound
dehiscence by m uscle co n tractio n in
the early postoperative period has been
considered. W e used six in n erv ated
flaps and this was recognized to be a
cause of suture line sep aratio n in the
one patient with a latissim us dorsi
flap. In o u r experience such a co m 
plication is rare. W e w ould n ot n o r
mally risk jeopardizing the blood su p 
ply to a fresh flap by ad ditional dis
section in the region of the v ascular
pedicle to divide either the m o to r
nerve or the origin o f the m uscle.
M cC raw , Dibbell and C a rra w a y 4 have
described the loss o f function to be
expected with d ifferen t in n erv ated
m yocutaneous flaps. T his loss of
function has not proved to be a m ajo r
problem with any of the flaps used
in o u r series.
T he intravenous injection o f flu o r
escein during the op eratio n to check
that flap circulation is ad e q u ate was
helpful. T his test was in tro d u ced in
1931 by Lange and Boyd5 an d has
proved rem arkably safe; the o c c u r
rence of allergic phen o m en a is ex 
trem ely low and no deaths have been
reported. The intensity o f skin lum i
nescence under ultraviolet light is an
expression of ex tracellu lar fluorescein
accum ulation. T he tech n iq u e o f the
test as used in 285 flaps was described
by M cCraw , M yers an d S h an k lin /'
Solidly fluorescent skin will alw ays
survive. Spotty fluorescence o ften sig
nifies viability, but skin an d m uscle
that are blue u n d er ultrav io let light are
destined to necrose and should be
trim m ed off in the o p era tin g room .
Only 1 of 10 fluorescent flaps ex h i
bited necrosis
postoperatively. T his
partial necrosis was probably d ue to
progressive edem a o f the pedicle. F o u r
flaps required som e trim m in g in the
o perating room . T h e h ig h er dose
of fluorescein provided us w ith the
best definition. T h re e o f 12 flaps in
w hich fluorescein w as not used u n d e r
w ent partial necrosis.
M yocutaneous flap p ro ced u res have
been em ployed in the trea tm e n t of a
wide variety of indolent w ounds. T h eir
usefulness in the ischem ic ulcers of
patients with sickle cell disease is
well described by H eckler, D ibbell and
M cC raw .7 G racilis m y o cu tan eo u s flaps
have been successful in th e m an ag e
m ent of ch ro n ic perineal sinuses fol-
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lowing abdominoperineal resection for
inflammatory bowel disease.8 Rectus
abdominis flaps have been used for
reconstruction in the patient with mas
sive abdominal wall defects.”
Summary

The combined experience with myocutaneous flaps in Saskatoon in which
22 flap procedures have been per
formed on 17 patients resulted in no
deaths and no total flap loss. The
results have generally been satisfac
tory. Only two patients had recur
rent wounds. There is a growing ten
dency, in view of our success, to use
the myocutaneous flap as the initial
procedure in patients with decubitus
ulcers. Fluorescein injected intra
venously at the time of operation in
10 patients was helpful in delineating
nonviable portions in 4.

We conclude that the myocutaneous
flap technique is firmly established as
a safe and effective means of dealing
with many wounds that are difficult
to cover.
We are grateful to Drs. L.R. Chasmar,
D.J. Classen and J.H. Zondervan for
their assistance in this study, and for
permission to use their cases in this
report.
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Arteriovenous Malformation of the Duodenum
G.R. Stallwood, b sc, m sc, md and T.A. R ichards, md, m sc, frcs[c ], facs

In their report of a 55-year-old woman
with an arteriovenous malformation
of the duodenum, the authors illustrate
some of the interesting clinical features
of this uncommon cause of chronic
gastrointestinal bleeding. The lesion
was treated by surgical resection.
Arteriovenous malformations have been
classified according to location, age
of the patient and family history. In
this patient the malformation was
considered to be a type 2 or congenital
lesion. The authors review the
literature on arteriovenous malfor
mations and emphasize the use of
selective visceral angiography for
diagnosing arteriovenous malformations
of the gastrointestinal tract.
Les auteurs signalent le cas d'une
femme de 55 ans souffrant de
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malformation arterio-veineuse du
duodenum et se servent de cette
description pour illustrer quelques uns
des aspects cliniques interessants de
cette cause rare de saignement gastro
intestinal chronique. Cette lesion a
ete traitee par resection chirurgicale.
Les malformations arterio-veineuses
ont ete classifiees selon le siege
anatomique, I'age du malade et les
antecedents familiaux. La malformation,
chez cette patiente, a ete consideree
etre de type 2, ou congenitale. Les
auteurs passent en revue la litterature
sur les malformations arterio-veineuses
et insistent sur I'angiographie selective
des visceres pour diagnostiquer les
malformations arterio-veineuses des
voies digestives.

Arteriovenous malformation of the
intestine is an uncommon cause of gas
trointestinal hemorrhage but recently
has been reported with increasing fre
qu en cy .'2 It is important not only that
these lesions should be considered in
the differential diagnosis of chronic
gastrointestinal bleeding but also that
the proper mode of investigation be

used to make the diagnosis. This re
port describes a patient with arterio
venous malformation of the duodenum
causing chronic gastrointestinal he
morrhage. The literature on this topic
is also reviewed.

Case Report
A 55-year-old Caucasian woman who
had a history of excessive ethanol con
sumption was admitted to hospital in
November 1976 because of fatigue and
melena of 2 weeks’ duration. Her hemo
globin value upon admission was 5.4 g/
dl. The patient had a family history of
anemia. Her mother suffered from ane
mia of “unknown cause” and her
father had a folate deficiency anemia.
One brother had recurrent gastrointes
tinal bleeding attributed to congenital
telangiectasia.
On physical examination no telangi
ectasia was noted on her lips, palmar or
plantar surfaces, buccal or nasal mucosa.
A grade II/VI systolic ejection murmur
was heard over the aortic and mitral
areas radiating into both carotid arteries.
The results of liver function tests and
hematologic and coagulation studies were
normal.
Esophagogastroduodenoscopy
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revealed no ulceration. A presumptive
diagnosis of hemorrhagic gastritis second
ary to alcohol consumption was made
and the patient was managed conserva
tively on a bland nonfatty diet with an
tacids. When she was discharged 3 weeks
later her hemoglobin value was normal
and she had no melena. She had re
ceived 9 units of blood throughout the
period of hospitalization.
During the spring and summer of 1977
the patient was admitted to hospital on
three occasions with melena, fatigue and
anemia. Findings on repeat barium ro
entgenography, endoscopy and colon
oscopy were normal.
In August 1977 she returned to hos
pital with the same complaints. Since
barium roentgenographic and endo
scopic examinations again gave normal
results, selective celiac angiography was
performed. This revealed the presence
of a vascular tuft or group of dilated
vascular channels indicating an arterio
venous malformation which was located
in a branch of the gastroduodenal artery
in the anterior wall of the first part of
the duodenum (Fig. 1). Early venous
filling in this area was also present (Fig.
2). Repeat duodenoscopic examination
demonstrated bleeding from the anterior
duodenal wall at this point.
At laparotomy close examination
showed an increase in the number of
small vessels on the serosal surface of
the anterior wall of the duodenal cap.
The duodenum was opened transversely,
distal to these vessels; the anterior wall
was bluish grey and thicker than normal.
Since the malformation was close to the
anterior pyloric sphincter, an anterior
pylorectomy was done in continuity
with removal of an adjacent 2.0- to 2.5cm portion of the anterior duodenal wall
which contained the malformation. The
window produced was closed transver
sely.
The resected specimen measured
3 x 2 cm. A small irregular area of
superficial mucosal ulceration over a

thickened wall could be seen. Histologic
examination showed superficial mu
cosal ulceration covered with fibrin clot.
Anastomosing dilated vascular channels
were not confined to the submucosa but
extended through the submucosa into
the serosa.
The patient's recovery was uncom
plicated. She has had no melena for 3
years and her hemoglobin concentration
has been stable at approximately 14.0
g/dl.
Discussion
This case exemplifies some inter
esting clinical features of arterio
venous malformation. The presenting
complaints, which may include fatigue,
hematemesis, melena or hematochezia,
are caused by chronic gastrointestinal
bleeding with resultant anemia.’ In
most instances, the diagnosis of ar
teriovenous malformation is delayed
because conventional methods of
examination (sigmoidoscopy, endo
scopy and barium roentgenography of
upper and lower gastrointestinal tracts)
do not always identify the cause or
site of bleeding. Conventional methods
may fail to determine the cause of gas
trointestinal hemorrhage in 8% to
22% of cases.2"1
Exploratory laparotomy7,5 was once
a popular diagnostic method for in
vestigating chronic gastrointestinal
hemorrhage. Retzlaff, Hagedorn and
Bartholomew” reported that 70% of
exploratory laparotomies resulted in
negative findings (excluding patients
with hematemesis). Since most arter
iovenous malformations cannot be
seen on gross inspection,7 exploratory
laparotomy is not recommended.1,8S
In 1960, Margulis, Heinbecker and
Bernard"1 first demonstrated the value
of angiography for the diagnosis of
arteriovenous malformation as a cause
of gastrointestinal bleeding. After the

►>

F IG . 1— A rterial phase o f selective
gastroduodenal a rte rio g ra m in left a n 
te rio r oblique p ro jec tio n . V ascu lar tu ft
(arrow ) appears to he in a n te rio r d u o 
denal w all. H e m o rrh a g e fro m this site
was confirm ed by duodenoscopy.

F IG . 2— L ate a rte ria l phase o f se lec t
ive hepatic a rte rio g ra m show ing early
venous filling.
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superior mesenteric artery was select
ively catheterized, contrast medium
was seen extravasating from a cecal
arteriovenous m alformation into the
cecal lumen. Sheedy, Fulton and
Atwell," in a series of 88 patients who
underwent angiographic studies for
chronic gastrointestinal hemorrhage
because the cause could not be deter
mined by conventional methods, found
that 45 % of the lesions could be diag
nosed by arteriography. Arteriovenous
malformation made up 50% of these
lesions, bowel tum ours 12% , visceral
artery aneuryms (mostly superior me
senteric artery aneuryms) 10% and
juvenile polyps 7% . Selective visceral
arteriography is often necessary to
diagnose
arteriovenous
malformations1’2’5’7’8,12 and this method also
proved valuable in our case.
Our angiographic findings demon
strate the classic appearance of an
arteriovenous m alformation (Figs. 1
and 2 ). There are large dilated vascular
channels or tufts which arise from
arteries and communicate with the
venous system without an intervening
capillary network. This results in ar
teriovenous shunting and early venous
filling.1’2’7’8’12 It is not necessary to de
monstrate bleeding from an arterio
venous malformation to prove it is the
true source of hemorrhage. In the
absence of other lesions, the m alform a
tion may be considered the cause of
bleeding. Bleeding has not recurred
after resection of a nonbleeding mal
formation discovered arteriographically.’2
Moore and associates7 derived a
clinical classification of arteriovenous
malformations based upon location,
age and family history. They de
signated a type 1 lesion as a single
malformation occurring in older pa
tients, most often localized to the ce
cum and ascending colon and not visi
ble grossly. Cavett and associates' re
viewed 47 patients with malformations
of this type and found 40% of lesions
in the cecum and 80% in the distal
ileum, cecum, ascending colon and
hepatic flexure collectively. The aver
age age of the patients at diagnosis
was 56 years and 75% were between
the ages of 50 and 80 years.
Type 2 arteriovenous malformations
occur in younger age groups and most
commonly are found in the small in
testine. They are frequently visible at
laparotomy; in 50% of cases large
abnormal mesenteric and subserosal
veins can be seen. M oore and as
sociates7 hypothesized that type 1
lesions are acquired whereas type 2
lesions are congenital in origin.
Lesions of hereditary hemorrhagic
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telangiectasia
(Rendu-Osler-Weber
syndrome) are classified by Moore
and associates7 as type 3 arteriovenous
malformations. Patients with these
lesions have a family history of re
current epistaxis and some family
members have skin and mucosal telan
giectasia. Small angiomas are often
found on lips and buccal mucosa.
Angiography reveals multiple punctate
angiomas in the stomach and proximal
small bowel of these patients. Patients
are older and present with epistaxis
and anemia. Gastrointestinal bleeding
is usually not severe and may be con
trolled in most cases with medical
therapy (synthetic estrogens and trans
fusions) in contrast to operative re
section which is the treatment of
choice for types 1 and 2 lesions.7
Boley and associates13'14 postulated
that acquired malformations or “vas
cular ectasia" of submucosal veins re
sult from chronic intermittent obstruc
tion of venous channels by circular
and longitudinal muscle of the colonic
wall. Later, mucosal veins, capillaries
and arteries also dilate and eventually
so do precapillary sphincters forming
a true arteriovenous communication.
This would explain why acquired le
sions occur in the submucosa and
mucosa of the bowel wall.
It is most likely that our patient
had a type 2 (congenital) malforma
tion. It was found in the duodenum
as opposed to the cecum or ascending
colon which are common sites for
type 1 (acquired) lesions. The mal
formation was visible on close inspec
tion at operation and extended through
the entire duodenal wall unlike ac
quired type 1 lesions which are rarely
identified at laparotomy and have
been reported to occur in the sub
mucosal and mucosal regions.7,1213
Review of the literature serves to
emphasize the importance of an or
ganized approach to a patient with
chronic gastrointestinal bleeding in
order to prevent chronic morbidity
and needless delay in diagnosis. First,
a complete history and physical
examination are necessary. Hematol
ogic tests, coagulation studies and en
doscopic examination may yield im
portant information. If no abnormality
is found then selective celiac, superior
or inferior mesenteric arteriography is
indicated to determine the cause, site
and extent of the lesion.5 Arterio
graphy is necessary for the diagnosis
of arteriovenous malformations and ra
diographic magnification methods have
been recommended to improve the
diagnostic yield, especially when small
lesions are present. Intraoperative ar
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teriography of the resected specimen
can confirm removal of a lesion.7 If
this technique is not used, a lesion may
not be included in the resected portion
of intestine and bleeding episodes may
continue postoperatively as witnessed
by Cavett and associates.1
We thank Drs. B.A. Richards and J.
Smart for information and assistance in
preparing this manuscript. Particular
thanks go to Dr. D. Bell, chief of radio
logy at the Joseph Brant Memorial Hos
pital.
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Rhabdomyosarcoma of the Brain
K yu H. S h in , m d , f r c p [c ]* and V.M. W h iteh ea d , m d , FRCP[c]f

The authors present a case of
primary intracranial rhabdomyosar
coma. This is only the 10th reported
case and is the only one in which
the patient has survived longer
than 2 years. A 9-month-old boy was
found to have a large mass
in the right posterior fossa.
Posterior fossa craniotomy revealed
an unencapsulated tumour involving
almost the entire right cerebellar
hemisphere and extending to the right
cerebellar pontine angle. Subtotal
removal was done for internal
decompression. On examination of the
specimen by light microscopy there
were definite sarcomatous features
with occasional rhabdopoietic elements
and many malignant giant cells.
The ultrastructural appearance con
firmed the diagnosis of malignant
rhabdomyosarcoma.
The child was treated with
combination chemotherapy and cobalt60 teletherapy. He is alive and well
2 years after operation and has no
clinical evidence of recurrent disease.
His physical growth and mental
development are satisfactory.
The response of our patient suggests
that such tumours may be
controlled by subtotal removal
followed by radiotherapy and
chemotherapy.
Les auteurs presentent un cas d'un
rhabdomyosarcome intracranien
primaire. II s’agit du lOe cas signale
de rhabdomyosarcone cerebral pur
et du seul qui a survecu plus
de 2 ans. Un gros tumeur a ete
trouve dans la fosse droite posterieure
d’un garcon de 9 mois. Une craniotomie dans la fosse cerebrate posterieure
a revele une importante tumeur
acapsulee qui occupait presque tout
I’hemisphere cerebelieux droit et qui
s'eiendait jusqu'a t angle pontocerebelleux droit. Une ablation sub
t o t a l a ete pratiquee afin de reduire
la compression interne. L'examen de

la piece de resection au microscope
optique a montre des caracteristiques
sarcomateuses definies avec des
elements rhabdopoietiques occasionnels et plusieurs cellules geantes
malignes. L'aspect de I'ultrastructure
cellulaire a confirme le diagnostic de
rhabdomyosarcome malin.
L’enfant a recu une association de
chimiotherapie et de telecobaltotherapie. Deux ans apres I'operation,
il est vivant et en bonne sante, sans
signe clinique de recidive. Son
developpement physique et mental
est satisfaisant.
La reponse de notre malade indique
que ces tumeurs peuvent etre
controlees par une ablation subtotale
suivie de radiotherapie et de
chimiotherapie.

Intracranial primary rhabdomyosar
coma is a very rare tumour, and its
histopathologic definition is controver
sial. The tumour is composed of pure
mesenchymal derivatives with both
embryonal and striated muscle cells. It
should be devoid of neuroblastic ele
ments.1 Nine cases of pure rhabdo
myosarcoma have been reported.2-10
We report a 10th case.
Case Report

A 9-month-old boy was admitted to
the Montreal Children’s Hospital on Jan.
19, 1977 with a 14-day history of otitis
media and upper respiratory tract infec
tion. On admission the only abnormal
finding was palsy of the right seventh
cranial nerve. Skull roentgenograms
showed widening of the coronal and
lambdoid sutures, a fracture of the right

parietal bone and a 2.5-cm shift of the
midline to the left. A vertebral angio
gram (Fig. 1) and computerized tomo
gram of the brain (Fig. 2) showed a
large mass occupying most of the right
side of the posterior fossa and extending
medially to the right margin of the pons.
At posterior fossa craniotomy per
formed 1 week after admission a large
unencapsulated tumour was found in
volving almost the entire right cerebellar
hemisphere and extending to the right
cerebellopontine angle. Subtotal removal
of the tumour was carried out for in
ternal decompression.
Examination of the tumour by light
microscopy (Fig. 3a) showed marked
pleomorphism and poorly differentiated
tumour cells with definite sarcomatous
features, occasional rhabdopoietic ele
ments and many malignant giant cells.
There were no neuronal or glial ele
ments. The ultrastructural appearance of
a malignant rhabdomyoblast is shown in
Fig. 3b. Subsequent investigations in
cluded bone, liver and spleen scanning
and tomographic examination of the mid
dle ear; the findings were normal. On
Feb. 7, 12 days after operation, combina
tion chemotherapy was begun. It con
sisted of vincristine (0.6 mg intravenous
ly), actinomycin (130 p.g intravenously),
cyclophosphamide
(140
mg intra
venously) and methotrexate 12 mg/m2
(intrathecally) every 6 weeks.
Using supervoltage cobalt-60 telether
apy, the whole brain was irradiated with
a total dose of 3000 rads over a period
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F IG . 1— Vertebral angiogram shows
slip
of right tonsillar hemispheric
branch of posterior inferior cerebellar
artery below foramen magnum and an
terior displacement of proximal portion
of basilar artery against clivus.
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F IG . 2— Computerized axial tomo
gram of brain. Large mass occupies most
of right side of posterior fossa, extend
ing medially to right margin of pons.
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of 4 weeks, in 20 treatments. Then an
additional tumour dose of 1500 rads
was given over a period of 2 weeks in
10 treatments to the posterior fossa. After
radiotherapy was completed on Apr. 18.
1978 he was maintained on combination
chemotherapy with vincristine, actinomycin, cyclophosphamide and intrathecally administered methotrexate in the
same doses as before every 6 weeks. The
chemotherapy was discontinued in Feb
ruary 1979. Two years after the oper
ation he is alive and well without clinic
al evidence of recurrence. His physical
growth and mental development are
satisfactory.
Discussion

The histologic origin of primary
T a b le

rhabdomyosarcoma of the brain ap
pears to be the ectomesenchyme of
the neural crests."
Tumours containing rhabdomyoblasts may be classified into three gen
eral types: teratomas, medullomyoblastomas and rhabdomyosarcomas. Rhab
domyosarcoma is quite distinct from
medulloblastoma and teratoma which
are markedly argyrophilic and com
posed of striated muscle cells and
other mesenchymal tissue but without
any neuroblastic or teratomatous ele
ments.4
The reported cases of pure rhabdo
myosarcoma of the brain, including
the present case, are summarized in
Table I .

Seven of the 10 reported rhabdo
myosarcomas of the brain were in
children, ranging in age from 9
months to 18 years. There were six
girls and four boys. Seven tumours
were located in the posterior fossa:
four in the cerebellum, one in
the cerebellopontine angle, one in the
brain stem and one in the fourth ven
tricle. Three of seven demonstrated
diffuse subarachnoid spread.
The use of combined treatment
modalities has resulted in an im
proved survival rate for children with
rhabdomyosarcoma." Not until che
motherapy was added to operation
and radiotherapy did substantial improvement occur. This is probably true
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Fig. 3a
FIG. 3—(a) Many malignant giant cells with hyper chromatic large nuclei and deeply eosinophilic cytoplasm
(hematoxylin and eosin. reduced by 24% from X400). (b) Ultrastructural appearance of malignant rhabdomyoblast. Fila
ments and abortive Z bands are seen in cytoplasm (reduced by 38% from X7000).
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Glucagon Therapy in Acute Pancreatitis:
Prospective Randomized Double-Blind Study
H.T. D ebas , m d , fr c s [c ],

R .J .

H ancock , md , fr c s [c ], P. Soon -S hiong , m b , b c h , H .A. S m y t h e , ph m b and
M.M. C a ssim , m d , frcs [c ]

The known suppressive actions of
glucagon on the secretion of pancreatic
enzymes and of gastric acid, and
the reported effectiveness of glucagon
in treating acute pancreatitis,
prompted the authors to carry out a
prospective, randomized, double-blind,
controlled trial of this hormone. Sixtysix patients with acute pancreatitis
admitted to the surgical service of the
Vancouver General Hospital were
randomized into two groups of 33,
receiving either glucagon or placebo
in addition to their conventional
therapy. The two groups were com
parable with respect to the cause
of the pancreatitis and the severity
of the disease. Glucagon did not
reduce the patients' analgesic
requirements or the duration of

abdominal signs, ileus, hyperamylasemia or hospital stay. Of the 66 pa
tients, 4 died. Three of these were in
the group receiving glucagon. The
authors conclude that, contrary to
theoretical expectations and the results
of past uncontrolled trials, glucagon
has no beneficial effect on the clinical
course or outcome of acute pancrea
titis, irrespective of the etiology
or severity of the disease.
L'activite suppressive bien connue du
glucagon sur la secretion des enzymes
pancreatiques et de I’acide gastrique,
ainsi que I’efficacite signalee du
glucagon dans le traitement de la
pancreatite aigiie ont incite les
auteurs a realiser une etude pros
pective controlee, randomisee, et a
double-insu de cette hormone.
Soixante-six malades accueillis au
service de chirurgie du Vancouver
General Hospital pour pancreatite
aigiie ont ete repartis au hasard en
deux groupes de 33 sujets qui ont repu,
en plus du traitement conventionnel,
soit du glucagon, soit du placebo.
Les deux groupes etaient comparables
pour ce qui est de la cause de la

pancreatite et de la gravite de la
maladie. Le glucagon n'a reduit ni
les besoins en analgesiques, ni la
duree des signes abdominaux, de
I’ileus, de I'hyperamylasemie ou du
sejour a I 'hop ita I. Quatre des 66
patients sont decedes, dont 3 dans
le groupe qui recevait du glucagon.
Les auteurs concluent que contrairement aux attentes theoriques et
aux resultats d’etudes anterieures
non controlees, le glucagon n'a aucun
effet favorable sur 1'evolution clinique
ou I'issue de la pancreatite aigiie,
quelle qu'en soit I'etiologie ou la
gravite.

Four physiologic actions of glucagon,
the 29-amino-acid pancreatic poly
peptide, suggest that it might have
beneficial effects on the clinical
From the division of general surgery,
course
of pancreatitis: (a) it is a
department of surgery, University of
powerful inhibitor of pancreatic en
British Columbia arid Vancouver
zyme;1 (b) it inhibits gastric acid
General Hospital, Vancouver, BC
secretion,2 which is the main drive
Accepted for publication Dec. 18, 1979
for secretin release from the intestine;
(c) it increases pancreatic blood flow;
Reprint requests to: Dr. H.T. Debas,
and (d) its inotropic action is capa
Department of surgery, Wadsworth
ble of improving cardiac output. In
Medical Center, Wilshire and Sawtelle
Blvds., Los Angeles, CA 90073, USA
deed, in an uncontrolled clinical study
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in 1973, Condon, Knight and Day3
showed that glucagon is of benefit to
patients with acute pancreatitis.
In a controlled double-blind ran
domized manner this prospective
study compares the effects of glu
cagon and placebo on patients with
acute pancreatitis admitted to the sur
gical services of the Vancouver Gen
eral Hospital. The study shows that
glucagon has no effect on the clinic
al course or on the outcome of acute
pancreatitis.
Patients and Methods
Sixty-six patients with acute pan
creatitis seen at the Vancouver Gen
eral Hospital between Jan. 1, 1975
and Dec. 31, 1977 were studied. The
criteria for entry into the study were:
the presence of typical symptoms
and signs of acute pancreatitis as
sociated with elevation of serum
amylase to three times the normal
level or operative findings of acute
pancreatitis at the time of exploratory
laparotomy. The arbitrary criterion of
elevation of serum amylase to three
times the normal value was adopted
because this value is high enough to
exclude most acute abdominal condi
tions that cause hyperamylasemia
simulating pancreatitis and low
enough that we did not exclude too
many patients with acute pancrea

titis from the study. Once we decided
to enter a patient into the study, the
hospital pharmacy randomly assigned
the patient into the study (group 1)
or placebo group (group 2). The
pharmacy then issued to the ward
glucagon (1 mg) or placebo (saline)
in 1-ml syringes. The patients re
ceived 1 ml of glucagon or placebo
every 3 hours by continuous intra
venous infusion in 100 ml of 5%
glucose in water. By this means we
avoided deterioration of glucagon in
the intravenous bottle. This would
occur if the drug stayed in solution
longer than 3 hours at room tem
perature.
Baseline studies included a com
plete history-taking and physical
examination, estimation of the serum
and urine amylase, the serum cal
cium, phosphorus, fasting blood
sugar, electrolyte and hemoglobin
levels, the leukocyte count and dif
ferential and performance of liver
function tests. The same examiner
who made the initial assessment
(H.T.D. or R.J.H.) also performed
subsequent daily clinical evaluation
of the abdominal signs. The amount
of fluid administered daily, the vol
ume of nasogastric suction, the lowest
blood pressure and highest pulse rate
and temperature each day and the 24hour narcotic requirement were also

Table 1— Comparison of Patients in the Glucagon and
Placebo Groups on Admission*
Group
1

2

33
52.5 ± 19.6

33
53.6 ± 18.6

23
10
13
18
2463 ± 1481
8.0 ± 2.4

18
15
14
15
2179 ± 1642
9.0 ± 0.8

Feature
No. of patients
Age, y rt
Sex
Male
Female
No. of patients with gallstones
No. of alcoholics
Serum amylase, IU/1
Serum calcium, m g/dlf
♦Differences w ere not significant.
(M ean ± standard deviation.

Table I I - Clinical Course of Patients*
Group
Variable
Duration of tenderness, d
72-h narcotic requirement, mgf
72-h volume of nasogastric
suction, If
72-h volume of fluid administered
intravenously, If

1

2

5
505 ± 440

7
356 ± 367

1.7 ± 1.7

1.8 ± 1.7

10.0 ± 2.3

♦Differences were not significant.
fM ean ± SD.
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8.7 ± 2.7

recorded. In addition the following
values were determined daily: blood
hemoglobin, leukocyte count and
differential, serum calcium, serum
amylase and 24-hour urine amylase.
Serum bilirubin, alkaline phospha
tase, fasting blood glucose and elec
trolyte levels were determined every
2 days.
Studies were continued until the
patient was free of pain and the
serum amylase had returned to nor
mal or, if the serum amylase level
remained elevated, until the patient
was pain free for 4 days. The total
number of hospital days, the final
etiologic diagnosis (e.g., biliary tract
disease, alcoholism, trauma) and any
side effects of treatment were also
recorded.
Following the completion of the
protocol, the code was given to the
computer analyst who then applied
the y2 test to evaluate any differences
between the glucagon and the placebo
groups. In instances where the blood
levels of chemicals (e.g., sugar, cal
cium) were compared, the signif
icance of difference between the two
groups was evaluated using Student’s
r-test for unpaired values.
Results
Comparison of Patient Groups

Patients in the two groups were
comparable in age, sex and initial
serum amylase and calcium levels.
Biliary tract disease and alcoholism
as etiologic factors were also equally
distributed (Table I). The severity of
disease in the two groups as assessed
by abdominal signs, tachycardia and
blood pressure changes, was also
similar.
Clinical Response

The clinical response in each group
was assessed by resolution of ileus
and abdominal tenderness and by the
amount of analgesic required, as well
as by the volume of nasogastric suc
tion and intravenous fluids required
(Table II). There were no statistically
significant differences between the
groups with respect to any of these
variables.
Hematologic and Biochemical
Responses

There were no differences between
the two groups with respect to daily
changes in hemoglobin concentration,
leukocyte count, liver function test
results or electrolyte levels. Although
the serum calcium concentration did
not differ in the two groups at the
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time of entry to the study, the con
centration 1 day after the onset of
treatment was significantly lower
(P < 0.05) in group 1 (8.4 ± 0.2 mg/
dl [2.10 ± 0.05 p.mol/1]) than in
group 2 (9.1 ± 0.1 mg/dl [2.27 ±
0.02 p.mol/1]). This is in keeping
with the known hypocalcemic effect
of glucagon.
Figs. 1 and 2 compare daily con
centrations of serum amylase and
fasting blood sugar respectively in
the two groups. It is clear that glu
cagon did not decrease the duration
of hyperamylasemia (Fig. 1). Plowever, patients in group 1 generally
had a higher fasting blood glucose
level (P < 0.05), which is again in
keeping with the hyperglycemic ac
tion of glucagon (Fig. 2).

rate in 257 patients studies was 11%
and that neither glucagon nor apro
tinin diminished the risk of death.
These studies underline the im
portance of controlled, prospective,
double-blind trials. Condon, Knight
and Day3 compared the 7% mor
tality in their glucagon-treated pa
tients with the 22% and 26% of
most previously published series in

Clinical Outcome
The mean hospital stay was 26 ± 5
days for group 1 and 20 ± 3 days
for group 2. Of the 66 patients
studied 4 (6%) died. Of the four
deaths, three were in group 1. There
was no statistically significant dif
ference with respect to either the
length of hospital stay or mortality
between the two groups. The cause of
death in the patient in group 2 was
cerebrovascular accident. Of the three
patients in group 1, severe hemorrha
gic pancreatitis verified at autopsy
was the cause in two; the third, a 91year-old man, died of congestive
heart failure.
Side Effects
There were no identifiable side ef
fects of treatment.

FID. 1— Serum amylase concentra
tions in patients treated with glucagon
(broken line) and placebo (solid line)
(mean ±
standard deviation). Each
point represents mean of 33 determina
tions of serum amylase in 33 patients.
Day 0 represents day before therapy
began. Upper limit of normal for serum
amylase in our laboratory is 300 IU/1.

We thank all the members of the
division of general surgery, Vancouver
General Hospital who allowed us to
study their patients, Ms. Ruth Kaplan
and Ms. Margaret McKinney for co
ordinating the data collection, Mirs.
Eva Germann for processing the data
and the nursing staff on the surgical
wards of the Vancouver General Hos
pital for their cooperation.

Discussion
Contrary to theoretical expect
ations and to the results of earlier
uncontrolled studies, this prospect
ive, randomized, double-blind trial
has shown that glucagon is of no
value in improving either the course
or the outcome of acute pancreatitis.
Since the completion of our study,
two similar randomized controlled
trials have led to the same conclu
sion. One of these studies was that
by Olazabal and Fuller4 from Case
Western Reserve University in which
26 patients with pancreatitis due to
alcoholism were randomized into the
two groups. No differences were
found between the two groups with
respect to symptoms, signs, labora
tory tests and requests for analgesia.
A much larger multicentre trial of
glucagon and aprotinin,5 concerned
principally with death from acute
pancreatitis, showed that the death
580

Britain. There is little validity in such
comparison since the mortality from
acute pancreatitis is changing. Ag
gressive management of blood-volume
deficit and metabolic abnormalities,
improved management of respiratory
failure and better nutritional support
with total parenteral nutrition have
all helped to reduce mortality in
acute pancreatitis. The patients in
our study were mostly referred to
the surgical service because they were
considered to have an “acute abdo
men” and, probably had a more sev
ere form of the disease than those
reported by Olazabal and Fuller.4
Indeed, several of our patients were
in hypovolemic shock on admission
to the study.
The dosage of glucagon we used (1
mg loading dose followed by conti
nuous infusion of 1 mg every 3 hours)
is comparable to that used by Con
don, Knight and Day3 and by others.
In this dosage it had demonstrable
biologic activity since it caused appre
ciable hyperglycemia and hypocal
cemia. Whether a higher dosage might
have been more effective in influen
cing the course and outcome of acute
pancreatitis is a matter of specula
tion. In the absence of any trend in
the present study, we doubt whether
a higher dosage would be any more
effective.
We conclude, therefore, that glu
cagon is ineffective in improving
either the course or outcome of acute
pancreatitis whatever the cause or
severity of the disease.
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Inadvertent Primary Vaginal Incision
during Cesarean Section
B ruce B ryan , md and R onald C. Strickler , md , FRCSfc], FACOG
A previously undescribed complication
of low transverse cesarean section—
primary entry into the upper vagina—
is reported in two women. The
patient at risk is a parturient whose
cervix is completely dilated and who
has been pushing in second stage
labour. Possible complications
include bladder injury, vesical fistula,
hemorrhage and laceration of adjacent
ligamentous structures. Management
requires meticulous hemostasis,
careful search for bladder injury and
anatomical closure of the vaginal
defect. The postoperative course and
prognosis of well managed cases
are good.
La penetration de la partie superieure
du vagin, une complication de la
cesarienne transversale basse qui n'a
pas ete decrite jusqu'a maintenant,
est signalee chez deux femmes.
La patiente particulierement exposee
est la parturiente dont le col uterin
est completement dilate et qui a
pousse durant la phase d'expulsion.
Les complications possibles incluent
lesion de la vessie, fistule vesicate,
hemorrhagie et laceration des struc
tures ligamenteuses adjacentes. Le
traitement requiert une hemostase
meticuleuse, la recherche minutieuse
des blessures de la vessie et la
fermeture anatomique de la breche
vaginale. L’evolution post-operatoire
et le pronostic des cas bien traites
sont bons.

A complication of low transverse ce
sarean section not described in the
English literature during the past 30
years occurred twice during 458 pri
mary cesarean sections performed at
Barnes Hospital, St. Louis, between
Sept. 1, 1977 and Jan. 31, 1979. In
both cases, the transverse incision,
which was thought to be through the
lower uterine segment, actually en
tered the anterior vaginal fornix leav
ing the myometrium completely intact.
From the department of obstetrics and
gynecology, Washington University
School of Medicine, St. Louis, Mo
Accepted for publication Jan. 8 1980
Reprint requests to: Dr. Ronald
C. Strickier, Department of obstetrics
and gynecology, 4911 Barnes Hospital
Plaza, St. Louis, MO 63110, USA
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The fetus and placenta were delivered occipitotransverse position failed. After
through an intact, completely dilated 2 hours of pushing in second stage
labour, fetal bradycardia that was un
cervix and the vaginal incision.
responsive to oxygen by mask and to
lateral positioning prompted immediate
Case Reports
delivery. The fetus was in a left occipito
Case /
transverse position at station spines -f2.
A 28-year-old primigravida presented During the low transverse cesarean sec
at term following spontaneous rupture of tion, the upper vagina was inadvertently
the membranes in early active labour. incised. She was delivered through the
Her past medical history and her ante vaginal incision of a 3490-g infant whose
natal course had been unremarkable. Apgar scores were 3 and 8 at 1 and 5
The cervix was dilated to 4 cm on ad minutes. The bladder was intact, but
mission and rapidly became fully dilated profuse bleeding from the vesical venous
with the fetal vertex in an occipitopos- plexus was incompletely controlled by
terior position. After 2 hours of pushing sutures and pressure. The vesicouterine
in second stage labour, the fetal vertex space was drained onto the anterior ab
had descended to station spines + 2 (de dominal wall for 72 hours. She was given
scent 2 cm beyond the ischial spines) antibiotics. The postoperative recovery
and remained in the occipitoposterior po was smooth and she was discharged 7
sition. When attempted forceps rotation days after operation. Follow-up for 18
and vacuum extraction to correct the months disclosed no complications.
persistent occipitoposterior position were
Discussion
unsuccessful, primary low cesarean sec
In both cases, the patients had
tion was performed, using a transverse
uterine incision which inadvertently en pushed in the second stage of labour
tered the vaginal fornix. The woman was for approximately 2 hours and a
delivered, through the vaginal incision, vaginal manipulation had been per
of a living 3380-g infant whose Apgar formed. At the time of cesarean sec
scores were 8 and 9 at 1 and 5 minutes, tion, the obstetrician entered the vesi
respectively. The base of the bladder was couterine
space immediately above the
lacerated during the delivery and there
was profuse bleeding from the vesical fold that identifies the superior m ar
venous plexus. The cystotomy was re gin of the bladder. After reflecting
paired in layers. Hemorrhage was con the bladder downwards, the obste
trolled using suture ligatures and pres trician made an incision over the fetal
sure. The anterior vaginal wall was re head. The incision was thought to be
paired with a double layer of sutures. The through the lower uterine segment but
woman was given broad spectrum anti actually entered the upper vagina,
biotics, received a 2-unit transfusion of and this was not recognized until after
whole blood and required drainage of the
bladder through a urethral catheter for
7 days. Her postoperative course was
otherwise normal. She was discharged 8
days after the operation and there have
been no complications during a 2-year
follow-up.
Case 2
A 27-year-old woman, gravida 3, para
2, was admitted at term in early labour.
Her cervix was dilated to 3 cm. Her
history was unremarkable except that a
pelvic fracture sustained in an automo
bile accident had preceded her two
previous uncomplicated vaginal deliveries.
Her time-cervical dilatation curve was
normal. An elective amniotomy was per
formed when the cervix reached 9 cm
dilatation. When cervical dilatation ar
FIG. 1—Primary transverse vaginal
rested over the next hour, oxytocin was incision
following delivery of baby. Ceadministered. A persistent anterior cer phalad margin
of incision, which re
vical lip was manually retracted over the tracts and becomes indistinct from an
fetal vertex and an attempt manually terior lip of fully dilated cervix, has been
to rotate the fetal vertex from a left exaggerated for clarity.
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delivery, when the margins were iden
tified for closure. In both cases, the
caudad margin was clearly seen while
the cephalad edge of the incision
through the anterior vaginal fornix
had apparently retracted to become
indistinct from the anterior lip of the
fully dilated cervix (Fig. 1). The re
pair approximated the distinct caudad
margin to the anterior lip of the cer
vix, followed by a second imbrication
layer of paravaginal and lower uterine
segment tissues.
The two complications we encoun
tered were bladder laceration which
was repaired primarily and profuse
venous bleeding from the base of the
bladder. Injury to the bladder or ure
thra, hematoma formation with pres
sure necrosis or infection could pre
dispose to fistula formation. Although
this complication did not occur in our
patients, vesicouterine and vesico
vaginal fistulas were the subject of one
report.1 The patient had been in labour
for 18 hours and difficulty was en
countered with the bladder.1 It is
possible that a primary vaginal
incision analogous to what we
describe initiated that patient’s com
plicated course. Other complications
that might accompany primary entry
of the vagina during cesarean section
include extension of the incision into
the cardinal ligament or cervix as the
cut is curved cephalad with scissors
and injury to the ureter or the de
scending branch of the uterine artery.
When a low transverse cesarean
section is performed on a woman
whose cervix is fully dilated, who has
pushed in second stage labour and in
whom the presenting part has been
delivered into the upper vagina, inad
vertent primary vaginal incision is
more likely. It should be possible to
avoid surgical entry of the vagina
rather than the uterus by incising the
lower uterine segment at or above the
reflection of the vesicouterine peri
toneum. Since the position of the re
flection onto the uterus is variable
or may be distorted by traction onto
the upper uterine segment, or both,
identification of the transverse uterine
muscle markings (as opposed to the
longitudinal appearance of muscle
forming the vaginal wall) is a further
safeguard to correct placement of the
uterine incision. Moreover, if the fetal
head is tightly impacted into the pel
vis, an assistant can provide upward
pressure onto the vertex with gloved
fingers in the vagina. This maneuver
may promote correct placement of the
lower segment incision over the fetal
head, may reduce the transabdominal
forces required to assist delivery and
/

should minimize extension of the in
cision and its consequences. If vaginal
entry has occurred, careful inspection
of the bladder is mandatory so that
primary repair of lacerations and
prolonged drainage of the bladder
can be effected. Hemostasis must be
meticulous and surgical drainage of
the vesicouterine space may be neces
sary. Imbrication of the vaginal fornix
with a two-layer closure using ab
sorbable suture appears adequate. Al
though both our patients received an
tibiotics prophylactically, this may not
be necessary. With proper surgical
management the postoperative course
is smooth and there appear to be no
long-term sequelae.
We thank Drs. N. Muschany and J.
Reed, who allowed us to report their
patients.
Addendum

Since this manuscript was prepared
two more cases of inadvertent vaginal in
cision during cesarean section have
occurred at our institution. The clinical
features of these two cases mirrored
those in this report.
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NOTICES

Course for General Surgeons
The annual refresher course for gen
eral surgeons will be held at the
Women’s College Hospital, University
of Toronto, Toronto, Ont. from Feb.
2-4, 1981. There will be symposia on:
the biliary tract, esophageal problems,
breast carcinoma, rectal carcinoma,
pediatric surgery, what’s new, and
how I manage, and workshops on
fractures, thoracoabdominal trauma,
gastroduodenal
surgery,
intensive
care, vascular surgery, sepsis and nu
trition, head and neck, and proctol
ogy. For further information contact:
Office of Continuing Medical Educa
tion, Rm. 245, Fitzgerald Building,
University of Toronto, Toronto, Ont.
M5S 1A8 or phone (416) 978-2718.
Chemotherapy Congress
The 12th International Congress of
Chemotherapy will take place July
19-24, 1981 in Florence, Italy.
The topics will include antimicro
bial, anticancer and antivral chem
otherapy as well as mmunology and
immunotherapy.
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Cystic Adventitial Disease of the Popliteal Artery
P ierre P age,

Cystic degeneration of the popliteal
artery is a rare vascular condition.
The authors report on the third case
recorded in Canada and provide a
follow-up report of the first recorded
case published in 1969. Observations
made at operation on the anatomical
relationship of the cyst give more
information on the etiology of this
curious entity. The clinical and
roentgenologic aspects, the etiologic
theories and treatment are briefly
reviewed. The authors conclude that
there are three principles of treatment
applicable to this condition: (a)
incision with evacuation of the cyst
may be effective, (b) the lesion
should be resected if evacuation is
unsuccessful and (c) popliteal
angioplasty should be avoided.
La degenerescence kystique de I’artere
poplitee est une pathologie vasculaire
rare. Les auteurs presentent ici le
troisiem e cas rapporte dans la lite r a 
ture canadienne. Ms revisent egalement
les donnees du premier cas publie en
1969. Les constatations operatoires
sur les relations anatomiques du
kyste donnent des informations
additionnelles pour aider a elucider
letiolo gie mal connue. Ils ont
revise brievement les aspects cliniques et radiologiques du probleme,
les theories etiologiques et les
modalites de traitement. Les auteurs
en arrivent a la conclusion qu’il existe
trois principes de traitement applicables a cette pathologie: a) I'efficacite
possible d'une incision pour
I’evacuation du kyste, b) resequer
la lesion si I’evacuation n'amene pas
de bons resultats et c) eviter
i'angioplastie poplitee.

md* and

F ernand L aurendeau,

At the time the first Canadian case
was published, 32 others had been
recorded in the world literature. More
recently, Flanigan and associates3
studied this rare condition and found,
by correspondence, a total of 115
cases. The authors pointed out in
their conclusion the need for further
observations by surgeons to determine
the cause of cystic adventitial disease.
Early in 1979 we treated a second
patient with this rare vascular disease.
Case Report

md,

FRCs[c]f

with poststenotic dilatation. The radiol
ogist considered adventitial disease as the
primary diagnosis, but could not rule
out completely the diagnosis of popli
teal entrapment syndrome, which was the
surgeon’s preoperative diagnosis.
On Apr. 2, through a posterior ap
proach, we isolated the artery and found
a soft, pale, cystic mass (2.5 x 4 cm),
which completely encircled the artery
over a 4-cm segment (Fig. 2). Because
we wanted to resect the whole mass we
did not attempt to evacuate the cyst.
By carefully dissecting the multiloculated
cyst, we identified a pedicle continuous
with the cyst cavities which led into the
knee joint capsule.
After resecting the involved segment
of the artery we cut the pedicle flush
with the knee joint capsule then restored
arterial continuity by a saphenous vein
interposition graft.
A longitudinal incision through the
resected specimen enabled us to see
the intact intima, the clear mucoid sub
stance in the cyst cavities and the en
croachment of the lesion on the arterial
lumen (Fig. 3).

A 29-year-old man was seen in March
1979 at the outpatient clinic of the Mai
sonneuve-Rosemont Hospital in Mont
real. His chief complaint was of inter
mittent claudication of the left calf which
had begun suddenly on Dec. 19, 1978
after mild direct external trauma to
the left knee. There was no past his
tory of any disease and in particular no
manifestation of any other vascular dis
ease.
The left knee appeared normal. There
was no edema of the left lower limb, no
trophic signs, no mass in the popliteal
area. The distal pulses were normal but
disappeared on active plantar flexion of
the left ankle as well as the knee and
after exercise. An arteriogram (Fig. 1)
showed an extrinsic, smooth, localized,
stenosis (50%) of the popliteal artery

In 1957, Hiertonn, Lindberg and
Rob4 described the principal features
of the disease: (a) it occurs in young
males, (b) it is associated with the
sudden onset of cramps in the calf and

FIG. 1— Arteriogram of left femoral
artery showing localized smooth ex
trinsic stenosis of proximal artery.

FIG. 2— LImbilical tape indicates nor
mal popliteal artery, adjacent to which
is cystic mass that completely encircles
artery.

Discussion

In 1969, the senior author (F.L.) was
the first to report a case of cystic ad
ventitial disease of the popliteal artery
in Canada.1 In 1975 Scobie and Curry2
reported a second case.
' Resident, department of surgery,
Maisonneuve-Rosemont Hospital,
Montreal, PQ
•Head, department of surgery,
Maisonneuve-Rosemont Hospital
Accepted for publication Dec. 5, 1979
Reprint requests to: Dr. F. Laurendeau,
Head, Department of surgery,
Maisonneuve-Rosemont Hospital,
5415, boul. de I'Assomption,
Montreal, PQ H IT 2M4
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development of typical intermittent
claudication, (c) localized stenosis or
occlusion of the popliteal artery is
present but generalized arterial
changes are not and (d) an intramural
cyst, which contains a gelatinous sub
stance and has a cyst wall suggestive
of mucinous degeneration, forms be
tween media and adventitia compres
sing the arterial lumen.
On clinical grounds, it is difficult to
distinguish this condition from popli
teal entrapment syndrome. Ishikawa,
Mishima and Kobayashi5 stressed that
in cystic adventitial disease the distal
pulse disappears when the knee is
flexed, but in our case it disappeared
also when the ankle was actively
flexed, which is why the surgeon’s pre
operative diagnosis was popliteal en
trapment syndrome.
This disease has three arteriographic
patterns depending on whether or not
the arterial lumen is occluded. The
most common pattern is that of ex
trinsic smooth stenosis similar to what
is reported here (Fig. 1). The second
pattern is that of arterial occlusion as
in the case we reported in 1969.1 The
third pattern is that of a curvilinear
scimitar sign produced by a cyst
located medially or laterally in rela
tion to the artery (Fig. 4).
In regard to the etiology, there are
three theories. The first, which has
the greatest support, is that the lesion
originates from microtrauma. However, this view has never been proved
beyond doubt and, as stressed by
Savage,6 it is difficult to understand
why the condition is not more com
mon. if trauma is the cause.

The embryologic theory has little
support because the mucin of the cyst
is more likely to be composed of
ground substance breakdown products
than epithelial cell secretions.3
The ganglion theory is most ac
cepted. Shute and Rothnie7 demon
strated the relation of the cyst with a
neighbouring joint. The histochemical
studies of De Laurentis and col
leagues8 demonstrated that the cysts
are rich in hyaluronic acid radicals.
Flanigan and associates3 summarized
the evolution of the pathologic change:
“The joint capsular degeneration pro
duces connective tissue change in
which cells secrete a substance de
rived from ground substance or col
lagen which contains hydroxyprolene.
These cells form cysts which invade
adventitia. Later, as multiple cysts
form, enlarge and coalesce with one
another to form multilocular cavities,
a sudden rupture of one cavity into
another can produce rapid growth
encroachment on the arterial lumen.”
The observations made in our case
corroborate this theory. If one finds
no relation between a cyst and the
overlying knee joint it is probably
because of degeneration of a part of
the cyst with subsequent separation.
Follow -U p of First Case

Our first patient was operated on
in June 1966. The arterial lumen was
obstructed by the cyst, but there was
no thrombosis. A gelatinous substance
extruded when an incision was made
through the adventitia and its evacua
tion permitted the reappearance of a
normal distal pulse in the popliteal
artery. Thirteen years later this pa
tient is asymptomatic.
Conclusions

The principles of treatment are
simple:

1. Evacuation may be effective, as
shown by the findings at the 13-year
follow-up of our first case.
2. The lesion should be resected if
arterial flow cannot be satisfactorily
reinstituted by evacuation. A saphe
nous vein bypass or an end-to-end an
astomosis is done if technically fea
sible.
3. Popliteal angioplasty should be
avoided.3
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NOTICES
continued from page 583
The deadline for the submission of
abstracts is Feb. 15, 1981.
For further information write to
the Secretariat, 12th International
Congress of Chemotherapy, Via della
Scalla, 10, Florence, Italy, 50123 —
Florence.

Clinical Application of
Hyperbaric Oxygen

The sixth annual conference on the
clinical application of hyperbaric
oxygen is scheduled for June 10-12,
1981 at the Memorial Hospital Medi
cal Center of Long Beach, University
of California, Irvine Center for Health
Education. This clinically oriented
conference will discuss the currently
accepted uses of hyperbaric oxygen
in plenary sessions, and will also in
clude original papers, workshops,
sound slides and scientific and com
mercial exhibits.
For further information, contact
Dr. G.B. Hart, Director, baromedical
department, Memorial Hospital Medi
cal Center, 2801 Atlantic Ave., Long
FIG. 3— Opened specimen shows in
FIG. 4— Scimitar sign-schematic re Beach, CA 90801.
tact intima compressed by mucoid sub
continued on page 589
presentation.
stance.
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Treatment of Achalasia: Esophagomyotomy
with Antireflux Procedure
J M B. N elems , md, frcs [c], J.D. Cooper , md , frcs[c ] and F.G. P earson, md, facs, frcs[c]

The results of Heller myotomy with
Belsey fundoplication in the treatment
of 32 patients with achalasia is
reviewed. Eighteen who received
no previous surgical treatment had
good to excellent results. Fourteen
patients who had undergone previous
Heller myotomy without an antireflux
procedure required further surgical
treatment. Inadequate myotomy and
reflux esophagitis were the causes of
failure. In this group four patients
who were treated by myotomy, Collis
gastroplasty and the Belsey procedure
still failed to achieve good to
excellent results. The authors conclude
that gastroplasty is contraindicated in
patients with achalasia.
On examine les resultats chez 32
patients du traitement de I'achalasie
par la myotomie de Heller avec
plicature du fundus de Belsey.
Dix-huit patients n'avaient eu aucun
traitement chirurgica! precedemment
et tous eurent d'excellents resultats.
Quatorze malades, qui avaient subi
precedemment une myotomie de
Heller sans procedure anti-reflux,
necessiterent une nouvelle intervention
chirurgicale. Les causes d'echec
furent une myotomie insuffisante et
une oesophagite de reflux. Dans ce
groupe, quatre patients traites par
myotomie, gastroplastie de Collis et
procedure de Belsey echouerent encore
dans cette tentative pour obtenir de
bons ou d'excellents resultats.
Les auteurs concluent que la
gastroplastie est contre-indiquee
chez les malades souffrant
d'achalasie.

We recognize that classic achalasia
may represent only a part of the spec
trum of primary motor disorders of
the esophagus, as suggested by VanFrom the department of thoracic
surgery, Toronto General Hospital,
Toronto, Out.
Presented at the spring meeting
o f the British Columbia
Surgical Society, Kamloops,
BC. May 2-5, 1979
Accepted for publication Mar. 5, 1980
Reprint requests to: Dr. J.M.B. Nelems,
St. Paul’s Hospital, 1081 Burrard St.,
V ancouver, BC V6Z IY6
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trappen and associates1 and Castell.2
None the less, we wish to report our
experience in the surgical management
of 32 patients with a presumed diag
nosis of achalasia. Investigators at the
Mayo Clinic, in a series of excellent
monograms,3'6 have made a compelling
argument for treating this disorder by
means of a left transthoracic longi
tudinal esophagomyotomy extending
from the esophagogastric junction distally to the level of the inferior pul
monary vein proximally, without
causing undue traction on the esopha
gus or unnecessary dissection of the
esophageal hiatus and without an anti
reflux procedure. Others,7-8 however,
have reported that the routine use of
an antireflux procedure in addition to
the modified
Heller
procedure
provides even better results. It is in
support of the latter philosophy that
we describe our experience.
Patients

preoperatively by esophageal man
ometry. The other 7 patients were
operated upon before this diagnostic
method was available. Endoscopy re
vealed esophagitis caused by food
retention in all the patients not pre
viously operated on and in six of those
who had already undergone operation.
In eight patients previously operated
on there was evidence of reflux eso
phagitis, two had ulcerative esopha
gitis without stricture and six had
stricture. All strictures were dilatable.
Operative Management

The 18 patients operated upon for
the first time underwent left thora
cotomy with esophagomyotomy that
extended from the proximal part of
the stomach to the level of the inferior
pulmonary vein. Unlike the technique
used by the Mayo Clinic investigators,
the proximal stomach was mobilized
intp the thorax to ensure that com
plete esophageal myotomy was per
formed. The hiatal hernia so created
was then formally repaired using the
Belsey technique. The lateral esopha
geal sutures were placed on one side
of the myotomized muscle.
Six of the 14 patients previously
operated on were found to have had
an incomplete distal esophageal myo
tomy. The myotomy was completed
and a Belsey repair performed.
The remaining eight patients who
had undergone previous operation
were found to have reflux esophagitis
with some degree of esophageal short
ening. They were treated by Collis
gastroplasty with Belsey fundoplica
tion.

Thirty-two patients underwent sur
gical treatment of achalasia between
1966 and 1976. They ranged in age
from 14 to 80 years (median 46 years)
at the time of operation. All com
plained of dysphagia, 6 suffered epi
sodes of pain, 12 had regurgitation of
esophageal contents and 7 had respira
tory symptoms. Fourteen of the 32
patients had undergone previous eso
phageal myotomy without an antire
flux operation. Three of these 14 patints had been operated on twice for
achalasia. Seven patients had under
gone previous pneumatic bag dila
tation without improvement in their
condition.
All patients had the radiologic fea
tures of achalasia— a smooth tapered
Results
narrowing of the distal esophagus and
no evidence of sequential peristalsis
Of the 32 patients in our study, only
in the body of the esophagus. Various 1 was lost to follow-up. The mean
degrees of esophageal dilatation were length of follow-up was 52 months.
reported; 20% had mild dilatation,
The criteria for evaluating the qual
60% had moderate dilatation and ity of the results obtained were the
20% had the radiologic appearance of same as those used at the Mayo
a megaesophagus. The radiologist re Clinic.6 An excellent result means that
ported an associated hiatal hernia in the patient became entirely asymp
three of the patients who had not tomatic. A good result implies that the
undergone previous operation and in patients were markedly improved but
six of the patients who had.
that they still had esophageal symp
Twenty-five patients were studied toms occasionally. A fair result in-
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We advocate mobilization of the
stomach to ensure adequate myotomy
and a formal repair of the hiatal her
nia so created. Partial fundoplication
of the Belsey type is probably the
repair of choice in the presence of a
myotomized esophagus. Fundoplicationof the Nissen type may be too
complete a barrier for the adynamic
esophagus to overcome.
There are several reasons for the
unsatisfactory results in the four pa
tients who underwent gastroplasty with
Belsey repair for severe reflux esopha
gitis and stricture. It is possible that
the presence of stricture predisposes
to less satisfactory results. However,
this was not the experience of Pearson
and Henderson9 in their management
of strictures by the combination of
Collis gastroplasty and Belsey fundo
plication. The more likely explanation
lies in the observation that the gastro
plasty tube functions in a fashion
similar to the lower esophabeal sphinc
ter.10 The longitudinal fibres of the
esophagus, as they fan out in the sling
fibres of the proximal stomach, are
incorporated into the gastroplasty
tube. Since the lower esophageal
Discussion
sphincter does not function normally
The Mayo Clinic series was large in patients with achalasia, it is reas
and the results were impressive. How onable to presume that the neuromus
ever, the reported results were ob cular function of the gastroplasty is
tained for patients who were treated
likewise impaired. This is the most
for the first time only. Of the 456 likely explanation for persistent dy
patients operated upon for the first sphagia in the gastroplasty tube even
time at the Mayo Clinic between though a large bougie will traverse
1949 and 1975 by esophagomyotomy the gastroplasty tube without dif
alone, 15% had fair to poor results.6 ficulty. The physiology of the gastro
The authors make no reference to re plasty segment is the focus of ongoing
peat operation for this condition. Ap studies and until this is more clearlyproximately 40% of our cases were defined it is recommended that gastro
referred, for reoperation, the patients plasty should not be used in the man
having failed to obtain satisfactory agement of patients with achalasia.
results from esophagomyotomy with
out an antireflux procedure. Incom
NOTICES
plete myotomy and reflux esophagitis continued from page 587
were the major reasons for failure.
The one poor and the three fair
Symposium on Facial
results were in patients who had un
Plastic Surgery
dergone previous esophagomyotomy
without antireflux operation. They The department of otolaryngology,
all had reflux esophagitis and sub division of facial plastic surgery, and
sequently underwent the Collis gas- extended programs in medical educa
troplasty-Belsey fundoplication. Of tion of the University of California
the 18 patients who had this combi School of Medicine at San Francisco
nation of surgery, 4 had an unsatis will present an interdisciplinary sym
factory outcome. Of the 24 patients posium in facial plastic surgery from
who had esophagomyotomy with Apr. 8-11, 1981 at The Stanford
Belsey repair there were no unsatis Court, San Francisco.
The course, designed for the sur
factory results. A substantial group of
patients were referred to us because geon who currently has an active
of failure following simple esopha reconstructive and facial plastic prac
gomyotomy without an antireflux tice, will focus on current trends and
operation. These failures could prob techniques of facial contouring. E n
ably have been prevented by complete rolment will be limited to encourage
and promote effective interaction with
myotomy with antireflux repair.

dicates that the patients continued to
have moderate symptoms but that
their overall condition was improved.
A poor result signifies that the patient
was unimproved or the symptoms
were worse. Fair and poor results
were considered unsatisfactory.
Of the 18 patients who underwent
primary surgical treatment, 1 was
lost to follow-up, 13 had excellent and
4 had good results.
Of the 14 who had undergone myo
tomy previously without an antireflux
operation, 6 underwent repeat myo
tomy with Belsey repair for incom
plete myotomy and 8 underwent gas
troplasty with Belsey repair for control
of reflux esophagitis. Of the six with
incomplete myotomy three had excel
lent results and three good. How
ever, of the eight who underwent
the Collis gastroplasty procedure,
one
was graded
as excellent,
three as good, three as fair and one as
poor. These four patients with un
satisfactory results had persistent
dysphagia not appreciably improved
by dilatation.
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the internationally known guest facul
ty: Jack Anderson, M. Eugene Tardy
and Richard C. Webster. Didactic
lectures stressing new advances will
be augmented by in-depth discussion
to ensure adequate evaluation of the
techniques presented. In addition, ca
daver dissections will be offered to a
limited number of course participants.
Preference for inclusion in the labo
ratory session will be given to early
applicants.
Roger L. Crumley and Larry D.
Schoenrock will be the program chair
men.
For further information, please
write Extended Programs in Medical
Education, University of California,
Rm. 569-U, San Francisco, CA 94143
or phone (415) 666-4251.
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BOOK REVIEWS

ACTUALITES CHIRURGICALES. 79e
congres franyais de chirurgie. I. Chi
rurgie abdominale et digestive. (Pre
miere partie). Edite par J-Cl. Patel.
160 pp. Illust. Masson, Paris; Masson
Publishing U.S.A. Inc., New York,
1978. $21, broche. ISBN 2-225-702462.

ACTUALITES CHIRURGICALES. 79e
congres francais de chirurgie. II.
Chirurgie abdominale et digestive.
(Deuxieme partie). Chirurgie experimentale. Edite par J-Cl. Patel. 161 pp.
Illust. Masson, Paris; Masson Pub
lishing U.S.A. Inc., N ew York, 1978.
$21, broche. ISBN 2-225-70400-7.
ACTUALITES CHIRURGICALES. 79e
congres franpais de chirurgie. III.
Chirurgie vasculaire et thoraeique,
orthopedic et trauinatologie. Edite par
J-Cl. Patel. 156 pp. Illust. Masson,
Paris; Masson Publishing U.S.A. Inc.,
N ew York, 1978. $21, broche, ISBN
2-225-70411-2.
ACTUALITES CHIRURGICALES. 79e
congres francais de chirurgie. IV.
Chirurgie generate, urologie-neurochirurgie. Edite par J-Cl. Patel. 215 pp.
Illst. Masson, Paris; Masson Pub
lishing U.S.A. Inc., New York, 1978.
$21, broche. ISBN 2-225-70422-8.

These four monographs are extensive
and extremely didactic. For each sub
ject there is an elaborate review of the
anatomy and surgical technique but very
few schematic representations. For in
stance, the section on the anal canal
contains four pages on anatomy but no
drawings.
The first book covers abdominal sur
gery. In a section on the treatment of
cancer of the stomach the authors con
sider the controversy between total gas
trectomy and proximal or distal gastrec
tomy. In their hands, total gastrectomy
for early cancer gave better results than
the less extensive procedures.
The surgical treatment of pancreatic
pseudocyst is reviewed. The authors
had good results with proximal pancre
atectomy but believe external drainage
procedures still have a place in the
treatment of this condition.
Anal fistulas and their problems are
covered. In the appropriate section left
colonic esophagoplasty is recommended.
The techniques and problems of an
astomosis in low anterior abdominal
resections are presented but unfortunately
the use of end-to-end anastomosis with
a stapling device, which has solved many
of these problems and probably also has
saved a few colostomies in some cases
of low-lying cancers of the rectum, is
not mentioned. Another unsolved prob
590

lem is the surgical treatment of acute
hemorrhagie gastritis.
In a discussion of severe, diffuse peri
tonitis, an interesting technique of conti
nuous irrigation of the abdominal cavity
is presented.
Also in this first book is a discussion
of sphincterectomy of the Oddi sphincter.
This appears at a time when most sur
geons avoid this technique because of
the high complication rate associated with
its use.
In the second book splenectomy, trau
matic and nontraumatic, is discussed and
its surgical complications and hema
tologic problems are reviewed. Although
the review of the complications is ex
haustive, no mention is made of
partial splenectomy and more conser
vative approaches to treatment in cases
of trauma.
A chapter on chemotherapy is in
cluded.
With respect to plication, the methods
of Noble and Childs-Phillips are re
viewed but no mention is made of other
types of plication, such as the Baker tube
plication which possibly gives a better
result.
The technique of highly selective vago
tomy is described but no representative
illustration is offered.
Many other techniques are also dis
cussed in this book, including colostomy,
ileostomy, and Whipple and esophageal
resections.
An interesting discussion is presented
on the treatment of perforated duodenal
ulcer. The authors’ method consists of
a very aggressive, nonsurgical approach
with suction, antibiotic therapy and care
ful monitoring of the patient as opposed
to traditional suturing of the ulcer or
vagotomy and drainage.
The Kraske (Localio) approach for
carcinoma of the rectum is discussed.
Choledochoscopy is described and the
advantages of this technique are con
sidered. The last portion of this second
volume is reserved for experimental sur
gery.
The third book presents discussions on
various vascular surgical techniques.
There is an extensive and interesting dis
course on lymphedema of the arm after
mastectomy, the treatment being pallia
tive.
Orthopedic trauma is covered in chap
ters that discuss shoulder dislocation,
fracture of the distal third of the radius
and dislocation of the cervical spine.
In the last volume, ablative surgery and
hormonal therapy for breast cancer are
put together. The concept of reducing
the tumour mass to allow for better
chemotherapy is considered.
Important topics such as thrombo
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phlebitis and gas gangrene are covered
in detail.
The treatment of anuria, urethral rup
ture and emergencies in neurosurgery are
also thoroughly discussed in interesting
fashion.
In summary, these books contain a
pot-pourri of good review articles that
are worth reading. Although most of the
topics discussed are of interest to gen
eral surgeons and to general practition
ers, I recommend these four volumes
particularly to surgical residents.
J acob G arzon,

md, frcs[c]

Ste. 150,
6000 Cote-des-Neiges Rd.,
Montreal, PQ
ADVANCES IN SURGERY. Volume
13, 1979. Edited by George L. Jordan,
Jr., James I). Hardy, William P. Longmire, Jr. and others. 329 pp. Illust.
Year Book Medical Publishers, Inc.,
Chicago, 1979. Price not stated. ISBN
0-8151-4917-4.

The editors of this volume of “Advances
in Surgery” continue to maintain their
standard of excellence in presenting a
variety of topics of interest to surgeons
by authors who are authorities in their
fields. The lead article by Professor
J.C. Goligher on sphincter-saving exci
sion for carcinoma of the rectum is
written in his usual lucid style and based
on extensive experience. He is objective
and honest in his approach to this con
troversial area. His paper is well illus
trated with clear sketches. He discusses
in detail the use of the end-anastomotic
stapler and comments on local coagula
tion, radiotherapy and local excision.
The article on the treatment of me
tastatic disease attempts to deal with too
many disease states in one short paper
and would have been of greater benefit
to the reader if it had included some
tabular data. The authors cover a lot
of detail in a superficial way. A table
of chemotherapeutic agents, their applica
tions, doses and toxic effects would have
been helpful. The described therapeutic
benefits and low mortality associated
with hepatic resection for metastatic
disease to the liver do not represent the
common experience.
J.F. Birk concisely updates burn thera
py and deals with various practical
aspects; this paper should be particu
larly helpful to surgical residents and
surgeons who occasionally treat burns.
The paper on prophylaxis of throm
boembolism is an excellent review of the
classic and new approaches to this prob
lem. It includes a critical analysis of the
benefits of low-dose heparin administra
tion. The bibliography is extensive and
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will be of value to those who wish to
study in this area further.
In updating colonoscopy, William I.
Wolf describes the historical aspects,
and advantages of and indications for
colonoscopy, but his main concern seems
to be colonic disease and the cancerpolyp controversy. Those readers who
hope to obtain technical tips from the
vast experience of the author may be
disappointed.
A fine cookbook approach to the treat
ment of traumatic wounds is given by
R.F. Edler and associates. It will prove
helpful to emergency physicians and resi
dents. Many of the principles outlined
are also of value in treating nontraumatic
wounds.
J.V. Town and R.E. Condon, in a
logical, well written article entitled
“Lower extremity amputations for is

chemic disease” advance the concept of
carrying out, whenever possible, belowknee amputation for end-stage ischemia
of the lower extremity. Perhaps, they
will convert those who still believe that
above-knee amutation is the best treat
ment for this condition.
The discussion of diagnoses and treat
ment of obstetric and gynecologic emer
gencies will act as a refresher course for
surgeons who will be faced with these
problems and will also be helpful to sur
gical residents.
F.H. Ellis, Jr. concisely reviews the
anatomy, pathophysiology, medical and
surgical treatment for esophageal hiatus
hernia. He describes the classic methods
and assesses the current approaches to
treatment with an overview based on
his own expertise.
In summary, the volume is well edited

and collated, providing a balanced ap
proach to a number of current prob
lems in surgery .It will be a valuable
addition to any surgeon’s library.
H arvey H. Sigman , md, frcs[c]

3755 Cote Ste-Catherine Rd.,
Montreal, PQ
CHEMOSURGERY.
Microscopically
Controlled Surgery for Skin Cancer.
Frederic E. Mohs. 378 pp. Illust.
Charles C Thomas, Publisher, Springfield, 111., 1978. $43.75. ISBN 0-39803725-6.
This long monograph represents the
life’s work of a man dedicated to a tech
nique that will find limited acceptance
by most physicians involved in the treat
ment of skin cancer. Introductory chap-

1980 DAVIS & GECK SURGICAL ESSAY AWARD

The presentation of the 1980 Davis & Geek Surgical Essay Award took place in Toronto on Oct. 1, 1980.
The winner of this year’s award was Dr. Leonard Makowka (second front right), who submitted a paper entitled “Stu
dies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation”. Dr. Makowka
is a resident in general surgery at the University of Toronto.
Mr. John W. Ployart (second from left), marketing manager of Davis & Geek, presented the award. Also present are
Dr. C. Barber Mueller (right), coeditor of the CanadianJournal of Surgery and Mr. F.J. Miller (left), teaching hos
pital representative of Davis & Geek.
The editorial board and the coeditors of the Canadian Journal of Surgery thank Davis & Geek for providing this
award. They extend their congratulations to Dr. Makowka and their thanks to those who participated in the 1980
competition.
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Ls t h e treatment of the pa p
~ent in shock has progressed
in recent years, various organ
systems have, in turn, been
the “ weak link’’ limiting
recovery. The deterioration
often becomes apparent first
in the kidney where disrup
tion o f cellular metabolism
causes acute tubular swelling
Ljsputpnesulting o ligu rE jl
Soon, the pulmonary vascu
lature begins to exhibit a
pattern o f interstitial oedema,
pooling o f blood in the stag
nant microcirculation and
aggregation of the formed ele

ments o f the blood. Diffusion
of oxygen from the alveoli is
greatly decreased, commonly
resulting in arteriovenous
shunting - a phenomenon in
which blood passes through
the lung without oxygenation.
If the shock state continues,
lysosomal enzymes in the
anoxic pancreas trigger the
release o f myocardial depres
sant factor (MDF), a vaso
active peptide which can
cause further deterioration of
the microcirculation.

Although cerebral blood flow
is maintained early in shock
at the expense o f the other
organs, this state of adequate^
perfusion does not persist for
long. Relatively soon, avail- «
able oxygen becomes crit^
ically low, and the brain, too,
turns to anaerobic metabo
lism. Lactate acid levels rise
and fluids leakjjitp the in- ^
testitial spaces. Continued
y
oxygen deprivation threatens
both the cellular integrity of
the brain and the central ner
vous system function.
Once shock has progressed >
beyond its early stage, fluid
administration alone is usu- ~

severe shock threatens each link in the
body’s chain o f organ systems
Solu-Medrol exerts a protective effect on the cell
to preserve tissue function and increase survival rates
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Solu-Medrol

(methylprednisolone sodium succinate)
Action:

Solu-Medrol, like other corticosteroids, exerts its action
by its anti-inflammatory effect.
Indications and Clinical Uses:

Intravenous administration of Solu-Medrol is indicated
in situations in which a rapid and intense hormonal
effect is required.
Shock:

In severe shock adjunctive use of intravenous methyl
prednisolone sodium succinate (Solu-Medrol) may aid
in achieving hemodynamic restoration. Corticoid
therapy should not replace standard methods of
combating shock, but present evidence indicates that
concurrent use of large doses of corticoids with other
measures may improve survival rates. In particular,
large pharmacological doses of Solu-Medrol have been
proven useful in bacteremic or endotoxin shock,
hemorrhagic shock, traumatic shock, and cardiogenic
shock.
Contraindications:

Except when used for short-term or emergency therapy
as in acute sensitivity reactions, Solu-Medrol is
contraindicated in patients with arrested tuberculosis,
herpes simplex keratitis, acute psychoses, Cushing’s
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:

Existence of diabetes, osteoporosis, chronic psychoses,
active tuberculosis, renal insufficiency or predisposition
to thrombophlebitis requires that Solu-Medrol be
administered with extreme caution. In the presence of
infection, the causative organism must be brought
under control with appropriate anti-bacterials, or
therapy with Solu-Medrol should be discontinued.
While therapy with corticoids does not appear to be
contraindicated in pregnancy, caution is recommended,
particularly during the first trimester. Also, newborn
infants of mothers who received such therapy during
pregnancy should be observed for signs of hypoadrenalism and appropriate measures instituted if such
signs are present. Since Medrol, like prednisolone, sup
presses endogenous adrenocortical activity, it is highly
important that the patient receiving Solu-Medrol be
under careful observation, not only during the course
of treatment but for some time after treatment is
terminated. Adequate adrenocortical supportive
therapy including ACTH, must be employed promptly
if the patient is subjected to any unusual stress such as
surgery, trauma, or severe infection. Patients should be
advised to inform subsequent physicians of the prior
use of Solu-Medrol.
There have been a few reports of cardiovascular
collapse associated with the rapid intravenous admini
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause
and relation to other medications (i.e., diuretics) is not
known at this time, but physicians should be alert to
this possibility.

Adverse reactions are not likely to result from short
term intravenous administration of Solu-Medrol, but
may be anticipated if continued therapy with oral or
intra-muscular corticosteroid preparations is to follow.
Medrol has less tendency than prednisolone to induce
retention of sodium and water, and in some cases has
been observed to produce diuresis and an increased
excretion of sodium. Likewise, therapy with Medrol
appears to produce less nervousness and psychic
stimulation than that produced by prednisolone. While
epigastric distress has not been totally lacking in
patients receiving Medrol, the incidence and severity of
this side reaction to date suggest that although Medrol
has an enhanced anti-inflammatory potency when com
pared with prednisolone on a weight basis, the socalled ulcerogenic potential of this corticosteroid is no
greater, and may even be less, than that of
prednisolone.
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Symptoms and Treatment of Overdosage:

Single large doses of Solu-Medrol do not have any
apparent toxic effect and require no specific therapy.
Continuous overdosage would require careful gradual
reduction of dosage in order to prevent the occurrence
of acute adrenal insufficiency.
Dosage and Administration:

In treating severe shock there is a tendency in current
medical practice to use massive (pharmacological)
doses of corticosteroids. The following are Solu-Medrol
doses suggested by various authors:
Author

Dose

Repeat

Oaks
Weil
Melby
Cavanagh
Dietzman

100 mg
200 mg
250 mg
15 mg/kg
30 mg/kg

Every 2-6 hours
100 mg. every 4-6 hours
Every 4-6 hours
Every 24 hours
In 4 hours if needed

Therapy is initiated by administering Solu-Medrol
intravenously over a period of at least 10 minutes. In
general high dose corticosteroid therapy should be
continued only until the patient’s condition has
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose
short term corticoid therapy are uncommon, peptic
ulceration may occur.
In other indications initial dosage will vary from 10 to
500 mg depending on the clinical problem being
treated. The larger doses may be required for short
term management of severe, acute conditions. The
initial dose usually should be given intravenously over
a period of at least 10 minutes. Subsequent doses may
be given intravenously or intramuscularly at intervals
dictated by the patient’s response and clinical
condition.
Availability:

As Solu-Medrol (methylprednisolone sodium succinate)
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials
with water for injection.
Product monograph is available on request.

Adverse Reactions:

With the exception of the differences noted in the
preceding paragraph, Medrol is similar to hydro

cortisone and prednisolone in regard to the kinds of
adverse reactions and metabolic alterations to be
anticipated when treatment is intensive or prolonged.
Negative nitrogen balance is usually counteracted by a
high protein intake. In patients with diabetes mellitus,
Solu-Medrol may increase insulin requirements during
the period of administration. Ecchymotic manifesta
tions, while noted only rarely during the clinical
evaluation of Medrol, may occur. Excessive loss of
potassium is not likely to be induced by effective
maintenance doses of Medrol. If such reactions are
serious or distressing to the patient, reduction in
dosage or discontinuance of corticoid therapy may be
indicated. While a retardant effect on wound healing is
seldom encountered, except in high doses, it should be
a matter of consideration when Solu-Medrol is admin
istered in conjunction with surgery.

References:
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2. Lillehei RC, et al (1974) In Principles o f Surgery.
2nd Ed. Schwartz SI (Ed), p 133
3. McConn R (1972) Shock in Low- and High-Flow
States. Exerpta Medica, p 28
4. Webb WR (1977) The Organ in Shock. A Scope
Publication, p 16
5. Lefer AM (1974) Circ Shock, 1: 165
6. Lieberman A, et al (1977) J Neurol Neurosurg
Psychiat, 40:678
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ters are devoted to a description of the
technique and its applications. Chemosurgery is defined as the removal of
malignant, gangrenous or infected tissue
by chemical fixation, followed by ex
cision of that tissue in layers, comple
mented by the concurrent examination of
microscopic frozen sections to ensure
complete removal. The technique is
based on the premise that the surface
extent of skin cancers and other cuta
neous lesions bears no relation to their
surface appearance and dimensions.
The author coined the term “chemosurgery” in 1936, and the first of his
more than 60 publications on the subject
appeared in 1941. The concept is entirely
empirical and originated while he was
doing experimental work on the dif
ference between inflammatory response
of normal and malignant tissue in rats.
One of the inflammation-inciting agents,
20% zinc chloride, was observed to
produce fixation in situ of tissues with
preservation of histologic architecture.
The author adapted this work to the field
of clinical dermatopathology and thus
set the stage for a career devoted to
chemosurgery.
Following the introduction, the use of
chemosurgery in treating basal cell car
cinoma, squamous cell carcinoma and
malignant melanoma is described in an
unnecessarily ritualistic and detailed
manner. Application of the technique to
such benign conditions as cutaneous gan
grene and various dermatoses is also
covered. The author’s theoretical basis
for this rather controversial form of
therapy is not clear.
Any surgeon familiar with the man
agement of basal cell carcinoma would
be put off by the description of the
primary management of a 1-cm basal
cell carcinoma of the nasal bridge. The
painstaking and protracted procedure
involving multiple quick sections takes
approximately IV 2 hours. The author
then describes healing by second inten
tion of the large defect over a period of
several weeks and notes that the patient
is free of recurrence 4 years later. The
cosmetic result is illustrated by a photo
graph taken at what can only be termed
a “questionable angle”. Plastic surgeons
can only sympathize with the unfortunate
patient who might have undergone exci
sion and reconstruction with a small
glabellar flap taking less than 20 minutes
of the patient’s time.
Dr. Moh’s thesis appears to be that
because a small percentage of malignant
cutaneous lesions have an “iceberg” con
figuration, and therefore tend to recur
if not adequately excised, all should be
treated by his time-consuming, laborious
and therefore expensive technique. The
fact that the chapter on the treatment
of gangrene of the extremities by chemosurgical techniques was left to the end
may be no accident. Had it appeared
earlier, readers with the most rudi
mentary knowledge of modern concepts
of wound healing and surgical technique
would have read no further.

THE CANADIAN JOURNAL OF SURGERY

The book is not without merit. The
chapter on modes of spread of cancer
demonstrates the author’s familiarity with
the unpredictable tendency of certain
cutaneous malignant lesions to spread
along or be turned aside by various
tissue planes. The chapter on nonchemosurgical management of nonmalignant
growths, while of interest, would seem
to be outside the scope of this book.
The bibliography contains 177 ref
erences of which more than one third are
to works of Dr. Mohs himself.
G. A llan T aylor ,

dds , m d , f r c s [c ]

Plastic surgeon,
Ottawa Civic Hospital.
Ottawa, Ont.

MODERN HOSPITAL. International
Planning Practice. Ervin Putsep. 668
pp. Illust. Lloyd-Luke Ltd., London,
1979. Price not stated. ISBN 0-85342141-4.

Despite the constraints of budgetary
controls, hospitals continually strive to
maintain the three basic principles: provi
de good patient care, promote of
medical education and foster clinical and,
if possible, basic research. In a new hos
pital milieu, improvement in all these
areas can best be promoted by expert
planning in hospital design and function.
Furthermore, planning must take into
consideration the community in which
the hospital will be built and the needs
it must satisfy.
Ervin Putsep’s opus is a comprehen
sive and almost encyclopedic resource in
the field of hospital planning. His great
experience and knowledge in the field

are obvious from the factors taken into
account in his detailed recommendations.
All aspects of health care—economics,
patient needs, medical roles, etc. are de
scribed according to the needs of a
modern institution, demanded by conti
nuing advances of medicine in a modern
society. The book covers almost all
aspects that must be considered in to
day’s hospital design, such as hospital
infection, environment, installations, tech
nology, to mention but a few. Data
processing methods in laboratories and
patient areas are discussed and described
as necessary adjuncts to efficient adminis
tration, not only for present needs but
also future developments which must
anticipate obsolescence.
The author has taken into considera
tion the newer concepts of hospital care
—so-called general care and specialized
care of a comprehensive university hos
pital type. In his discussions, Putsep
has consulted an extensive bibliography
supporting his thoughts and considera
tions. His discussions of the economics of
health care and attitudes to health and
preventive medicine are most interesting
and thought-provoking. The paragraphs
on nursing are most timely in that they
criticize constructively the role of the
nurse, a role that she is trying to define
in the midst of her own identity crisis.
Planning, design, statistics, norms and
so on are explored in fair detail. Costbenefit construction and function, trans
portation systems for patients and goods
are discussed and evaluated. Routes of
hospital infection and preventive meas
ures are described in detail. The author
presents general considerations but goes
into detail where necessary, for example,
in the description of operating theatres,

intensive care areas and laboratories.
Various types of illumination are de
scribed and compared. The importance
of noise abatem ent and background
music in v ario u s hospital areas are
discussed and the effects considered. The
importance o f proper ventilation is
stressed.
Apart from his excellent recommenda
tions regarding present and future tech
nical needs in the hospital, the author
comments in some detail on the patient
as an individual and on necessity of
planning for his privacy and comfort.
Quality of ca re must be appreciated in
all planning considerations.
Laboratory services, surgical centres
and radiology facilities, including radio
therapy and scanning, are treated in ex
cellent detail and contain much valuable
information for the hospital planning
team.
Emergency and outpatient areas are
described and delineated with recom
mendations for traffic control, trans
portation and other factors.
This volume is an excellent compen
dium of facts and information. Almost
all aspects of hospital planning and de
sign are covered. The author’s great
knowledge, research and experience are
evident throughout this impressive book
which will be valuable not only to hos
pital planners and administrators but
also to those charged with the reponsibility of designing and constructing
a modern facility. This book would
be an important addition to the hos
pital library.
W il l ia m

R. S l a t k o f f ,

md

156 Melbourne Ave.,
Montreal, PQ

Critique of Items 539-542 (SESAP III)
Distinctive antigens and chemical products are identified with growing and metastatic neoplasms, and
increasingly sensitive and accurate assays permit quantitation of these substances. Correlating their
values and directional change with the size (bulk) and activity of the related neoplasms has improved
the ability to predict how successfully operation, radiation, or adjunctive chemotherapy are control
ling the progress of the disease.
a-Fetoprotein levels have been correlated with both hepatoma and malignant teratomas. Calcitonin
levels are directly related to the activity of medullary carcinoma of the thyroid gland, which occur in
conjunction with pheochromocytomas (MEA-II syndrome). Excretion of 3-methoxy-4-hydroxymandelic acid
(VMA) is an established screening test for pheochromocytoma, and urinary or serum catecholamine levels
can be specific in this diagnosis. 5-HIAA is a metabolite of serotonin which can be elevated in metastatic
carcinoid. As additional means are sought to chart the course of neoplastic disease, and as we discover more
about the altered chemistry of neoplastic cells, other products that may be predictive of specific cell activity
will be added to this list.
539

E

540

B
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As a further service to its readers the Canadian Journal of Surgery is pleased
to accept suitable classified advertisements. The deadline is 1 month before
the issue date. Copy should be mailed to: Canadian Journal of Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8. Rates are available on request.
Ayerst Laboratories
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Calmic Inc.
Neosporin
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Ti-Cron
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Endo Laboratories
Percocet
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With the expansion of the medical school
undergraduate enrollment, and the comple
tion of the Acute Care Unit of the Health
Sciences Centre Hospital on this campus,
positions w ill become available within the
Department of Surgery during 1981. Appli
cants should have obtained their Fellowship
of the Royal College of Physicians and
Surgeons of Canada, or hold a comparable
qualification; be eligible for registration by
the College of Physicians and Surgeons of
British Columbia; and have demonstrated
an ability for research and clinical care of
patients, as well as experience in teaching.
Appointments w ill be either Geographic fu ll
time. or part-time. Rank and salary w ill be
according to experience and qualifications.

With the expansion of the medical school
undergraduate enrollment, and the comple
tion of the new Children's Hospital, a
position w ill become available within the
Department of Surgery during 1981. Appli
cants should have obtained their Fellowship
in the Royal College of Physicians and
Surgeons of Canada in Cardio-vascular and
Thoracic Surgery, and be eligible for regis
tration by the College of Physicians and
Surgeons of British Columbia. The applicant
must have a proven record in clinical re
search and a strong interest in pediatric
and adult cardio-vascular and thoracic inten
sive care organization and applied research.
Rank and salary w ill be according to expe
rience and qualifications.

Applications, accompanied by a curriculum vitae, and
requests for further information should be sent to:
Ethicon Sutures Ltd.

The Head, Department of Surgery
Faculty of Medicine
700 West 10th Avenue
Vancouver, B.C. V5Z 1L5
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Inside Back Cover
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Glaxo Laboratories
Zinacef
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Hoffmann-La Roche Ltd.
Nipride
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Norwich-Eaton Pharmaceuticals
Vivonex
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Ross Laboratories
Ensure

CARDIOVASCULAR THORACIC
SURGEON

SURGEON

FELLOWSHIP GENERAL SURGEON
needed in Vanderhoof, BC
Get away from the competition of city
practice. Come to a small town in the out
door paradise of the interior of British
Columbia. Practise your science with chal
lenge and commitment.
This is a well-established practice with a
wide ranging area. New 65-bed hospital with
a well-equipped operating room. Partnership
is available.
If you are interested please contact:

Dr. C. H. Stephen or Dr. G. C. Joly
R.R. # 2 , Vanderhoof, BC V0J 3A0
or telephone: (604) 567-2201

Applications are invited for appointment
to the University of Western Ontario, Depart
ment of Surgery, Division of Cardiovascular
and Thoracic Surgery.
Applicants must have a record of special
competence in cardiovascular research and
arrythmia surgery. Certification by the Royal
College of Physicians and Surgeons of
Canada, and eligibility for licensure in Onta
rio are essential. This geographic full-time
appointment w ill be at the University Hospi
tal. London, Ontario, Canada.
Applications should be submitted to the:
Chairman, Department of Surgery, The Uni
versity of Western Ontario, London, Ontario,
Canada, N6A 5A5. Closing date for receipt of
applications is December 31. 1980
— S80-001
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SACKVILLE MEMORIAL HOSPITAL
Sackville, New Brunswick, Canada
Roussel Canada Inc.
tdarac
560, 561, 562
Sofra-Tulle
526 , 527

Smith & Nephew Inc.
Flamazine

540, 541

Upjohn Company of Canada, The
Dalacin C
504, 505, 506
Gelfoam
512, 513
Solu-Medrol
592, 593, 594

596

GENERAL SURGEON
Applications are invited from medically qualified
Practitioners to serve as a General Surgeon and to
associate with six General Practitioners and an Intern
ist, in a University town having a 60 bed accredited
hospital, serving a population of 12,000. Vacancy due to
recent death of surgeon. Duties would commence as
soon as possible. Submit resume, credentials, refer
ences and telephone contact to:
Dr. B. E. W. Barnhill, Secretary, Medical Staff
P.O. Box 29
Sackville, New Brunswick, Canada, E0A 3C0
Telephone: (506) 536-0128
— T017
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